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CHAPTER I 
INTRODUCTION 
Tn5253 (formerly called as the Ocat-tet element or the BM6001 element) was 
identified as a part of the chromosome of the clinical isolate, Streptococcus pneumoniae 
BM6001 (176) .. It is a 65. 5kb long site-specific conjugative transposon carrying the 
antibiotic resistance determinants for chloramphenicol and tetracycline (208). By 
inserting heterologous DNA at various sites within the transposon, Vijayakumar, et al. 
(208).have generated a detailed restriction map of the entire transposon. Earlier work 
indicated that Tn5253 is a composite transposon consisting of two independent 
conjugative transposons, a smaller one named Tn5251 and a larger one named Tn5252 
(7). The.smaller element, Tn5251, carries the antibiotic resistance determinant for 
tetracycline and is I Sc.kb in size. It is a member of the Tn916 family of transposons. 
Like Tn916, Tn5251 can.conjugally transfer from one cell to another and can integrate at 
multiple target sites. The point of insertion ofTn5251 withinTn5252 is in the middle 
region. Tn5252 is a 47.5kb long conjugative transposon that carries the antibiotic 
resistance determinant for chloramphenicol. The genetic integration ofTn5252 is site-
specific. The unique target site of Tn5252 in pneumococcus is identical to that of its 
parent element (Tn5253) (7). Earlier work has shown that the cat (chloramphenicol 
1 
acetyl transferase) gene, located in the middle of Tn5252, is flanked by IS-like 
elements. This accounts for the spontaneous curing of the cat gene. The observation 
that Tn5251 and other IS (Insertion Seguence)-like elements integrate within the middle 
region ofTn5252 seems to suggest that Tn5252-like elements could auto-accumulate 
resistance genes or other transposons. Tn5252 is the prototype of the larger composite 
conjugative transposons. A functional map of the transfer-related regions of the 
transposon has been generated (97). The nucleotide sequences of the target, the right, 
and the left termini have been obtained (206). ·. Two proteins that are involved in the 
transfer process have been purified and their activity identified (188, 189). An operon 
consisting of genes encoding transport proteins has been identified (1, 2). 
Previous studies have indicated that the left and the right ends of the transposon 
are important for the conjugative transfer process. Since no structural or functional 
information of the right end of the element was available, this work was initiated to 
investigate the right junction region of the conjugative transposon Tn5252. Analysis of 
the 3 .27.,kb Eco RI right junction fragment of the transposon demonstrated the presence 
of a DNAcytosine-methyltransferase gene that has been shown to be functional. 
Presence of DNA methyltransferases in a variety of gene transfer systems has been 
reported. The role ofDNAmethylation inthese systems will be described briefly. 
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(a) Regulation of Gene Expression: 
Methylation has been shown to play a very important role in controlling the 
transposition frequency of some transposons. 
TnlO: 
TnJO is a compound transposon found in Escherichia coli. It carries the 
antibiotic resistance determinant for tetracycline: Tnl O is flanked by ISJ O on both ends 
and the two IS elements are in an inverted orientation relative to one another. ISJ 0-
Right is a fully functional insertion sequence that is capable ofindependent transposition 
(157). ISJO-R carries a transposase gene that reads from outside-to-inside. To promote 
transposition ofTnlO, the transposase protein can·act on the outside ends of both IS 
elements (ISJO-'R and L). The protein can also act on one outside end and one inside 
end and promote thetransposition ofISJO. To promote chromosomal rearrangements, 
the protein can act on two inside ends (58). Transcription of the transposase gene has 
been shown to be infrequent (151,179). It has also been shown that the translation of 
the transposase transcript is very inefficient (178). In someE. coli mutants Roberts, et 
al. ( 15 7) observed an increase of 10-20. fold in Tnl O transposition.. Subsequent analysis 
revealed that these effects were due to mutations in the dam gene. There are two dam 
sites (GATC) in ISJO, one site overlaps the -10 region of the transposase promoter, and 
the other is at the other end ofISJO at the inner terminus. Methylation at the promoter 
region decreases the transcription of the gene .. Methylation at the inner terminus 
decreases the ability of transposase to utilize these ends for transposition or 
3 
rearrangement. It has been shown that the promoter and the inner terminus of the IS 
element function coordinately (99). Absence of methylation results in increased activity. 
Bemimethylated species methylated at both·sites on the template strand are much more 
active than that methylated on the non-template strand (99). These and other relevant 
observations suggest that IS10 preferentially transposes when the element is in an 
unmethylated or a transiently hemimethylated state. Thus, the tqmsposition of TnJ 0 
occurs when the replication fork just passes through or after conjugal transfer, during the 
complementary. strand synthesis . 
. Tn5/fn903: 
Tn5 is a compound transposon that carries the gene for kanamycin resistance. It 
is very similar to TnlO. Tn5 is flanked by IS50-R and IS50-L. As in TnlO the two IS 
elements are in an inverted orientation relative to one another. Tri5 also has dam sites at 
similar positions that are regulated by dam methylation (222). Hemimethylation 
activates the transposition activity (51,134). Another element, Tn903, which has only 
O":e dam site in the promoter region of the tran~posase (157), has also been shown to be 
regulated by dam methylation (99). 
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Bacteriophage Mu mom gene: 
The mom (modification ofMu)gene product modifies the adenine in the 
sequence 5'.,(G/C)A(C/G)NPy-3' and the modification leads to the formation of N6-
carboxy.:methyladenine (93). The modified DNA is prntected against Type I and II 
restriction endonucleases. This modification is toxic to the cell. Thus, the expression of 
this gene is very efficiently controlled and limited to a short interval late in the 
development of phage. Mu. Expression of the mom .gene requires the host Dam function. 
There are three dam recognition sites upstream of the mom promoter regi~n (192) and 
methylation of tllese three sites stimulates the expression of mom gene about 20-fold 
(74). If one or more of the GATC sites are removed, the transcription of the mom gene 
becomes dam independent (146). However, Dam methylation has been shown not to be 
the only regulator of ~xpression of the mom gene (93). 
Bacteriophage Pl ere gene: 
The ere gene of Pl produces a site-specific recombinase (Cre) that promotes 
recombination at the loxP sites. Cre is required in at least two stages of the P 1 life cycle: 
(a) immediately after infection, to avoid degradation of the terminally redundant linear 
phage DNA. (b) After replication, for efficient partitioning of Pl monomers into the 
daughter cells. The ere gene has three relatively weak promoters, P 1 ere, P2cre, and 
P3cre. Pl ere is the most upstream of the three and has two dam sites in its -35 region. 
Expression of ere from this promoter is increased 3-4 fold in a dam mutant strain (192). 
5 
P2cre has one dam site in its -35 region and there is no difference in expression between 
a wild-type E. coli and dam mutant. P3cre has no dam sites in its promoter region. 
Immediately after. injection of the P 1 DNA, the promoters are in an unmethylated or a 
hemimethylated state. During this time the ere gene is rapidly transcribed and Cre is 
made in abundance. Cre protein binds to the loxP sites and circularizesthe phage DNA, 
thus avoiding degradation of the ends. Subsequent methylation decreases the extent of 
transcription but a low level of transcription has been shown to be enough for the 
partition process (192). 
Bacteriophage Pl pac cleavage: 
The packaging of bacteriophage Pl DNA into thecapsid is initiated by cleavage 
at a unique site called the pac site. Packaging proceeds in one direction from the cut end 
until a headful of DNA has been packaged, usually more than one monomer. This 
headful packaging mechanism ensures a terminal redundancy. An important step in the 
packaging process is cleavage at one, at most, a few pac sites per concatemer. If each 
pac site were cut at the same time then monomers would result and there wouldn't be a 
terminal redundancy. The pac site has been localized to a 150:..160 hp segment of DNA 
that contains seven dam methylation sites, three at one end and four at the other (193). 
Deletion of either one or both ofthe clusters inactivates the pac site. Moreover, 
unmethylated pac sites are insensitive to cleavage. Sternberg and Coulby (193) have 
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shown thatPl codes for its own Dam-like methylase. During the early stages of 
infection, the replicating DNA is not completely methylated and so the pac sites are 
unavailable for cleavage. Later in the infection some of the pac sites become methylated, 
due to the expression and action of the phage encoded methylase. As soon as some of 
the pac sites are methylated, the pac site is available for cleavage and the process of 
packaging itself blocks further cleavage of the pac sites in the same concatemer (193). 
(b) Anti-Restriction: 
A number ofbacteriophages that have the ability to infect E. coli, Salmonella, 
Shigella, and Bacillus species, have a variety of mechanisms by which they overcome the 
restriction activity of the hosts. The presence of unusual bases in the genome of the 
infecting bacteriophages has been shown to provide resistance to restriction (15, 16, 75). 
Proteins that can inhibit the restriction activity of the host have also been isolated (127, 
128). Bacteriophages T3 and T7 have developed an.efficient mechanism for anti-
restriction, they contain.the gene 0.3 that codes for the Ocr protein. Ocr has been shown 
to bind the type-I restriction enzymes (105) and inhibit the restriction and the 
modification activities (10,106, 187). In addition to Ocr, T3 (but not T7) also codes for 
an S-adenosylmethionine (AdoMet) hydrolase (196). Thus, T3 proteins not only block 
· type-I restriction but also inhibit type-In restriction, as AdoMet has been known to 
stimulate type-III restriction activity. 
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Phage 'A also has an anti-restriction mechanism specific for type-I RIM system. 
The anti-restriction protein '·'Ral'' has been shown to reduce restriction. Its primary 
effect has been shown to be stimulatingthe methylationofunmodified DNA(105), a 
reaction which has been known to be very inefficient in type-I RIM systems. Recent 
studies have confirmed that Ral stimulates the modification activity of both the 3-subunit 
restriction enzyme and the 2-subunit modification enzyme (124). 
Sequence biases in the phage DNA have also been shown to be a mechanism by 
which the host-encoded restriction is avoided (21, 86, 118). · This is clearly demonstrated 
by phage T7. The estimated number of sites for the two host-encoded Dam (GATC) and 
Dem (CCA/TGG) restriction-modification (RIM) systems are 114 and 56, respectively 
(170). However, only six Dam sites and five Dem sites (52) have been shown to be 
present in this. phage. This indicates that selection was directed against these sequences 
as the presence of these sequences was disadvantageous for the.production of phage 
particles. Selection against Dam sites and other restriction enzyme recognition sites in 
the genomes of other phages that infect members of the family Enterobacteriaceae have 
also been demonstrated (133,174). In some cases, the presence of few recognition sites 
of certain restriction enzymes can be tolerated as they do not lead to restriction. For 
example, in the phages T3 and T7 there are very fewEcoRII sites and these are not 
restricted. The restriction enzyme requires at least two sites in close proximity for 
restriction and in the case of T3 and T7 they are far away for any restriction (107). 
Another mechanism by which phages avoid host-encoded restriction is by 
specifically modifying certain bases with the help of modification methylases that they 
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encode. This increases the ability.of the phage to infect the host effectively as the· 
modified base makes the DNA resistant to cleavage by the host-encoded restriction 
enzyme. A variety of temperate phages ofBacillus code for such modifying enzymes. 
These enzymes have been well characterized. If the phages have to infect a host 
effectively then they have to modify the bases that the new host's restriction 
endonuclease would recognize. To accomplish this, the phages of Bacillus code for 
multi-specific methylases thatrecognize more than one target site and modify the 
cytosines in them. For example, the Bacillus amylo/iquifaciens phage H2, which codes 
for a methylase (M.H2II), methylates the target sequence GGATCC at the 5'-cytosine 
residue, which is also the recognition sequence of the host-encoded restriction system 
(BamHI) (43). The methylation by the B. subtilis phage <j>3TII- and pl ls encoded 
methylases that modify TCGA overcomes the restriction potential of the BsuMI system 
(PyTCGAPu) (22, 88). The methylation of GGCC by different phages (SPR, SpJ3, <j>3TI, 
p 11 s, p 11 b, and H2) prevents the restriction by BsuRI ( GGCC). The SPR phage-
encoded methylase (M. SPR) modifies the 3' cytosine in CCGG, and this modification 
protects the sequence from BsuFl restriction (CCGG). There are othermethylation 
specificities identified in the suite of phage methylases that correspond to no known host 
restriction-modification specificities{l43). It is very likely that these specificities are 
directed towards other phage sensitive bacteria that might have as yet unidentified 
restriction-modification systems that match these specificities. 
Hill, et al. (77) have demonstrated the presence of a DNA methyltransferase gene 
in the genome of L. lactis phage <!>50. They have also shown that this was probably 
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picked up recently from a plasmid as a 1.3-kb of DNA sequence of the phage coding for 
the methylasewas identical to that of the plasmid. Conjugative plasmids in the 
incompatibility groups I and N have also been shown to code for anti-restriction 
functions. This anti-restriction activity coded by the ardgenes has been shown to be 
directed towards type-I RIM systems. Theard genes were located nearthe origin of 
transfer and they are expressed very early in the conjugation process in the recipient (12, 
13, 49, 55, 154). 
The presence of a DNA CS-cytosine methyltransferase in Tn5252 could account 
for an observation made by Guild, et al. (64), several years ago. They observed that the 
transfer of a plasmid, plP501, from Rx 1, a null strain lacking both the restriction and 
modification genes of Dpnll system (forDiplococcus pneumoniae)was restricted in a 
Dpnlt recipient (as compared to a Dpnff recipient) whereas the transfer of the Tn5253, 
from the same donor cell to the Dpnlt host was not. However, the chromosomal DNA 
isolated fromthe host harboring Tn5253 was sensitive to DpnII. This suggested that the 
transposon was not subjected to restriction during conjugation. This lack of restriction 
of the transposon was interpreted to mean either one of the following two things: (a) 
during the mating, only one strand is transferred or (b) the DNA is in a protected state 
during the transfer process. 
As mentioned previously, bacteriophages and some conjugative plasmids have 
been found to carry methyltransferase genes to protect their DNA from the host-encoded 
restriction systems during infection or transfer. Although transposition of some 
transposons have been shown to be controlled by host-encoded methylases. Tn5252 is 
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the only transposon shown to encode a methylase. A thorough investigation of this 
methyltransferase would help us understand if this gene is involved in regulating the 
conjugal transfer process and determine if it. is responsible for the anti-restriction 
reported by Guild, et al. (64). 
Specific aims 
.. •· 
1. To obtain the sequence of the rightjun~tion 3.27 kb EcoRI fragment of DNA 
. . ; . 
,·. . ' . . ' ·. . . . . 
between coordinates 46.4 and 49.7 ofTn5252 and study the structural organization 
ofthis region. ·· 
2. To analyze the DNA sequence fotopen reading frames (ORFs), sequence 
similarities, and identify the role(s) of on~ or more of the genes by site"-specific 
mutagenesis. 
3. To purify the gene prnduct(s) of one or more of the genes for,structural and 
functional studies. 
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CHAPTER II 
LITERATURE REVIEW 
The Organism: Streptococcus pneumoniae 
S. pneumoniae is a Gram positive,. lancet-shaped diplococcus that belongs to the 
family Streptococcaceae. It is non-sporeforming and non-motile. S. pneumoniae is a 
facultative anaerobe and the main product of its metabolism is lactic acid. It is catalase 
and peroxidase negative and has very complex nutritional requirements. This organism is 
carried in the upper respiratory tract of many healthy individuals. The immune status of 
the individual at the time of colonization and the virulence of the infecting strain 
determine whether the strain remains confined to the nasopharynx or becomes invasive. 
S. pneumoniae was first isolated in 1881 from human saliva by Pasteur and 
Sternberg in independent studies (91). Since then, it has been extensively studied. These 
studies led to the important scientific discoveries of Avery, et al. in 1944 (5). In spite of 
extensive research on this organism, a· comprehensive list of all its virulence factors is far 
from complete (3, 90). 
S. pn<;umoniae still remains one of the leading causative agents of bacterial 
pneumonia and bacteremia. It is the second most frequent causative agent of bacterial 
meningitis (46) and otitis-media (141), after Haemophilus influenzaetype b. The 
incidence of pneumococcal infections is highest in infants under two years of age and in 
people over 60.years of age. Each year, in developing countries a large number of 
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children under the age of five years die due to pneumococcal pneumonia. In the last four 
decades mortality due to pneumococcal bacteremia has remained stable between 25 and 
29% of all the deaths due to dieseases (3) in spite of the availability of antibiotics. 
Drug Resistance in S,. pneumoniae 
Pneumococcus remained susceptible to most of the antibiotics during the early 
post-antibiotic era, in spite ofisolation of a sulfonamide-resistant strain as early as 1939 
(70). Sulfonamide resistance was found to be linked to mutationsat a chromosomal 
locus (81, 82). Tetracycline resistance appeared in clinical isolates in 1963 (57), · 
followed by penicillin resistance (72), and resistance to MLS (Macrolide, Lincosamide 
and StreptoGramin) antibiotics (50) in 1967. Further investigations revealed that 
penicillin resistance was not due to the production of J3-lactamase (159) but due to 
accumulation of chromosomal mutations that confer stepwise resistance (223). 
Resistance to MLS antibiotics was found to be due to the erm gene whose product 
methylates the 23S subunit of the ribosomal RNA (213). Chloramphenicol resistance, 
due to.the production of chloramphenicol acetyltransferase(which detoxifies 
chloramphenicol), was reported in 1970 (47, 138). In 1977, kanamycin resistance, due 
to the production of aminoglycoside 3 '-phosphotransferase was reported (26). In the 
1970s, there was a dramatic appearance of multiply-resistant pneumococci in South 
Africa (87), Paris (47) and Japan (138). All these clinical isolates were resistant to 
chloramphenicol and tetracycline at very high levels. One such strain isolated from a 
patient suffering from sinusitis in Paris was the strainBM6001 (47). 
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Source of Antibiotic Resistance 
Antibiotic resistances have often been shown to be carried on R-plasmids. 
Several observations led to the possibility that Cm\ Tcr antibiotic resistances of strain 
BM6001 could also be due to the presence of such plasmids. The observations were: 
. . 
(i) Chloramphenicol, erythromycin and. kananiycin resistance determinants of clinical 
isolates of pneumococcus were similar to the plasmid-encoded resistance determinants of 
Staphylococci and other Streptococci(181). 
(ii) BM6001 and the strain from Japan, N77, both were found to contain inducible 
chloramphenicol acetyltransferase activity like the· ones often associated with plasmids.· 
. . 
(iii)Dang-Van, et al. ( 47) found that following growth in ethidium bromide medium, 
BM6001 segregated chloramphenicol-sensitive variants at a frequency approaching 10-3 
CFU/ml j but these remained Tcr. 
(iv) The DNA from BM6001 transformed laboratory strains to chloramphenicol 
resistance only at a very low frequency and did not transform to tetracycline resistance at 
all. 
Dang-Van, et al. (47) and Robins~Br~wil, et al. (159) attempted to isolate covalently-
closed-circular molecules from these clinical isolates but could not demonstrate the 
presence of plasmid DNA in these isolates. Snyth and Guild (182) also were not able to 
. ·. . 
detect any plasmid DNA from the strainBM6001 while they were able to isolate a 
cryptic, 2.0 megadalton plasmid, pDPl, from another virulent strain ofpneumococcus. 
As bacteriophages have been demonstrated in S. pneumoniae (14) and in the 
BM600l? Dang-Van, et al. (47) investigated whether the chloramphenicol and 
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tetracycline resistances in BM6001 were associated with one or more prophages. 
Analysis of 100 independent R6 clones lysogenized by the phages from BM6001 for 
resistances to chloramphenicol or tetracydine or both showed that all clones were 
susceptible to both the antibiotics like.their parent strain, R6. This eliminated the 
possibility of phage borne antibiotic resistance (47). Thus, the absence of plasmid DNA 
and phage borne antibiotic resistance led to the possibility that these antibiotic 
. resistances might be chromosome- borne. 
Cmr and Tcr are Chromosomal Insertions 
The first convincing evidence that chloramphenicol. and tetracycline resistances 
were due to heterologous insertions in the chromosome came from genetic and physical 
data. Shoemaker, et al. (176) observed that (i) transformation ofRxl (wild-type 
S. pneumoniae) with the DNA from BM6001 gave rise to Cmr and Tcr colonies at 
frequencies that were less than 1 % of those expected for transformation by homologous 
point markers. They also observed that the transfer frequency of the tet gene was eight-
fold lower than the transfer frequency of the cat gene. (ii) Transfer of tet was extremely 
sensitive to shearing of the DNA, whereas the transfer of cat was less so. {iii) the 
transfer frequency of cat to a strain that was Tc\ DP1320, was observed to be 30-fold 
higher than that ofRxl. Similarly, the presence of cat in the recipient, DP1321, 
increased the receptivity for tet by two-four fold. (iv).cat activity was observed to co-
sediment with the chromosomal marker (thy) and velocity distribution of cat was found 
to shift by the shear treatment of DNA. (v) In dye-buoyant density gradients, cat activity 
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was found to co-band with the chromosomal marker (nov-1) at the position expected for 
linear DNA and not with that of plasmid DNA. 
(vi) cat was found to be linked to nov-1, a chromosomal marker. (vii) tet was also linked 
to cat. Thus, it was concluded that cat and tet loci are. a part. of a large heterologous 
insertion in the chromosome of S. pneumoniae BM6001. Shoemaker, et al. ( 17 6), 
estimated the lengths of cat region to be approximately 4-8 kilobases (kb) long and that 
of tet to be above 30 kb: This heterologous chromosomal insertion carryin~ the cat and 
tet region was called flcat-tet. 
flcat-tet is Conjugative Transposon 
Shoemaker, et al. (177) reported that O.cat-tet element could be transferred from 
one cell to another, through a process that requires cell-to-cell contact. The frequencies 
of this transfer ranged from 10-6 to 10"5/donor, unlike the transfer of plasmids which 
were in the ran~e of 10·3 to 10~1/donor (185). The transfer process was recA 
independent and DNase resistant, no mobilization of chromosomal markers was 
observed: The transconjugant that nbw contains the .0.cat-tet also behaved like the 
parental strain .. They also observed that the transfer took place only on solid surfaces, 
like nitrocellulose filters, and not in broth (177, 183): Both intra- and inter-specific 
conjugative transfers offlcat tet were observed (26, 80). Thus, these flcat-tet 
insertions and other similar elements detected in other species (26, 47,59, 65, 83) were 
termed "Conjugative Transposons". 
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Uniqueness of Conjugative Transposons 
Conjugative transposons are unique. They differ from other gene transfer 
systems such as phages, plasmids,· and transposons, but, at the same time, share. some 
features with them. Conjugative transposons are phage-like. Their integration and 
excision from the host DNA (plasmid or genomic) resemble that of the lambdoid phages 
(161). In fact, the nucleotide sequences of the genes involved in the integration and 
excision processes reveal thatthey code for enzymes of the lambda integrase family (97, 
149, 150, 153, 197). However, these transposons do not form infectious particles. 
The conjugative transposons are plasmid-like. They are transferred by 
conjugation and have a covalently.,.closed-circular intermediate during their transfer. 
However, these circular intermediates do not replicate like plasmids, at least in the hosts 
tested so far (156, 173). 
The conjugative transposons are transposon-like, as they excise from, and 
integrate into DNA. However, their mechanisms of integration and excision are different 
from those of the well-studied transposons like Tn5 andTnJO (38, 156, 161, 171). 
Unlike transposons, these elements can mobilize themselves.from one cell to another by 
the process of conjugation. 
Classification of Conjugative Transposons 
Conjugative Transposons were first identified in Gram-positive bacteria but now 
a variety of them have been identified in.Gram-negative bacteria. They differ from one 
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another iri their size, the traget specificity, the antibiotic resistance they carry, the host 
range·etc. 
Conjugative Transposons of Gram Negative Bacteria: 
Conjugative Transposons have been identified in several species belonging to the 
. . 
genera Neisseria, Kingella, Vibrio, Salmonella and Bacteroides. Tn9 J6:.type of 
conjugative transposons have beeri observed in Neisseria gonorrhoeae and in Kingella 
spp (103, 158; 200). As Tn916 can mobilize itself between Gram-positive, aswell as, 
Gram-negative bacteria, this observation is not all~together surprising. Waldor, et al. 
(210) have identified a novel site-specific conjugative transposon (named SXT) 
containing the determinants for sulfamethoxazole, trimethoprim and streptomycin 
resistance in Vibrio cholerae 0139.· SXTis a 62-kb transposon, that has been shown to 
mobilize itself from V. cholerae 0139 to E. coli. It has also been shown that SXT can 
also transfer itself from·one species to another (210) .. Ctnscr94, an orientation-specific 
conjugative transposon, was identified in Salmonella senftenberg 5494-57 (218). This 
transposoil has been shown to insert at two ·specific sites in the chromosome. · The 
transposon is 100 kb in size (78) and codes for the enzymes needed for sucrose 
fermentation. It is the first conjugative transposon identified in enteric bacteria. 
The best studied among the Gram-negative conjugative transposons are the non-
replicating Bacteroidal Units (NBUs). This group oftransposons has been identified in 
Gram-negative anaerobicBacteroides species (161). These transpsons range in size 
from 65 to over ISO kb (162). Most of the NBUs have been shown to carry a resistance 
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gene for tetracycline ofthetetQ typeand not the tetM type carried by Tn916. Unlike 
other conjugative transposons, these elements have been shown to integrate into co-
resident plasmids and mobilize them in cis. They have also been shown to mobilize other · 
unlinked integrated transposons (161, 162). 
Coniugative Transposons of Gram Positive Bacteria: 
Two transposons that belong to this category were the first conjugative 
transpsons to be identified. They are Tn916 and Tn5253. The conjugative transposons 
' ' 
of Gram-positive bacteria can be 'classified i~to two classes based on their sizes and 
sequence similarity: 
(a) Tn916/Tn1545 family 
(b) Tn5253 family. 
(a) Tn916/Tn1545 family: 
Thes·e are sn1aller conjugative transposons wh~se size ranges from! 8 kb to 25 
kb. The transposons that belong to this family usually carry the tetM-type determinant 
conferring tetracycli.ne resistance: The tetM marker provides the host with the ability to 
·resist tetracycline as well as minocycline, a semi-synthetic derivative of tetracycline 
(172). 
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Tn916: 
Tn916 was one of the first conjugative transposons identified. It was found in 
the chromosome of Enterococcus faecalis DS 16 (59). It carries the tetM determinant 
for tetracycline resi.stance and is a "simple transposon", in the sense that· it transposes as 
a single unit (172). Tn916 has been shown to insert into various sites on a highly 
conjugative plasmid, pAD 1, and also into various sites on the chromosome of recipient 
bacteria. The transfer process has been shown to be recA independent. The 
transconjugants carrying independently-acquired Tn9 J 6 have widely different donor 
potentials for subsequent transfer. Transfer frequencies range from <10-9 to >10-4 per 
donor. These transconjugants have also been shown to differ in the number of copies of 
Tn916 they acquired,· half the members of a population of transconjugants have more 
than one copy of Tn916. The integration event of Tn916 has been shown not to 
generate direct repeats at its junctions (27, 42). The presence of either four or five 
T-residues at the end of the transposon has been observed after the transposition of 
Tn916. This has been suggested to be related to the slippage at the right end of the 
element by the site-recognition apparatus (38). An excised circular form ofTn916 has 
been isolated from E.coli. This circular form has been shown to integrate into different 
chromosomal locations upon transformation into B. subtilis protoplasts (173), thus 
providing physical evidence for the presence and involvement of a circular intermediate 
in transposition. This transposon has been studied extensively and its complete 
nucleotide sequence has been determined recently ( 41). 
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Tnl545: 
S. pneumoniae BM4200 is·a multiple antibiotic-resistant clinical isolate. It has 
been shown to be resistant to. sulfonamides, trimethoprim, penicillins, chloramphenicol 
(cat), macrolide-:lincosamide-streptoGramin B-type (MLS) antibiotics (ermAM), 
tetracycline (tetM) and kanamycin (aphA) and other structurally related aminoglycosides 
(26). Buu-Hoi, et al. and Snuth, et~l. (26, 65) have shown that all the resistances were 
chromosome borne. They have also observed the conjugative transfer of cat-tet-erm-
aphA but they did not observe the transfer of any.of the other resistances. earlier and 
Courvalin(29) doned the tet-:erm-aphA determinants in E.coli and observed that the 
segment exhibited recA-iridependent transposition and named this element Tn1545. This 
transposon is 25.3 kb in size and the transpositionand the structural features of this 
element have been shown to be similar to that of Tn9 l 6. 
The Tn916/Tn1545 family oftrarisposons includes members that closely resemble 
Tn916 and so far several.members of the family have been identified .. Some of the family 
. . 
members include, Tn919 from S. sanguis (38); Tn918, Tn920, Tn925 and Tn3702 from 
E.faecalis (38,39); Tn370.3 fromS. pyogenes(120); Tn5031, Tn5032 and Tn5033 from 
E. faecium (38); and Tn525J from S; pneumoniae (7). 
The host range of this family of transposons has been observed to be remarkably 
broad. Members of this family have either been isolated from or have been introduced . 
. . 
into at least 52 different species (both Gram-positive and Gram-negative) from 24 genera 
(41). 
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(b) Tn5253 family: 
The members of this family of conjugative transposons are larger in size than the 
Tn9 l 6/Tnl 545 family of transposons. They are above 50 kb in size and they usually 
code for multiple antibiotic resistances. Tn5276, found in the chromosome of 
Lactococcus lactis NIZO RS, Tn3701, found in the chromosome of S. pyogenes A454, 
and Tn3951, found in the chromosome of S. agalactiae Bl09 are all members of this 
family. 
Tn5276: 
This conjugative transposon is 70 kb in size. It has been shown to cany the gene 
necessary for the production of nisin; · a lantibiotic that is used to prevent the growth of 
undesirable bacteria in the dairy industry. It also has been shown to carry the genes that · 
are needed for sucrose metabolism, for reduced bacteriophage sensitivity and immunity 
to nisin (152, 153). Raush, et al. (152, 153) have shown that this element integrated 
itself into the.chromosome of Lactococcus lactis without any target duplication .. The 
· element has been observed to have at least five different target sites. It has been shown 
to insert in one or more of these five sites, in an orientation-specific manner. Another 
: . - . •·, ·. 
nisin-sucrnse element, Tn5301 that is similar to.Tn5276 has been identified in L. lactis 
FI5876 (79). 
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Tn3701: 
Tn3701 is a composite conjugative transposon identified originally in the 
chromosome of S. pyogenes A454 (120). It is .50 kb in size and carries the determinants 
for chloramphenicol (cat), erythromycin (erm) and tetracycline (tetM) resistance. ·By 
DNA-DNA hybridization experiments, Le Bouguenec, et al. (120), have shown that 
Tn3701 contained a 19.7 kb :segment within itself that was similar to Tn916. This region 
has been shown to carry the erm-tet genes; They have also shown•that this region could 
' ' 
transpose itself to different sites on the chromosome from plasmids but lacked the 
. . : .·· . . ;: . . .... ' 
conjugative properties. This small element within Tn3701 has been named Tn3703. Le 
Bouguenec, et al. (120) have also $hownthat the erm gene and some adjacent DNA can 
spontaneously cure itself suggesting that the erm gene might be located in another 
transposon. The erm insertion into a gene that is needed for the conjugation function of 
Tn3703 could have rendered that gene inactive and was predicted to be the reason for 
the lack of conjugative functions of Tn3703 (119). 
Tn395J': 
This 67-kb composite conjugative transposon \Vas found in the chromosome of 
S, agalactiae B 109. It carries the determinants for chloramphenicol, tetracycline, and 
erythromycin resistances (84). This element has been shown to be able to conjugally 
transfer to other Streptococci belonging to Groups A, B, C, D, G, and H (80, 83). The 
genetic integration of this element has been shown to be site-specific (84). Smith and 
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Guild (184) demonstrated that this element can transpose into pADl, a hemolysin 
plasmid of E. faecalis. The erm-tet determinants have been shown to reside in a 22 kb 
EcoRI fragment (84) and this segment has been shown to be similar to Tn916, like 
Tn3703 (120). Inamine and Burdett (84) have also shown that this 22-kb EcoRI 
fragment, when cloned in E.coli DB 11, expressed both erm and tet resistances. 
Tn5253: 
As mentioned earlier, this dement was originally identified in the chromosome of 
S. pneumoniae BM6001 and it carries the determinants for chloramphenicol and 
tetracycline resistance. This element was referred to as the BM6001 element or the 
O.cat-tet element and later named Tn5253. Tn5253is the most extensively studied 
member of this. family. This is a composite conjugative transposon whose integration is 
site-specific. This transposon has been shown to transfer to other streptococci during 
filter-matings at a frequency of 10-7 to 10"6 per donor (181 ). Vijayakumar, et al. (208) 
have constructed· a restriction map of this 65. 5 kb transposon by inserting an E. coli 
vector, pV A891, which is incapable of autonomous replication in Streptococci, at a 
number of sites specifically withinthe transposon. This enabled them to identify the 
junctions and the target site ofthetransposon (207). DNA-DNA hybridization of 
Tn5253 has shown that the DNA segment carrying the tet determinant was similar to 
Tn916, like Tn3703 and Tn3951 (120). This observation showed that there is a region 
in Tn5253 that is homologous to Tn9 J 6 but does not answer the question of whether it 
is capable of transferring itself independently like Tn916 or not (as in the case of 
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Tn3703). Ayoubi, et al. (7) cloned a 23-kb Xbal fragment ofTn5253 into the pVA891 
vector to generate the plasmid, pVJ403, and introduced it into E. coli. In the absence of 
selection (tetracycline), they observed that there was a deletion of about 18-kb from this 
plasmid. When pVJ403 was introduced into S. pneumoniae, it was observed that the 
element carrying the tet gene (18-kb) transposed into the chromosome. This indicated 
that, like Tn3703, the region ofTn:5253 that was similar to Tn916 was capable of 
independent transposition .. It was also shown.that this 18-kb segment was able to 
conjugally transfer itself to other streptococci and integrate at different sites in the 
chromosome, unlike Tn3703. The segment ofTn5253 that carries the tet gene and can 
transpose independently was named Tn5251: Tn5251 belongs to the Tn916/Tn1545 
family of conjugative elements. The remaining DNA after the excision ofTn5251 has 
also been shown to transfer conjugally to other streptococci (7). This segment was 
named Tn5252. Tn5252 is 47.5-kb long, carries the cat gene, and is a site"'.specific 
transposon having the same target-site specificityas its parental element, Tn5253. The 
cat gene has been shown to be flanked by IS-like elements (207). This accounts for its 
spontaneous loss at detectable frequency. These observations suggest that smaller 
elementslike Tn5251 were added later to larger ones like Tn5252 to generate the 
composite elements such as Tn5253 (Fig. 1). Thus, Tn5252-like elements should be 
considered the prototype of composite conjugative transposons such as Tn5253. 
25 
Tn5253 (65.5 kb, Cm ,Tc, Tra+) 
a cat tet b 
:·:·:·:·:·:·:·:•••:•:•:•: •:•:::.:::•:• ••:•:•:•:[~ ::::::=t•::• ·•·•·•·•·•·•·•·>·•·••· ~ : :::•:•:•:::•:•:•:•:•:::•:•:•:•:•:•: •:•: I 
rpt rpt 
Tn5251 (18 kb,Tc, Tra+) 
a Tn5252 (47.5 kb, Cm, Tra+) b 
:::J::•:• ·•·•·<:::•:•:•:•:•:•:•:·:~ ····::: ::::::::::::::::::·::::::::::::::::::::::::::::::::::::::::::::::•:::::::::::•:•::::·:~ 
a Tn5252L1cat (39.2 kb, Tra+ ) b 
N •:•:::::•:•••:•:•:::•:•<•••~ •:•••:• ::::::::::::::::•::::::::::::::::::::::::::::::::::::: :::: ::::::::::.:::•:•:•:: C::::. 
0 10 20 30 40 50 60 70 kb 
Figure 1. Structure of the Composite transposon Tn5253 and its derivatives. The 
DNA remaining after the transposition of Tn5251 is termed Tn5252 . Spontaneous 
loss of cat occurs at a detectable frequency (because of the flanking repeats), 
Tn5252 /::,.cat is still transfer proficient. (Picture printed with permission from 
Kilic, et al. (97)). 
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Tn5252: 
Unlike the Tn9 I 6ffnl 545 family of transposons, these elements have never been 
. . 
isolated from Gram-negative bacteria and even in the Gram-positive bacteria, of these 
large elements ar.e not common. As the molecular details about these elements are very 
limited, the focus of our lab has been to gain a broader understanding of the biology 
Tn5252-:-like elements. The Tn916/Tn1545 family and the Tn5252"'.like transposons differ 
mainly intheirtarget specificity. Theintegratidn ofTn5252 is at a unique target site in 
S. pneumoniae (7) where~s. the Tn916ffnl545 family oftransposons tends to integrate 
. . . . . 
. ' . 
at multiple sites in the chromosome {31,.'.45) .. To gain i11sight into the nature of 
integration, Vijayakumar, et al. (206) obtained the nucleotide sequence of the termini of 
the transposon (Tn5252) from pneumococcal transconjugants. Comparison of the 
sequences revealed a nearly perfect identity (with the exception of two bases) between 
the left and right termini (over a 72 bp sequence). The 72 bp sequence present in the left 
termini and the right termini have been shown to belong to the transposon and the 
chromosome of S. pneumoniae respectively. Thus, the 72 bp sequence was identified to 
be the signal for the site-specific integration of the .element.· . Analysis of S. gc/rdonii 
transconjugant revealed the prese°:ce of the,72 bp sequenc.e in the left terminus, as 
expected but at the righttermim.is only a 35 bp sequence was observed (6). Thus, a 35 
bp sequence was shown to be adequate for the site-specific integration of the transposon. 
To localize the transfer-related regions in the transposon, Kilic, et al. {97) inserted 
heterologous DNA (p V A891) at various sites in the transposon to create mutants. 
Analysis of the results of filter-mating experiments done with these mutants as donors 
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led to the localization of the regions of the transposon that are involved in transfer 
functions. Interestingly, insertions and deletions in the middle ofTn5252 were found not 
to affect the transfer functions whereas the mutations at the ends were found to reduce 
the transfer frequency dramatically. · This result was consistent with the observation that 
. ' . . . 
. , 
the smaller conjugative transposon, Tn5251 and the cat gene flanked by IS-like elements 
integrated within. the middle region of Tn,5252 {97). To understand the functional role of 
transfer-r~lated regions of Tn5252, Srinivas, et al. (188,189) obtained about 6 kb 
. . .• . . . 
nucleotiQe sequence from the left. end of the transposon. Further ~alysis led to the 
purification of a DNA relaxase and a regulatory protien. The DNA relaxase has been 
shown to nick in a site-specific manner Withi11 a region in the middle of the transposon 
(188). The regulator has been shownto bind to sequences upstream of an integrase-like 
gene, the DNA relaxase, another functionally unidentified gene and also to its own 
promoter (189). Nucleotide·sequence was also obtained from another transfer-related 
region, located near the right end of the transposon (1, 2). Analysis of the sequence 
revealed the presence of an operon-like structure consisting of at least ten genes. The 
predicted proteins of these genes showed a tendency to form trans~membrane segments 
(1) an·d the.Se also showed significanCsimilarities to transpon: proteins from other 
systems .. These observations suggested that these proteinsmight be involved in 
transferringTn.5252 across the membrane(lt 
As the end~ of the transposon ha;e been established to b·e important for the 
transfer, the work described in this thesis focuses on the right-most end of the 
transposon Tn5252 where no structural or functional information was available. 
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Preliminary work to this end revealed the presence of a functional DNA 
methyltransforase ( 164). 
DNA Methyltransferases 
DNA methylation is a major form of modification in bacteria, fungi, phages, 
animal viruses, plants, and vertebrates. In prokaryotes, DNA methylation has been 
shown to be involved in restriction-modification (R/M), mismatch repair and gene 
regulation (131, 143, 203).· DNAmethyltrarisferaseshave been classified into three 
groups, Type-I, II and Illbas~d on their structure (refer Table XXII for a summary). 
Type-I 
Type-I is the most comple~ cif ~11 the three methyltransferase groups. Previous 
studies have indicated that these methylases are multi-functional enzymes, catalyzing 
both restriction and modification r~actiorts. They have also been shown to be restriction-
dependent ATPases and DNA topoisomerases (17). ·Magnesium, ATP, and S-adenosyl 
L-methicinine (AdoMet) are required f()r restriction a~d_ modification. The restriction of 
DNA has been shown .to be random and is far from. the asymmetrical recognition sites. A 
separate modification methylase .has been isolated recently (117) and has been shown to 
. . ' . . . . . . . 
be an efficient_mono~furtctional methylase, thus, disproving previous studies. Thirteen 
different type-I systems that had been described by the early 1990s, eight of which were 
found in E. coli (Eco AI, EcoBI, EcoDI, EcoDXXI, EcoEI, EcoKI, EcoR124I and 
EcoR124/3I), four in Salmonella species (SrySBI, SrySPI, SrySQI and SrySil) and one in 
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Citrobacter ( C.frAI) {215). Type:-I RIM systems from other bacteria like Pasteurella 
hemolytica {76); Klebsiella pneumoniae (123), Mycoplasma pulmonis (180), L. lactis 
{169) and another Salmonella species (S. enterica) {201) have been reported recently. 
Among the type-I RIM systems, the two methylases that have been well characterized 
are from E. coli B (117) and Kl2 (199). It was observed that they both contain two 
non-identical sub-units that are the same as two of the three sub,..units of the 
corresponding restriction enzymes. Later analysis of the type-I RIM systems has shown 
the involvement of three genes in type-I systems and they are hsdR, hsdM., and hsdS 
(hsd, for host specificity for DNA). It has been showri: that hsdM. and hsdS are necessary 
. . . ' 
.,. . . 
for modification of the target (199) and the hsdS gene product has been shown to be 
responsible for recognizing specific sequences in DNA for both restriction and 
. . . . 
modification. In EcoK and E(:oB, hemimethylated DNA has been shown by far to be the 
preferred sµ.bstrate for methylation. Vovis, et al .. (209) and Burckhardt, et al. (24) 
observed that methylation of a hemimethylated substrate occurs 100 times faster than 
methylation of a completely unmodified substrate. This observation is physiologically 
relevant, as hemimethylated DNA is the normal product of DNA replication or repair. It 
has also :been ~hown that EcoB and EcoK are allelic ~nd they share homology with other 
restriction-modification systems from Salmonella species {140). Recently Meister, et al. 
(136) have shown that the hsdS from the EcoDXXI system recognizes a different target 
site because of a Tn5 transposition within the hsdS gene . 
. '
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Type-ID 
The restriction enzymes of type-III RIM systems have been shown to be 
comprised of two non-identical sub-units that require ATP and Magnesium for activity. 
Unlike type-I enzymes, restriction is independent of the presence of AdoMet, although it 
stimulates the reaction. In the presence of ATP and AdoMet, restriction and 
modification are competing reactions (69). Restriction of DNA has been shown to occur 
at a fixed distance from the asymmetrical recognition sites. A separate modification 
enzyme lacking the endonuclease activity has been isolated from the type-III restriction-
modification (RIM) system (20). Hadi, et al. ( 69) have shown that the modification 
methylase consists of one of the two sub-'units of the restriction enzyme. This sub-unit is 
the one that recognizes the target sequence in both the restriction and the modification 
reactions. EcoPl, EcoP15, Hinfl.II, and StyLTI are the only four type~IIIRIM systems 
that have been identified so far and all four of them have been shown to methylate 
adenine residues in one strand only. In the case of EcoPl and EcoP15, the recognition 
sequences have been shown to be AGACC (8) and CAGCAG (68) respectively. Only 
one strand is methylated, as adenines are present in only one strand. Both HintIII and 
Hinel (isoschizomer of HintIII) have been shown to recognize the target sequence, 
CGAAT (145). Both the strands have adenine residues but only one strand is 
methylated. In cells harboring the type-III RIM systems, DNA replication generates one 
daughter DNA molecule containing the parental modification and a second daughter 
molecule with the corresponding site completely unmodified. This unmodified DNA 
should be restricted but it is not. The reason for this lack of restriction was understood 
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from the observation that T3 phage DNA is restricted by the EcoP 15 RIM system 
whereas the DNA of its close relative T7 is not. Although T7 has 36 EcoPI5 sites in its 
genome (52), all the EcoP15 sites (CAGCAG) in T7 are in one DNA strand and all the 
CTGCTG are in the other strand. In T3 (from the partial sequence that was available) 
the EcoPl5 sites are in both the orientations. This led to the hypothesis that two sites 
have to be in aninverse orientation for restriction, and sites present in only one 
orientation cannot be restricted but can be modified. This hypothesis was later tested 
and proved to be correct (135). 
Type-II 
Type-II RIM systems have a simple sub-unit structure. There are separate 
enzymes that catalyze restriction and modification. Magnesium is required for restriction 
and AdoMet.is required for modification. The restriction enzymes have been shown to 
cut at, near, the sequences that they recognize. In case of methyltransferases, only one 
of the strands has been shown to be methylated during each methylation event. This 
observation is consistent with the fact that the natural substrate for the enzyme within the 
cell is newly replicated hemimethylated DNA (33). Although both the endonuclease and 
the cognate methylase recognize the same target sequence, they have not been observed 
to show significant similarities in their primary sequences (30, 221). This suggests that 
they both have evolved independently and use different strategies to interact with 
identical targets (203). The lack of similarity between the endonucleases and their 
cognate methylases could be explained by the fact that they both catalyze different 
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· reactions. No detectable similarities .. have been observed between endonucleases that 
have been isolated from different organisms but recognize the same target site 
(Isoschizomers) and cut at the same positi011, as in the case of BsuRI and NgoPII (98, 
198). However, there are a few cases of isoschizomeric enzymes that have been 
.· . . ': 
observed to share some similarity. · These pairs are, EcoiU and RsrI ( 191 ), BsuBl and 
Pstl(22J), TthHB81 and Tdql(ll), FnuDI andNgoPII, andC/r9I andXmaI (217). 
Unlike the ertdonucleases, the methyltransferases share sequence similarities. 
. . '· ··. . . 
" • j •• : ..... ·: . • 
Methyltransferases froni a variety of organisms have been cloned and sequenced (216) 
. . . 
and comparison of the amin9 acid sequences of these methylases have helped distinguish 
. . . 
between the conserved regions and thevariable regions (IOO;I 16,147f 
Methyltransferases have been divided into two classes based _on the modification that · 
they introduce. The first class includes enzymes that methylate the pyrimidine ring 
carbon yielding C5-methylcytosinl Members of the second class methylate the 
exocyclic nitrogens and form either N4-methylcytosine or N6-methyladenine. Two 
families of CS-cytosine methyla~es (SmC-cytosine methylases) have been described. The 
first family includes members that are predominantly accompanied.by their cognate 
endonucleases asa part.of the RIM system: These methylases ha~e been shown to be 
mono-specific in that they recognize and modify a single DNA recognition sequence 
(216, 101). The second family co~tains methylases that have been shown to be multi-
specific in that these methylases recognize and methylate several different DNA 
sequences. These are not accompanied by any restriction endonucleases. There are very 
few members·in this family and have so far been limited to the methylases encoded by the 
bacteriophages of Bacillus. Although the two families differ in their ability to recognize 
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and methylate different DNA sequences, they still have been observed to show an overall 
similarity except for the variable region. Analysis of several smC-cytosine methylases 
have shown that they ~onsist of ten conserved blocks (I to X) of amino acid residues, in 
a sequential order. Most of the conserved blocks have been observed to be separated 
from each other by short regions of similar length, .but with no sequence conservation. 
Clusters of invariant positions enclose about 200 a:mino acids in the N-terminal half and 
about 50 amino acids in the. C-terminal half (Fig. 7, 116, 147). The preservation of the 
ten conserved blocks in all the smc methyltransferases suggest that they are responsible 
for functional or structural properties that are common to all the cytosine methylases. 
. . 
Binding to AdoMet and covalent binding to.theC6-position of the cytosine to be 
methylated are two common functions and these two functions have been attributedto 
two distinct blocks. Block I (Fig. 7) consisting ofF-X-G-X-G (or a similar glycine rich 
sequence) was presumed tp be a part of the AdoMet binding site. The presence of this 
block was observed in a wide variety of AdoMet-dependent methyltransferases (Mtases) 
including the DNA, RNA, protein, and small molecule Mtases (85, 92, 100, 217). Wu 
and. Santi (219) proposed that the smc methylases function catalytically analogous to 
thymidyl~te synthase (166) and tRNA (uracil-5)-Mtase (165), enzymes that transfer 
. • .. · 
single methyl groups from AdoMet to the CS position ofpyriniidines. A covalent 
intermediate has been suggested to be generated by a nµcleophilic attack on the C6-
.· position of the cytosine, by a cysteine residue, (32, 60) present in the Pro-Cys dipeptide. 
(which is absolutely conserved in all the smC-Mtases) of conserved block IV (Fig. 7). 
This has been suggested to activate the CS position of the cytosine and this activated CS 
initiates a nucleophilic-attack on the methyl group of AdoMet. Chen, et al. (32), and 
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Friedman and Ansari (60) have recently identified the sulfhydryl group in the Pro-Cys 
di peptide as the active nucleophile in M.HaeIII and M.EcoRII. The activity of several 
methylases have been shown to be abolished when this conserved cysteine is replaced 
(137, 214, 220). Between the conserved block VIII and IX is the variable region that 
had been proposed to carry the target-recognizing domains (TRDs), which are 
responsible for the enzymes' characteristic capacities to interact with defined DNA 
sequences (Fig. 7). Experimental proof for this assumption has been provided initially in 
the case of multi-specific methylase(9, 204, 214) and recently in the case of mono-
specific methylases, M.HpaII andM.HhaI (101). In the case of mono-specific 
methylases, the variable region has been observed to be 80-120 amino acids long and in 
the case of multi-specific methylases, it has been observed to be 200-300 amino acids 
long. The TRDs have been shown to represent contiguous segments consisting of about 
40 amino acids each. They have been shown to be arranged consecutively without any 
overlap or separation by linker amino acids (203). Walter, et al. (212) have also shown 
that the TRDs can be rearranged within and exchanged among multi-specific methylases 
without functional loss. The methylases encoded by the bacteriophages, p 11 s and H2II 
have been shown to contain TRDsthat resemble active TRDs of other methylases but do 
not contribute to the enzymes' rnethylation potentials (112, 113). Lange, et al. (112) 
have functionally activated these inert TRDs (also termed as Pseudo domains) by site-
directed mutagenesis. Analysis of the putative TRDs of the mono-specific M.HpaII, 
M.Mspl and M.BsuFI (all of which recognize the sequence CCGG) (212) have revealed 
that the TRD of M.HpaII is substantially different from that of MMspI and M.BsuFI. 
This is an interesting observation as M.HpaII methylates the inner cytosine whereas 
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MMspI and M.BsuFI both methylate the outer cytosine. This observation suggests that 
the TRDs function is not just to direct what target to recognize but also to direct which 
cytosine.to be methylated (203). 
Unlike the 5mC-methyltransferases, the N4mC and N6m A methyltransferases show 
much higher sequence diversity among themselves .. Comparison of the amino acid 
sequences ofN4mC and N6m A methylases have revealed only two conserved segments, 
namely F-X-G-X-G and (NSD)-P-P-(YF) (30, 100, 115). Conserved segment I (F-X-G-
X-G) has been suggested to be involved ih AdoMet binding because of its homology to a 
similar motif in 5mc methylases and other AdoMet-binding proteins (85). Conserved 
segment II ((NSD)-P-P-(YF)) has been suggested to be involved in the transfer of 
methyl groups to the adenines or cytosines of the target DNA Crystal structures of 
M.HhaI (34) and M.HaeIII (155), both of which are 5mC cytosine methylases, and of 
M.Taql (108), a N6mA methylaseand M.PvuII (129), a N4mC methylase have been 
resolved recently. Comparisons of the crystal structures have indicated that motifs I to 
III and X are responsible for AdoMet binding (34, 102, 108, 168). Motifs IV, VI and 
VIII have been observed to be responsible for catalysis (168), as they form an active site 
along with motifs V arid VII. Although the primary amino acid sequence comparisons 
failed to highlight conserved domains, structural comparisons of these methylases with 
catechol-0-methyltransferase (COMtase) and other DNA methylases have shown 
striking similarity, in-spite ofthe fact that these methylases methylate different substrates 
(144). Guided by this common domain structure, Malone, et al. (129) have compared 
33 N6m A, nine N4mC, one 5mC and one COMtase with each another. They were able to 
identify nine segments of sequence similarity corresponding to motifs I to VIII and X in 
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the smc methylases. However, they were not able to identify a region homologous to 
motifIX of the smc methylases. Based on the analysis they observed that the methylases 
differ in the relative linear order of the three regions, the AdoMet binding region (motifs 
I to III and X), the catalytic site (motifs IV to VIII) and the target recognition region. 
Thus, they have grouped the methylases into three groups, a, f3, and y based on the 
order in which these regions are present. In group a the AdoMet binding region (motifs 
X-I-11-III, in that order) is at the amino terminus followed by the target recognition 
region and then the catalytic region ( motifs IV-V -.YI-VII-VIII, in that order). In case of 
f3, the order is catalytic region, target recognition region and then the AdoMet binding 
region. In case ofy, the AdoMet binding region is at the N-terminus followed by the 
catalytic region and then the target recognition region. The difference between smc 
methylases and the methylases that belong to group y is that in case of group y motif Xis 
at the N-termini whereas it is at the C-termini in the case of smc methylases. This . 
circularly permuted motif order is not very surprising for two reasons: (a) It had been 
pointed out, before the crystal structures were resolved, that the two previously 
identified conserved segments I (suggested to be involved in AdoMet binding) and II 
(suggested to be the catalytic site) appeared in different orders in various methylases 
(100, 216, 217). (b) It hasbeen shown that there are some smc methylases that have 
two separate subunits (each consisting of different motifs) and both the subunits have to 
be present for functionality (95, 122). It has also been shown that regions of the 
methyltranferase when expressed separately could complement each other if allowed.to 
interact with each other in vivo (148). 
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CHAPTER ill 
MATERIALS AND METHODS 
Bacterial Strains 
The laboratory strain that is equivalent to the wild-type S. pneumoniae used in 
this study is a non-encapsulated strain Rxl (97). Rxl is derived from R36A strain of 
Avery {5). The pnuemococcal strains used in this study are listed in Table I. 
S. pyogenes ATCC 1961.5 used for conjugation experiments in this study was 
provided kindly by the·Stillwater Medical Center. 
E. coli strains used in this study are listed in Table IL 
Growth and Storage of Bacterial Strains 
Streptococcal strains were grown in casein hydrolysate (CAT) medium (10g of 
casein hydrolysate, 5g tryptone, Sg NaCl, and. lg yeast extract in one liter of distilled 
water). The medium was autoclaved, cooled, and supplemented with sterile, 20% · 
glucose and 0.5 M KilIP04 to yield a final concentration of 11 mM and 16 mM, 
respectively. The supplemented medium was called CATPG broth or agar (1.5% w/v). 
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TABLE I 
Streptococcal Strains 
STRAIN ·· GENOTYPE REFERENCE 
S. pneumoniae 
Rxl hex- 175 
DP1002 nov~l 63 
DP1004 str-1 63 
DP1322 Tn5253 (cat tet) 181 
DP1343 nov-1, Tn5253 (cat tet) 181 
DP1402 str-1, BM4200 (cat tet erm aphA) 181 
DP1617 hex-, str-1, ery-2, nov-1,Jus, sulf-d 181 
DP31 l l hex+, str;.41, Dpnlt 64 
DP3218 rif, pIP501 (CmEm) 181 
SPlOOO str-1,fus, Tn5252 (cat) 7 
SP1206 nov'.'l, Tn5252(cat n Em) Tra- This study 
SP1207 nov-1, Tn5252 (cat n aphA) Tra- This.study 
SP1208 nov~l, Tn5252 (cat o.aphA) Tra-
pIP501 (Cm Em) This study 
SP1209 nov-1, Tn5252 (cat n aphA) Tra-, 
pIP501 (Cm Em), pLSl (tet) This study 
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Table I continued 
SP1210 nov-1, Tn5252 (cat n aphA) Tra~, 
pIP501 (Cm Em), pSJ017 (tet) This study 
SP1211 nov-1,Tn5252 (cat n aphA) Tra-, 
pIP501 (Cm Em), pSJl 17 (tet) This study 
SP1212 nov-1, Tn5252 (cat n aphA) Tra-, 
pIP501 (Cm Em), pSJl 19 (tet) This study 
SP1213 str-1, Tn5252 (cat to Em) Tra- This study 
SP1214 str;.1, Tn5252 (cat naphA) Tra- This study 
SP1254 str.;.1, Tn5252 (cat n Em) Tra+ 97 
SP1255 str-1, Tn5252 (cat n Em) Tra- 97 
SP1262 . str-1, Tn5252 (cat n Em) Tra+ This study 
SP1264 nov-1, Tn5252 (cat) Tra+ This study 
SP1265 nov-I, Tn5252 (cat n Em)Tra+ This study 
SP1273 nov-1, Tn5252 (cat n Em) Tra+ This study 
SP1292 str-1, Tn5252 (cat n Em), pLSl (tet) 
Tra+ This study 
SP1293 str-1, Tn5252 (cat n Em), Tra+ 
pSJl 07 (tet) This study 
SP1294 str-1, Tn5252 (cat n Em), Tra+ 
pSJl 17 (tet) This study 
SP1295 str-I, Tn5252 (cat n Em), Tra+ 
pSJl 19 (tet) This study 
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Table I continued 
SP1296 .· nov-1, Tn5252 (cat n Em), Tra+ 
pLSl (tet) .. This study 
SP1297 nov-1, Tn5252 (cat n Em), Tra+ 
pSJ107 (tet) This study 
SP1298 . nov:.1, Tn5252 (cat n Em), Tra+ 
pSJI 17 (tet) This study 
SP1299 nov-1, Tn5252 (cat ·n Em), 
pSJI 19 (tet) This study 
SP1322 nov-1, pSJ107 (tet) This study 
S. pyogenes · 
ATCC 19615. opt Stillwater 
Medical Center 
nov-1 Chromosomal point mutation conferring resistance to novobiocin. 
fus Chromosomal point mutation conferring resistance to fusidic acid. 
str-1, str- 41 Chromosomal point mutation conferring resistance.to streptomycin 
' . .. . . -
ery-2 . ·. Chromosomal point mutation conferring·resistance to erythromycin · 
. . . 
sulf-d Chromosomal point mutation conferring resistance to sulfonamide 
. . ~ 
aphA Arriinoglycoside phosphoryl transferase type A (resistance to kanamycin) 
cat Chloramphenicol acetyl tranferase (resistance to chloramphenicol) 
tet Resistance to tetracycline (type M) 
Em Resistance to erythromycin 
opt Resistance to optochin 
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STRAIN 
JM109 . 
C600 
GM2163 
ER2508 
XLl-Blue MRA 
XLl-Blue MRF' Kan 
BL21 (DE3) 
TABLE II 
. E.coli Strains 
. RELEVANT GENOTYPE 
F', rec Al~ lacZq A (lacZ)Ml 5, Mer A", rK· mK + 
F", lacYI, dam13::Tn9, dcm-6, mcrBI, 
hsdR.2 (rK· m/), mcrA 
Ion:: TnlO, A(malB), A(mcr-mrr)20 
A(mcrA)183, A(mcrCB-hsdSMR-mrr)113 · 
A(mcrA)183, A(mcrCB-hsdSMR-mrr)l 13, 
recAl, lac[F' proAB laciqZAM15.Tn5 (Kan1)] 
p· ,ompT, hsdSB( fB-mB"), gal, dcm (DE3) 
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S. pnuemoniae cultures were grown to an ODssonm = 0;2 (which is approximately 
2.0 x 108 CFU/rril). Due to the induction of autolysis at the stationary phase, 
pneumococcal cultures to be stored were never allowed to grow beyond ODssonm= 0.2. 
S. pyogenes was growri overnight prior to storage. The cultures were stored at -80°C 
with 10% (v/v) sterile glycerol. 
E.coli strains were grown in Luria-Ber:tani (LB) medium(lOg tryptone, 5g yeast 
extract, and.Jog NaCl in onelitet ofdistilled water). The pH of the medium was 
adjusted to 7.5 with NaOHandthe medium sterilized. The agar concentration used was 
2.0% w/v. For short-term storage, overnight cultures of E.coli were Stored at -20°C 
. . . . . 
. . . 
with 50% v/v giycerol while long-term storage was at-80°C with JO% glycerol. All the 
· bacterial cultures were-grown at 37°C unless and otherwise indicated. Each of the above. 
mentioned media was supplemented with rhe appropriate antibiotic, wheneverthere was 
a need to do so. The concentrations of the antibiotics used to select bacterial strains 
used in this study are tabulated in.Table III. 
·Pbtsmids 
Vector plasmids used in this study were pBluescript SK+, pVA891, pLS1, 
. . . . .. •' 
pMAL-2 and pET-30+ a-c. pVA891 (126) isanE.coliplasmid carrying Cmr andEmr. 
When inserted into the chromosome of pneumococcus, it expresses Emr. The broad,. 
host-range plasmid pLS1 (190) is a derivative ofpMV158 isolated from Streptococcus 
agalactiae (25). pLS 1 can autonomously replicate and express tetracycline resistance in 
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Table ill 
Selective Antibiotic Concentrations 
Genotype/ Phenotype 
Streptococcu.$ pn.eumoniae 
cat (Tn5252) 
nov 
str 
rif 
aphA (Tnl 545) 
tet 
Cmr {pIP501} 
Streptococcus pyogenes . 
cat (Tn5252} 
. opt 
Escherichia coli 
Antibiotic 
chloramphenicol 
erythromycin . 
novobiocin 
streptomycin 
rifampicin ..... 
kanamycin· · 
tetracycline 
chloramphenicol 
. chloramphenicol 
erythromycin 
optochirt 
chloramphenicol · 
44 
. . 
· Concentration (µg/ml) · 
Stab Plate/Broth Overlay 
5 15 
3 
10 10 
200 200 
10 
200 1000 
2 5 
3 5 
5 
5 
20 
15 
Table III continued 
Cmr (pLysS) chloramphenicol 34 
Emr erythromycin 200 
Tcr tetracycline 10 
Kanr (pJHI) kanamycin 50 
Kanr (Tnl 545) kanamycin 25 
Kanr (pET30) kanamycin 70 
Ampr ampicillin 100 
Smr spectinomycin 300 
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S. pneumoniae (167) and in recombination-proficient E. coli (109). The prokaryotic 
expression vector plasmids pMAL-2 and pET-30+ a-c plasmids were purchased from 
New England Biolab (NEB) and Novagen, respectively. The relevant features of these 
and other plasmids used are listed in Table IV .. 
· Enzymes, Chemicals ~md Antibodies 
Restriction endonucleases, DNA .molecular weight standards, and most of the 
commonly used modifying enzymes were purchased from one.of the following suppliers: 
BethesdaResearch Laboratories (BRL), Promega Biotech, New England Biolab (NEB), 
. . . 
and United States Biochemical Company (USBC). Sequenase Version 2.0 T7 DNA 
Polymerase and Deep Vent DNA Polymerase were purchased from lJSBC and NEB 
respectively. DNase I, RNase, antibiotics, and bovine serum albumin (fraction V) 
(BSA) were purchased from Sigma Chemical Company. Media and agar for bacterial 
growth were purchased froni Difeo and USBC. Agarose for horizontal gel 
electrophcm~sis was purchased from Fisher. Molecular biologygrade ultrapure agarose 
. . . . . 
from Bio-rad Laboratories ~as used for prep~atory gels .. { cx-32P}-dCTP, 
{ cx-35S }-dATP, {35S}-Methionine, {3H}:-S-Adenosyl L- Methionine, and 
{ 14C }- methylated proteins were purchased from New England Nuclear research . 
Products (NEN). Primers for sequencing and PCR reactions were made at the 
Recombinant DNA/Protein Resource Facility at Oklahoma State University. 
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Table IV 
Plasmids and Cloning Vectors 
PLASMID RELEVANT FEATURE ORIGIN/REFERENCE 
pBluescript SK+ Amp\ lacZcx. Stratagene 
pVA891 Cmr Emr 
' 
126 
pLSl Tcr · 190 
pMal-2 Amp\ lacZcx. New England Biolabs 
pET30 a-c + Kanr Novagen 
pRL425 Cm\ Em\ Ampr 56 
pDG792 Kanr (from pllil ), Ampr ATCC 
pDL276 Kanr (frompllil), lacZcx. Dr. J.J. Ferretti 
pLysS Cm\ T7 lysozyme + Novagen 
pAT21-1 Kanr,(from Tn1545) Dr. Patrice Courvalin 
pIP501 Cmr Emr Tra+ 
' ' 
64 
pSJl07 [pLSl EcoRI::3.27EcoRI], Tcr This study 
pSJI 14 [SK+ EcoRI/Kpnl:: 1.05 
EcoRI/Kpnl], Ampr This study 
pSJl 15 Exonuclease/S 1 derivative of 
pSJI 14, Ampr This study 
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Table IV continued 
pSJI 16 
pSJ117 
pSJ119 
pSJ126 
pSJ133 
pSJ136 
pSJ137 
pSJ144· .. 
pSJ150. 
pSJ170 
Exonuclease/S 1 derivative of 
.••.•.. pSJl 14, Ampr 
pSJ107 with the uniqueKpnl site 
· Klenowed, Tcr 
pSJ107Al.8,kb Xbal fragment, Tcr i 
.. : ' ' .. 
[pRL425HindIIT : :B:S"sffil/Aval Kanr 
··of.pDL276], Atpp\Kanr 
· [pMalC2 XmnI:: ORF6a.J (reverse 
orientation),· Ami{ 
[pMalP2 Xmnl:: ORF6a. ], Ampr 
[pE1'30bEcoI~V/HindIIl::pSJ136 
1.4kbEc/13611/HindIIIJ, Kanr 
.• [pSJI 19Xbal::pVA891Xbal], Tc\ 
.. [pDQ792C/al Ampr::pAT21-1 Clal 
Kan1, .Amp\ Kanr. 
' . . . : ' 
· [pSJl 26lfincll Ampr:: pSJI 50 · . 
i_NruIJS~al Kan1~ Amp\ Kanr 
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This study 
This study 
This study 
Thisstudy. 
This study 
This study 
This study 
This study 
' 
This study 
. This study 
· Table IV continued 
pSJ172 
lacZa 
[pSJ119Xbal Tcr::pSJ170XbaI 
Kan1, Tc\ Kanr .· 
Resistance to. ampicillin 
· Resistance to chloramphenicol 
Resistance to kamunycin 
Resistance· to tetracycline· · 
Resistance to erythromycin 
This study 
Capable of a~complementation ·enabling chromogenic 
differentiation 
T7 lysozyme+ The plasmid pLysS has the gene for making this enzyme 
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Polyclonal antibodies against ORF6a (generated by injecting purified protein into mice) 
were obtained from the Hybridoma Center at Oklahoma State University. The anti-
mouse secondary antibody conjugated with alkaline phosphatase was a generous gift by 
Dr. Kay Scheets. Miscellaneous chemicals and reagents were purchased from Fisher, 
Sigma USBC, and VWR. 
Transformation 
S. pneumoniae Transformation 
S. pneumoniae cells were made competent according to Guild and Shoemaker 
(63). The competent cells were stored at -80°C in 10% glycerol. For transformation, 
the cells were thawed in an ice-water bath and mixed with transforming DNA (1 µg/ml 
for chromosomal DNA and 10 µg/ml for plasmid DNA). Transformation was carried 
out at 37°C for JO min. Transformation was stopped by adding DNase I to a final 
concentration of 25 µg/ml and incubating the mixture for five min at 37°C. Appropriate 
dilutions of the transformed cells were made in CATPG broth. Appropriate volumes 
were then added to 4 ml CATPG brnth with 2% bovine blood or sheep blood and mixed 
with 4 ml ofCATPGag;ar cooledto 49°C (Cell layer), and poured on a 20 ml base 
CATPG agar. After the cell layer solidified, 10 ml of CATPG agar was overlaid {Buffer 
layer) and incubated for 90 min at 37°C to allow phenotypic expression (208). The 
plates were then overlaid with· 10 ml CATPG agar containing the appropriate antibiotic 
and incubated overnight at the same temperature. 
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Competence in S. pneumoniae is due to· the release of competence factors into 
the surrounding media. Pneumococcal ceHs can be made competent by the addition of 
the supernatant of competent cells· as they contain these competence factors. As 
preparation of pneumococcal competent cells is a tedious procedure, in some cases, 
competent cells wen~ not prepared but the supernatant ofllicl (the wild-type Strain) 
competent cells was used as· described. Host cells to be transformed were grown in 
CATPGmedia to an 0Dsso11111 ~ 0.2 and 100 µl of the culture was centrifuged (14,000 
rpm, 5 min) andkept on an"icea.water bath. Rxl competent cells were centrifuged 
• C • • 
.·, /. •. •. . . ' 
(14,000 rpm, 5 min) and the supernatant was transferred to a fresh microfuge tube at 
.. . . . . . 
.' . . .. : . 
0°C. This process was repeated once.more arid then .500 µl of the comp~tent Rxl · 
supernatant was added to the pellet of the host cells at 0°C and mi.xed. The transforming 
. . 
DNA was added and the mixture vvas incubated at 37°C for 2h and then plated using the 
· overlay technique .. 
E. coli Transformation 
Competent E.colfcells were prepared and transformed according to the method 
described by Hanahan (71). The competent cells were stored for two months at -80°C .. 
. . '• . 
Appropriate volumes of transformed cells were plated imme9iately.on LB agar plates 
. containing the selective antibi9tic. One hundred. tnicroliter of 20 mg/ml 5:..bromo-4-
chloro-3-indolyl-fl'.'D-galactopyranoside (X-gal), and 10 µI of20 mg/ml of isopropylthio-
13:..n: .. galactoside (IPTG) were used for chromogenic. differentiation of recombinants and 
these were spread on the LB agar surface (100 mm) and dried before use. 
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Conjugation 
Conjugation between pneumococcal donors and recipients was performed by the 
method described by Smith and Guild (183)with minor modifications. The cells were 
grown t9 an ODssonm = 0.2in Difeo CATPG broth supplemented with 0.001 % choline 
chloride. The donors and recipient.s were mixed at ratio of 1: 5 in the presence of 10 
mM MgS04, 2 mg/ml BSA, and 100 µg cifDNase I. Approximately lx 109 cells were 
filtered onto a nitrocellulose filter(Millipore: 13 inm diameter and 45µm pore size). The 
filters were placed cell side down on Difeo CATPGagar containing 10 mM MgS04,2 
mg/ml BSA, 1 mM CaCb,·and 100 µg/ml DNase I, and overlaid with the same agar. 
Each mating was done in triplicate and n~peated at least one more time to check for 
reproducibility. Incubations were carried out at 37°C for 4 h maximum. The cells were 
harvested by cutting out both layers of agar with the filter. Each filter was then 
resuspended in 3 ml of resuspension broth (CATPG containing 10 mM MgS04, 
2 mg/ml BSA, 100 µg/ml DNase I and 10% Glycerol). After vortexing thoroughly, the 
. . 
liquid portion was transferred to a tube .and stored at ~80°C for late~ plating. 
. . . 
Appropriate· dilutions of the conjugation mix were plated by the overlay method with 
selection and scored for the transconjuga.~ts as well as the parental strains. While 
selecting for Kanr transconjugants, the 90 min expression time was·given for phenotypic 
· expression but without the buffer layer. After 90 min, the drug layer containing 
appropriate antibiotic(s) was poured over the cell layer. 
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Conjugations between pneumococcal strains and S. pyogenes strains were 
essentially performed the same way. To screen for the transconjugants (S. pyogenes 
.QTn5252) and the recipient (S.pyogenes), appropriate volumes of the mating mixture 
were spread on the surface of the plate. · The donor S. pneumoniae was plated by the 
overlay method of plating. 
The transconjugants were individually checked for unselected markers by replica · 
plating on selective CATPG agar with 2% bovine blood or sheep blood. Ifless than 50 
transconjugants were observed, all of them were replica plated, if more, then 50 were 
selected at random for replica plating. 
Chromosomal and Plasmid DNA isolation 
Chromosomal DNA isolation from S. pneumoniae 
To isolate the chromosomal DNA, S. pneumoniae cells were grown in CATPG 
to an ODssorun of 0.4, and ethylenediamine tetraacetic acid (EDTA), was added to a final 
concentration of 10 mM. ·. After a ten minute incubation at 0°C, the cells were 
centrifuged at 5,000 rpm i~ a Sorvall GSA rotor at 4°Cfor 10 min. The pellet was 
washed once in 25 ml oflx SSC (O: 15 M sodium chloride,·~5 mM sodium citrate) and 
centrifuged at 5,000 rpm for 10 min. The pellet was resuspended in 4 ml of2X SSC and 
5 ml of solution I { 5 mM EDTA, 0.1 % Sarkosyl, 10 mM Tris-HCI (pH 8.0), 1 % Triton-
X-100 and 100 mg/ml RN ase} was added and incubated at 3 7°C for 10 min or until the 
solution cleared. 1 ml oflysis mix {0.2% sodium deoxycholate (DOC), 0.1% Sodium 
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dodecyl sulfate (SOS) in lx SSC} was added and incubated at 65°C for 30 min. The 
lysate was purified according to the method described by Marmur, et al. (132) with some 
modifications. Briefly, the viscous lysate was extracted twice with an equal volume of 
phenol: · chloroform.;isoamyl alcohol (25 :24: 1 ), twice with chloroform-isoamyl alcoh9l 
(24:1), and precip,itated with two volumes of95% ethanol at -20°C for 30 min. The 
DNA was pelleted by centrifugation at 4°C at 20,800xg for JO min. The pellet was 
vacuum dried at 65°C and resuspended in TE buffer (10 mM Tris-HCl (pH 8.0), .1 mM 
EDTA). The concentrationoftheDNA was measured in a UV spectrophotometer 
(Spectronic 1001, Milton Roy Co.) and· stored at .,20°C. 
Plasmid DNA isolation from S. pneumoniae 
For small plasmid prep~rations, single colony isolates of S. pneumoniae were 
' ' 
grown in 6 ml CATPG broth with appropriate selection to an ODssorun ofOA. A3-ml 
aliquot of the culture was centrifuged at 11,750 x g for one minute and the supernatant 
discarded. The pellet was res_uspended in 50 µl lx SSC. Fifty microliters SOS/DOC 
. ' . . 
[(0.2% w/v) SOS and 0.51%(w/v) DOC] were added to the cell suspension and 
incubated at 37°C until lysis was observed. The.lysate was boiled for five·min and 10 µl 
of the sample was electrophoresed on an agarose gel. 
Large-scale plasmid purification was done by growing a 250 ml culture of 
S. pneumoniae (supplemented with 0.001% choline chloride) to an OD5sorun = 0.4. Ten 
milliliter of0.5M EDTA was added to the culture at 0°Cand the cells were centrifuged· 
at 7,000 x gin a Sorvall GSA rotor for 10 min at 4°C. The cells were washed once in 
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30 ml IX SSC and pelleted before resuspension in I ml O.IX SSC. Five and one-half 
milliliter oflysing solution containing I volume I OX lysis buffer [I% ( w/v) DOC, 0 .1 % 
(w/v) SOS], I volume oflM Tris-:-HCl {pH 8.0) and 9 volumes lOX SSC were added 
and the cells were incubated at 37°C until lysis. Seven and one-:-half milliliter of 4.4% 
· (w/v) SDS solution[4 volumes of20% (w/v) SDS, 5 volumes of IOX SSC, and I 
volume ofTris-HCl, pH 8.0] was added to the lysate and incubation was continued at 
65°C until the lysate cleared. To thelysate, 5.0 ml of4MNaCl was added, and the 
lysate was' left overnight at 4°C. The following day, the lysate was centrifuged for 40 
min at 4°C at 11,000 x g. 100 µl ofRNase (10 mg/ml) was added to the supernatant and 
the lysate was extracted once with chloroform-Jsoamyl alcohol (24:1). The plasmid 
DNA in the aqueous phase was precipitated at -20°C for an hour with 95% v/v ethanol, 
centrifuged and resuspended in 4 ml TE buffer (10 mM Tris-.HCl, pH 8.0, I mM EDTA). 
Cesium chloride (1.05 g/ml) andAOO µl of ethidium bromide (10 mg/ml) were added and 
centrifuged at 227,640 x gin a VTi65.2 rotor at l7°C for 18 h in an XL-70 
ultracentrifuge (Beckman). The plasmid DNA band was extracted using a 22-G needle. 
To remove the ethidium bromide, the fraction was further extracted with water saturated 
butanol, a~d · dialyzed overnight in 4L of TE buffer. ·• The concentration of the DNA was 
measured in a UV spectrophotometer (Spectronic 1001, Milton Roy Co.) and stored at -
20°c. 
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Plasmid DNA isolation fromE. coli 
Small-scale plasmid DNA isolation was done as described by Sambrook, et al. 
(163). A single colony of E. coli was inoculated in 3 ml (or 5 ml) of LB with 
appropriate antibiotic selection and incubated overnight.at 37°C. One and.one-half 
milliliter ( or 3 ml) of the overnight culture was centrifuged at 11,750 x g at room 
temperature for 30 secs; Cells wei;e resuspended in 200 µl of ceH resuspension solution 
[50 mM glucose, 25 mM Tris-HCI (pH 8.0), and 10 mMEDTA] byvortexing vigorously 
and kept at room temperature for 5 min. Cells were lysed with 200 µ1 offreshly 
prepared lysis solution [0.2NNaOH, 1% SDS] and kept at room temperature for 
another 5 min. The lysate was mixed with 200 µl of neutralization solution [3 M 
potassium acetate (pH 5.2)] and held on ice for five min. The lysate was centrifuged at 
11,750 x g at room temperature, twice for 5 min. The supernatant fluid was transferred 
to a fresh tube. Plasmid DNA was precipitated with two volumes of 95% ethanol at .. 
20°C for 15 min. The DNA was pelleted, vacuum dried and resuspended in 50 µl TE 
buffer. Ten microliters of the plasmid DNA was electrophoresed on an agarose gel to 
check for recombinant plasmids. For restriction endonuclease analysis, the plasmid DNA 
was extracted using phenol-chloroform prior to ethanol precipitation. 
Large-scale plasmid purification was performed essentially in the same manner as 
the miniprep except for the use of a 250 ml culture for scale-up and a CsCl density 
gradient to separate the plasmid from the genomic DNA. In case of low copy number 
plasmids, an additional plasmid amplification step was performed by growing the cells 
for a further 12 h in the presence of spectinomycin (300 µg/ml). Cesium chloride at 
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1.0 g/ml and ethidium- bromide at 1 mg/ml were added to the DNA resuspended in TE 
buffer, centrifuged at 227,640 x gin a VTi65.2 rotor at l 7°C for 18 h (or at 383,700 x g 
for 4 h) in the XL-70 ultracentrifuge (Beckman). The plasmid DNA band was extracted 
using a 22-G needle, to remove the ethidium bromide it was further extracted with water 
saturated butanol, and dialyzed overnight in TE buffer. 
DNA Manipulation 
Cloning 
The DNA fragments ofTn5252 were subcloned in plasmid vectors and 
transformed into E.coli host cells, and in some cases, competent S. pneumoniae cells. 
Ligations were carried out in 20 µl volume with less than 5 µg DNA at a ratio of one 
vector to five inserts at 16°C for 24 h. Ligations that·were used for transforming 
competent pneumococcal cells were.carried out in a reaction volume of 60 µI·with 
approximately 10 µg of DNA with a vector:insert ratio of 1 :5. For insertion 
mutagenesis, the insert:vector ratio was 1: 1 in a 60 µl volume. After overnight 
ligations, the ligation mixture was extracted with phenol-chloroform, linearized with 
restriction enzyme and used as donor DNA in transformation of competent 
pneumococcal cells. 
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Agarose Gel Electrophoresis 
DNA samples were analyzed at rqom temperature by separation on horizontal 
agarose gels using 1/2X TBE (45 mM Tris-borate, and 1 mM EDTA, pH 8.3). 
Depending on the size of the DNA,the concentration of the agarose varied from 0.8%-
1.2%. The DNA samples were mixed with tracking dye containing 5% (v/v) glycerol, 3 
,: ' :· .• . 
mM EDTA (pH 8.0), bromophenolblue (0,04%) and xylene cyanol (0.04%), before 
loading. Typically, the gels were run at 5 volts/cm constant electric current for 
approximately 90 min. After electrophoresis, the separated DNA samples were observed 
on a 300 nm UV illuminator after. the gels were stained in ethidium- bromide (1 µg/mi 
final concentration) for 10 min followed by destaining in deionized water for the same 
period. Photographs were takenusing a Kodak Polaroid camera or an Alpha Imager 
2000 of Alpha Innotech Corporation. Molecular weight standards (HindIIT fragments of 
phage Lambda and HaeIIT fragments of phage <!>XI 74 or 1 kb ladder ofBRL) were run 
along with the DNA samples for size comparison. Preparative minigels were used to 
purify s~ecific DNA fragments, and 0.8% gels were made with ultrapure agarose (Bio-
Rad). After staining and destaining, a gel slice containing the DNA fragment was 
electroeluted and purified according to Sambrook; etal. (163). 
Conversion of3' overhang to blunt-end with Klenow fragment 
The single stranded 3' overhangs were converted to a blunt end using the 3'-->5' 
exonuclease activity of Kienow DNA Polymerase. The reaction mix consisted of 4.5 µg 
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of digested DNA, lX Kienow buffer and Kienow DNA polymerase (1-5 units) in a final 
volume of 5 0 µI.· The reaction was incubated at room temperature for 15 min. 
Following phenol:chloroform-isoamyl alcohol extraction, the DNA was precipitated with 
1/2 volume 7.5 M ammonium acetate and 2 volumes ethanol for 20 min at -20°C and 
used in ligation reactions. 
DNA Sequencing with T7 DNA Polymerase 
(Sequenase version 2.0) 
Dideoxy-chain-termination method of sequencing (163) was carried out with 
Sequenase version 2.0 (USBC) T7 DNA polymerase, and [a-35 S]dATP (12.5 mCi/ml) 
from NEN. M13F, Ml3R, pMalE were the standard primers used. Primers specfic for 
the transposon DNA under study were synthesized at the DNA/Protein Recombinant 
DNA/Protein Resource facility of Oklahoma State University. 
DenaturingPolyacrylamide Sequencing Gel 
Seven percent (w/v) polyacrylamide gel containing a concentration gradient in 
TBE buffer was prepared according to the methods described by Biggin, et al. (18). For 
electrophoresis, a Sequi-Gen Sequencing Cell from Bio-Rad was used. Both the glass 
plates were thoroughly cleaned and air dried. The gel plate was coated with "Glue" 
(10ml 95% ethanol, 30 µ1 glacial acetic acid, 50 µl of G-methacryloxy propyl 
trimethoxysilane and 0.5 ml of ddH20), and the buffer chamber plate was coated with 
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Sigmacote (Sigma). Gel solution A contained 17 .5% .(v/v) of 40% acrylamide solution 
(38% acrylamide and 2% bis-acrylamide), 25% (w/v) urea and 10% (v/v) TBE buffer. 
Immediately before pouring the bottom plug as well as the gel, 0.3% (w/v) ammonium 
persulfate (APS) and 0.05% TEMED (N, N, N',N'-tetramethylethylenediamine) were 
added to the solution. The plates were assembled and the b·ottom was plugged with the 
solutionB [Solution A supplemenied with 2~%(w/v) of sucrose and 0.005% (w/v) of 
bromophenol blue]. The gel apparatus was filled with the denser solution Bat the 
bottom of the gel at a ratio of 1: 5 (solutio~ B: solution A) and the chamber was filled 
with solution A,. .. The gel was allowed to solidify at room temperature for at least 18 h. 
Constructions of nested deletions for sequencing 
Nested deletions were created of DNA fragments over 1. 0 kb in size cloned in 
· pBluescript vector. The recombinant plasmid was doubly digested with two restriction 
enzymes in such ~ way that they left a 5' - recessed end near the primer binding site and a 
3' - recessed end near the end of the insert DNA. This was done to provide a substrate 
for the enzyme e~onuclease III used for creating deletions as it contains a specific 3 ' ---
>5' exonuclease activity. The reaction mixture~ a total volume of 100 µl; containing 
approximately· 5 µg of double digested DNA, 10 µl of lOX exonuclease buffer (0.66 M . 
Tris-HCl, pH 8.0 and 6.6 mM MgCh) and exonuclease III (450 U/reaction) on ice. The 
reaction was started by transferring the tube to 30°C water bath and 10 µl samples were 
removed every minute for 10 min and transferred to 0°C. The first five· samples were 
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combined in one tube and the last five samples in another before adding .150 µI of S 1 
nuclease solution (150 U Sl nuclease, 1% glycerol, 60 mMNaCI, 
1.3 mM ZnS04, and 8 mM potassium acetate, pH 4.6). The tubes were transferred to 
room temperature for 20 min. This was done to generate plunts ends as S 1 nuclease acts 
on single stranded DNA. The reaction was terminated with 20µ1 of S 1 stop buffer ( 50 
mM EDTA and 0.36 M Tris base). The samples were extracted with phenol: 
chloroform-isoamyl alcohol and·chloroform-isoamyl alcohol followed by ethanol 
precipitation. The DNA was ligated.and transformed into E.coli JM109 cells. The 
. . 
deletion derivative plasmids were isolated, their sizes confirmed by restriction analysis 
and used for sequencing. 
Preparation of Plasmid DNA templates 
Double-stranded-DNA templates were prepared with the Wizard miniprep DNA 
purification system (Promega) according to the manufacturer's recommendations with 
some m.odifications. 10 ml of an overnight culture was centrifuged and resuspended in 
200 µI of cell resuspension solution (50 mM glucose, 25 mM Tris-HCI (pH 8.0), and 10 
mM EDTA). The cells were lysed by the addition of200µ1 lysis solution (1% SDS and 
0.2 N NaOH) a:t room temperature for five min. The lysate was next neutralized with 
200 µl of3.0 M potassium acetate (pH 5.2) for 5 min at room temperature. After 
centrifugation at top speed in a microfuge (13,000 x g), the supernatant was transferred 
to a fresh microfuge tube and 1 ml of DNA purification resin was added to it and mixed 
by inversion. The mixture was passed through a purification column using a 3 ml 
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disposable syringe. The column was washed once with 2 ml of column wash solution 
(80 mM potassium acetate, 8.4 mM Tris-HCI (pH 7.5), 40 µM EDTA, and 55% 
ethanol). The excess wash solution was removed by brief centrifugation and the DNA 
was eluted with 100 µl TE buffer and stored at -20°C. · This protocol provided DNA that 
could be used for fluorescent sequencing at the Oklahoma State University Recombinant 
DNA/Protein Resource facility. 
Denaturing the Plasmid DNA 
The double-stranded..:DNA (dsDNA) (lµg) was denatured with 0.2 NNaOH and 
0.2 mM EDTA at room temperature. It was neutralized with 0.3 M Tris-HCI, pH 4.5, 
. and 0.8 M sodium acetate on ice. The denatured DNA was precipitated with ethanol, 
pelleted, vacuum dried and stored at -20°C. 
Priming of Denatured DNA 
Annealing of template to primer was carried out. by setting up a 10 µl reaction 
volume containing 1 µg DNA, 30 ng primer, and IX Sequenase reaction buffer and 
incubating it at 37°C for 20 min. A number of synthetic primers were constructed at the 
Recombinant DNA/Protein Facility, Oklahoma State University. M13 forward and 
reverse primers (Promega), and malE primer (NEB) were also used. 
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Labeling of the Plasmid DNA 
The primed DNA wa~ transferred to 0°C and 3.5 µl oflabeling mix and 2.0 µl of 
Sequenase version 2;0 were added. Labeling was allowed to proceed for 10 min at 0°C. 
The labeling mix was prepared by mixing 10 µl of[cx.35-S] dATP, 16 µl of0.1 MDTT 
and 34 µl of dGTP mix for obtaining long stretches of DNA sequences. For obtaining 
sequences closer to the primer binding site, 10 µl of dGTP mix, 10 µl of 
{cx.35-S} dATP, 28 µl of0.1 MDTT and 52.0 µlofdouble distilled water (ddH20)were 
mixed. The enzyme was diluted 1 :7 with 1 µl of enzyme and 7 µl of enzyme dilution 
buffer. 
Termination 
Four tubes, labeled G, A, T, C were placed at 49°C in a warming block and to 
each.tube 2.5 µl of the corresponding termination mix (ddNTP) was added. The labeled 
DNA (3.5 µl) was added to each of the four tubes, centrifuged, and incubated for 4 min 
at 49°C. All the tub~s were transferred to room temperature and 4 µl of stop buffer 
(95% formamide, 20 mM EDTA, 0:05% bromophenol blue and 0.05% xylene cyanol 
FF) was added to each tube and stored at -20°C until ready for sequencing. 
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Denaturing Polyacrylamide Sequencing Gel Electrophoresis 
Following polymerization, the gel was prerun for 1 hour or until the temperature 
reached 40-45°C, using 0.5X TBE in the chamber and IX TBE in the bottom tray at 35 
Watts constant power. Before loading, samples were denatured in a 95°C water bath for 
2 min and immediately loaded on the gel. To get effective resolution of the sequences, 3 
M sodium acetate was added to the bottom ofthe tray to yield a final concentration of 1 
M after the bromophenol blue in the sample ran off. At the completion of 
electrophoresis, the gel apparatus was dismantled and the glass plate with the gel was 
fixed for an hour at room temperature in 10% glacial acetic acid. The gel was briefly 
rinsed with distilled water and dried overnight at 65°C. The gel was exposed to X-ray 
film (Kodak XAR-5 or BIOMAX MR) until sufficient exposure was obtained. The 
sequences were manually read by placing the autoradioGram on an illuminator. 
Nucleotide Sequence Analysis and Molecular Modeling 
To analyze DNA sequences for restriction sites, identification of open reading 
frames and predictions of amino acid sequences, Mac Vector 4.5.3 software proGram 
was used. Similarity searches and bestfit analyses of the deduced amino acid sequences 
of potential open reading frames were performed by using the UWGCG Sequence 
Analysis Software Package (Genetic Computer Group, Inc. Wisconsin) via the 
University of Oklahoma Computer Center or the internet. 
64 
To predict the structure of ORF6a, SWISS-MODEL 
(http://www.expasy.ch/spdbv/mainpage.htm) was used. Multiple sequence alignment was 
also done using this service. 
Southern Hybridization 
Blotting 
DNA-DNA hybridizations were essentially performed according to the method 
described by Southern (186). DNA samples for blotting were first digested using the 
appropriate restriction enzymes. The fragments were separated on 0.8% agarose gels, as 
described earlier. The DNA fragments were denatured with 0.5 MNaOH for 30 min at 
room temperature. The DNA was transferred onto a Genescreen Plus nylon membrane 
(NEN) using a Model 785 Vacuum Blotter (Bio-Rad). After transfer,the membrane was 
soaked in 2X SSC for 5 min, air-dried, and stored in a dessicator under vacuum. 
Pre-hybridization 
Before hybridization with a radiolabeled probe,.themembrane with the DNA was 
placed in a "seal-a-meal" bag to which 10 ml of the prehybridization solution (lg 
Dextran Sulfate, 0.58g NaCl, 1 ml 10% SDS and 8 ml ddH20) was added. The solution 
was spread evenly on the membrane, and after squeezing out air bubbles, the bag was 
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sealed and prehybridization was carried out in a 65°C water bath overnight with gentle 
shaking. 
Nick translation 
Labeling of DNA to be used as probe for Southern hybridization was carried out 
as follows. Probe DNA (0.5-1.0 µg)was nic::k translated in the presence of 0.5 µl of 
DNase I (0.5 µg/ml), 5 µl of lOX buffered dNTP mix (5 µMeach of dATP, dTTP and 
dGTP), 5 µl {a.-32P} dCTP(lOmCi/ml), and0.5 µlofE. co/iDNApolymeraseI 
(9000U/ml}in a 50 µ1 total volume. The DNA was labeled at 16°C for 2 h. The reaction 
was terminated by adding 25 µl of O. 5 M EDT A, 25 µl of sheared salmon sperm DNA (2 
mg/ml), 50 µl of7.5 M ammonium acetate and 50 µl of TE. The DNA was precipitated 
with 100% ethanol for 15 min at-20°C, pelleted, dried, and resuspended in 600 µl of TE. 
The efficiency of incorporation of the isotope was measured by diluting 1. 0 µl of the 
labeled probe in 5 ml of liquid scintillation cocktail (Beckman) and measuring the 
radioactivity in an LS 6000 SC liquid scintillation counter (Beckman). 
Hybridization 
Labeled DNA (1-4 x 106 CPM) was mixed with 100 µl 20X SSC, 400 µl 
sheared salmon sperm DNA (2 mg/ml) and the volume was adjusted to 2.0 ml with 
ddH20 in a screw capped tube. The probe was denatured by boiling for 10 min. The 
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denatured sample was cooled rapidly by swirling in an ice bath for 3 min. The plastic 
bag containing the prehybridized membrane was cut open and. the denatured probe was 
added into the bag using a Pasteur pipette and resealed. Hybridization was carried out in 
a 65°C waterbath with gentle shaking for at least 18 h. Following hybridization the 
membrane was removed from the bag and washed twice with 2X S SPE buffer { 17. 53% 
. . 
(w/v) NaCl, 2.76% (w/v) ofNaHi,P04~ and 0:74% (w/v) ofEDiA, pH 7.4} for 15 min 
at room temperature, twice ~th 2X. SSPE, 2% SDS for 45 min ~t65°C, twice in O. lX 
. . .. ·. 
SSPE buffer for 30 min at room temperature, a~d once in 3 rnM.Tris base (unbuffered) 
. . 
solution for 15 min at room.temperature. The membrane was briefly air-dried, and 
exposed to X-ray film (KodakX-OMAT AR) at-80°C forvaryingtime periods. The 
exposed film was·. developed according to the manufacturer's recommendation. 
In vitro Transcription and Translation 
. In vitro transcription and coupled translation were performed using the S30 
extract system of Promega using circular DNA as the template. 
E.coli S30 Extract system for circular DNA 
The standard reaction consisted of 4 µg of DNA template, 5 µl amino acid 
mixture lacking methionine, 20·µ1 S30 premix (lacking aminoacids but containing all 
other required components, including NTPs, tRNAs, an ATP generating system, IPTG 
and appropriate salts), 1 µl {35S}- metluonine (1,200 Ci/mole at 15 mCi/rnl), 15 µl S30 
67 
extract and nuclease-free water to bring the final volume to 50µ1. After mixing the 
components by a quick spin, the reaction was allowed to proceed for 2 hat 37°C. The 
reaction was stopped by transferring the tubes to 0°C for 5 min. 
pBESTluc DNA was included irt the protocol as the positive control. A negative 
control with pLS l alone, the vector used for the cloriing of passenger DNA, was also 
included. 
Gel Analysis of Translation Products 
Once the.,,S30 extract reactionw~s completed,. a 5 µl aliquot was removed for 
acetone precipitation. 20 µLof acetone was added to the reaction mix and incubated at 
0°C for 15 min. The pellet was dried for 15 min under vacuum, resuspended iri .20 µl 
sample buffer, arid heated at 100°C for 5 min before loading on a SDS-polyacrylamide 
gel. 
Discontinuous SDS-Polyacrylamide Gel Electrophoresis (PAGE) 
Discontinuou~ SDS-PAGE was performed and described by Laemmli (111 ). A 
stock solution pf22% (w/v) aciylamide A (BRL) was prepared by dissolving 100g 
acrylamide and 2.7g bis-acrylamide (Fisher) in a total volume of500 ml of ddH20 and 
· stored at 4°C. The concentration of acrylamide in the separating gel varied from l 0-12% 
(w/v) depending on the size of the proteins to be separated; however, the stacking gel 
was always 3% (w/v). To make the electrophoresis mixture for the separating gel, 10.0 
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ml of 1.5 M Tris-HCl (pH 8.8), 0.4 ml of 10% SOS, a calculated volume of acrylamide 
A to yield the required concentration and ddH20 to make a final volume of 40 ml were 
· mixed and deaerated for 15 min. Before pouring the mixture into the gel casting 
assembly, 0.4 ml of 5% ammonium persulfate (APS) and 40 µl of TEMEO were added. 
The acrylamide 'was overlaid with water saturated butanol and allowed to polymerize for 
30 min. The stacking gel was made by mixing 1.35 ml Acrylamide A, 0.1% SOS, 2.5 ml 
' ' 
of0.5 M Tris-HCl (pH 6.8) and 6 ml of ddH20. After deaeration, 150 µl APS and15 µl 
TEMED were added and poured over separating gel. Electrophoresis was carried out in 
Tris-Glycine-SOS buffer, using Life Technologies Model 250 power supply, at 20 mA 
constant current through the stacking gel and then the current was increased to 45 mA 
when the blue dye has entered the separating gel. Typically; one run was completedin 3-
. 4 h. For rapid screening of the protein products or western blot~, the mini-protean II gel 
electrophoresis apparatus (Bio-Rad) was used which had a run time ofless than an hour. 
Samples for electrophoresis were prepared by either pelleting 1 ml of cells and 
resuspending in 100 µl . IX sample buffer or,· if collecting fractions, 100 µl of the fraction 
was mixed with an equal volume of2X sample buffer. Broad range {2-212 kDa) protein 
markers {NEB) were also run along with experimental samples as a reference for size 
' ' 
determination in· each gel. To visualize unlabeled proteins; after electrophoresis, gels 
were stained overnight in 50% ethanol, 10% glacial acetic acid, and 0.1 % Coomassie 
brilliant blue R. The gels were then destained in warm 7% glacial acetic acid. 
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· Fluorography 
Following electrophoresis, labeled protein bands were visualized by fluorography. 
. . . 
Fluorography was carried out according to the method ofLaskey (114). In brief, the 
gels were soaked for 30 min in DMSO (Dimethyl sulfoxide)and this was repeated three 
times. This was then followed by soaking in 22% 2,S~diphenyloxazole (PPO)/DMSO for 
3 h. The gels were finally washed in double di.stilled water for l h and vacuum dried on 
a 3 mm Whatman filter paper. The dried gel was exposed to X-ray film (Kodak X-
OMAT AR) at-80°C and the film was developed following the recommendations of the 
supplier. 
Western Blot 
The electrophoretic transfer of the proteins froin the SDS-PAGE gels was done 
using the mini Trans-Blot Electrophoretic transfer cell of Bio-Rad according to the 
manufacturer's recommendations, Briefly, transfer buffer (25 mM Tris, 192 mM 
. . . . . . . . . . 
. . . ' . 
. . 
Glycine) was made and stored at 4°C, at least overnight.. After electrophoresis of the 
. . . 
proteins, the discontinuous SDS-P AGE gel w~s removed from the glass plates and the 
stacking gel wa.s trinuned off the gel, cut .nitrocellulose rriembrflne, pre;.cut filter papers 
and fiber pads were all soaked in the transfer buffer for 30 min at room temperature. 
The blot was assembled (as per the manufacturer's instructions) with the gel and the· 
membrane sandwiched between filter papers·and fiber pads and all the air bubbles were 
removed. The whole assembly was placed in the buffer tank and the tank was filled with 
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the transfer buffer. The frozen Bio-Ice cooling unit that was prepared earlier by freezing 
deionized, distilled water was also placed in the buffer chamber. A stir bar was also 
placed at the bottom of the buffer chamber for complete mixing. Then the power was 
turned on and run at 100 volts at 250 mA for one hour, After one hour, it was 
disassembled and .the membrane was checked to make sure that the prestained protein 
markers had transferred. After this step, the membrane was rinsed in 50 ml of PBST 
(PBS with 0.05% Tween 20}for 15 min. At the end of 15 min, the solution was 
removed and appropriate amount of the antibodies (primary antibody) diluted in PBST 
(usually 1/200 of the final volume) was added and.the blot shaken at room temperature 
for at least 1 h. The solution was discarded and the blot was washed 3 x with 50 ml 
PBST, five min each. The secondary·antibody conjugated to alkaline phosphatase (rabbit 
antimouse IgG-alkaline phosphatase) diluted inPBST (1/5000) was added and the blot 
was shaken at room temperature for 2 h. The blot was washed 3 x in 50 ml PBST, 5 min 
· each and washed once with PBS for 5 min. Then the blot was transferred to the alkaline 
phosphatase buffer [O. lM Tris-HCI (pH 9.5), O. IM NaCl, 0.2 mM MgCh, 2 µM ZnCh 
and 0.02% NaN3] and left in that buffer until ready to expose to Lumiphos-530. On a 
clean, dry glass plate, 0.5 - 0.6 ml ofLumiphos-530 was spread (matching the width of 
the blot). The blot was taken from the alkaline phosphatase buffer, excess buffer was 
drained off, and placed carefully so that the protein side touched Lumiphos--530 and left 
for 1-2 min. The blot was removed, the excess ofLumiphos-530 was drained off and 
the blot was kept inside a plastic sheet protector and was exposed to an X-ray film 
(Kodak XAR-5 or BIOMAX MR) until the bands were visible. The blot was exposed to 
Lumiphos-530 again, if needed. 
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Preparation of E.coli totallysate 
(for absorption of anti-E.coli antibodies) 
The host cells used for purifying the ORF6a protein were BL21 (DE3) · 
containing the plasmid pLysS, and the expression vector used for doning QRF6a gene 
was pET30b. Totai lysate from these cells ~as prepared tti cross~react and remove the 
contaminating antibodies from the polyclonal antisera ·developed against ORF6a. .The 
host cells containing the plasmids pET30b + and pLysS were grown in 20 ml Rich broth 
at 3 7°C, overnight with appropriate ~elections .•. The n~xt morning, 1 liter of fresli rich 
broth with 2.5 mM betaineHCl and appropriate selections was inoculated with·lO ml of 
the overnight grown culture and incubated at 37°Cuntil an ODssonm of0.6 was reached. 
The cells were centrifuged at 11, 750 x g for 20 min and the pellet was resuspended in 
100 ml of lX SSC. The cells were centrifuged again for 20 min at 11, 750 x g and the 
pellet was resuspended in 10 ml solution of20% sucrose and 50 mM Tris-HCl{pH 8.0) .. 
To this, 100 mg oflysozyme was added and incubated at 0°C for 10 min. 4 ml of0.3 M 
. . . .. . : 
EDTA was added and incubation was continued at 0°C for another 10 min. To this,.14 
mlsolution of0.4% Triton-X--100, 30 mM EdTA, 50 mM Tris-HCl (pH 8.0), 50 µg/ml 
. . . 
DNase I and 50 µg/n:tl RNase was added very slowly and swirled gently at room 
temperature for 15 min. 2 ml of 10% Triton-X-100 was added later and incubated for 
20 min at 37°C. It was sonicated six times for 20 sec pulses and centrifuged at 
23,000 xg for 30 min. The supernatant was stored in aliquots at -20°C. 
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Absorption of Anti"'.E, coli antibodies 
The totallysate prepared was used for absorption as described in Sambrook, et 
al. (163). • Briefly, the antiserum was diluted 1:10 with TNT [10 mM Tris-HCl (pH 8.0), 
150 mM NaCl, 0.05% Tween 20] containing 1 % gelatin and .5% nonfat dried milk. For 
every milliliter of this diluted antiserum, 0. 5 ml of the lysate prepared was added and 
incubated at room temperature for 4 h. The absorbed antibody was stored at 4°C in the 
presence of0.05% sodium azide until needed. 
DNA Amplification with the Polymerase Chain Reaction (PCR) 
DNA amplifications were performed with Deep Vent DNA polymerase (NEB). 
The basic PCR protocol was as recommended by the manufacturer with some 
modifications. PCR assays were done in 100 µl total volumes in 0.5 ml micro-centrifuge 
tubes. Transposon DNA from the streptococcal species under study served as a 
template DNA. A typical reaction mixture contained 10-100 ng of template DNA, two 
primers each at 0.2 - 1.0 mM concentration, IX concentration of Vent reaction buffer 
{ 10 mM KCl, 2 mM (NRi)S04, 20mM Tris-HCl (pH8.8), 2 mM MgS04 and 0.1 % 
. . 
· Triton X-100}, 1.25 mM each dNTPand 0.75 UDeepVent DNA polymerase. The 
reaction mixture was overlaid with 100 µl. sterile mineral oil, briefly centrifuged, and 
PCR performed in a Coy Tempcycler Model 60 (Coy Laboratory Products, Inc.). 
On average, 30 cycles of amplification were carried out, each consisting of a 1 
minute denaturation period at 94°C, 45 sec annealing at a temperature which was 5°C 
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lower than the calculated melting point of the primer with the lower Tm, and a variable 
extension period at 72°C. The Tm (also called Td; dissociation temperature), was 
calculated by the relation, Tm= 4(G+C)+ 2(A+T), where the letters stand for each 
nucleotide in the primer;·· The extension period was determined by allowing. I minute per 
kilobase ofDNAat 72-75°C and, therefore, depended on the length of the DNA segment 
to be amplified:. After the amplification 100 µl of TE buffer was added to the microfuge 
tube and briefly centrifuged, then approximately 195 µl of the bottom layer was 
transferred to a fresh microfuge tube arid .stored at -20°C until ready for gel purification. 
. ' 
5 µl of the amplified DNA was checked on an agarose gel to assess the quality 
and quantity of the amplified product. PCR amplified products were then purified by 
using preparative iniru-gels{0.8%) made with ultra pure agarose (Bio-Rad). After 
destaining, a gel slice containing the DNA fragment was electroeluted into a dialysis bag 
and purified according to Sambrook, et al. (163). 
Protein Purification 
Protein purification using the pMAL P2 system (pilot) 
The strain containing plasmid pSJ136 was grown overnight in rich broth with 
ampicillin. From this overnight grown culture, fresh rich broth was inoculated with 
selection and grown to an OD60onm of0,5. One ml of this culture was centrifuged and the 
pellet was resuspended in 50 µl of IX SDS-PAGE buffer and stored and this served as 
the uninduced control.· To the rest of the culture, 0.3 mM IPTG was added and the 
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mixture incubated at room temperature for 3 h:. A 500 µl sample was taken from this 
culture every hour until 3 h and was centrifuged. The pellet was resuspended in 100 µ1 
' . 
of lX SDS-PAGE buffer and stored, to compare the level of induction. The rest of 
theculture was split into two and was centrifuged. One of the pellets was resuspended in 
4 ml of column buffer [20 mM Tris-HCl (pH 7.4), 200 mMNaCl and 1 mMEDTA], and 
the other was resuspended in 8 ml ofa solution containing 30 mM Tris-HCl (pH 8.0) and 
20% sucrose. The cells were stored at -20°C. 
For obtaining the cellular fraction (crude extract), the cells stored in the column 
. . ·.· . 
buffer were thawed and sonicated .in short 15.,sec pulses, 1 O times with · I-minute 
intervals. The sonicated cells were centrifuged at 20,000 x g at4°C for 25 min. The 
supernatant representing the cytoplasmic fraction was stored. The pellet obtained was 
resuspended in 4 ml 8 M urea and stored as the insoluble fraction.· Five hundred 
micro liter of the crude extract was mixed with the amylose resin and incubated on ice. 
After 15 min, it was briefly centrifuged, the supernatant was removed and stored, this 
served as.the fraction that was not bound to the resin. The pellet was resuspended to 
50 µl of lX SOS-PAGE buffer and stored as the fraction bound tothe resin. · A small 
· fraction of the resin bound crude extract (50 µI) was mixed with 10 mM Maltose and 
. ' . . . : . . . . 
incubated for 10 min at room temperature. Then it was centrifuged and the supernatant 
was removed a~d stored .. This>wasthe fraction containing proteins released by maltose. 
For obtaining the periplasmic fraction, 20 µl of0.5 M EDTA was added to the . 
cells stored in Tris/sucrose and incubated for 10 min at room temperature with shaking. 
Then the mixture was centrifuged at 11,000 x g at4°C for 10 min. The supernatant was 
discarded; the pellet resuspended in 8 ml of ice-cold 5 mM MgS04, and shaken for 
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10 min in an ice-water bath. It was centrifuged at 4°C for 10 min at 11,000 x g. The 
supernatant is the cold osmotic shock fluid. 
Purification of Target Protein Using the pET system 
The protein ofinterest to this study was purified in larger quantities using the 
pET system using the BL21 (DE3) host containing the plasmid pLysS. The method used 
was as suggested by the ma~ufacturer .. Briefly, glycerol stock culture was used to 
streak a LB ag~r plate with appropriate. antibiotics and incubated overnight. A single · 
colony was picked from the plate; t1sed to inoculate a 25 ml fresh rich broth with 
ap~ropriate antibiotic selection and incubated with shaking until OD6oonm= 0.6. The 
culture was stored at 4°C ovemighf The following day, 20 mi of the overnight culture 
was centrifuged and the pelleted cells were used to inoculate I liter of rich broth 
containing appropriate antibiotics and 2.5 mM betaine-HCI. The culture was incubated 
for 3 h at 3 7°C until the OD60onm reached O. 6, A 1 ml sample was removed, the cells 
pelleted and resuspended in 100 µ1 of IX sample buffer to serve as the uninduced 
. ·. ; . . ; .. •. . 
ccmtrol. The remaining culture was iriduced with IPTG at a final concentration of 1 mM 
and incubated at roomtemperature for 3 h. A 1 ml sample was collected, pelleted and 
resuspended in 100 µl of 1 X sample buffer after every hour to compare the level of 
expression with that of an uninduced sample. At the end of 3 h, the flask was transferred 
to ice for 5 min and the cells were pelleted by centrifugation at 5000 x g for 5 min at · 
4°C. The pellet was resuspended in 30 ml IX Binding buffer (5 mM imidazole, 0.5 M 
NaCl, 20 mM Tris-HCI pH 7.9) and 0.1% triton was added and stored at-20°C 
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overnight. After thawing at 0°C, 0.05% sarkosyl and l mM PMSF were added and the 
sample was sonicated for 4 min in 20 sec bursts with the tube in an ice-water bath to 
avoid heating of the sample that may lead to degradation of proteins. Soni cation was 
continued until the sample was no longer viscous. The iysate was centrifuged for 30 min 
at 10,000 x g. 100 µl of the superiiatant (soluble fraction) was mixed with 100 µl of2X 
sample buffer and stored. A majority of the protein of interest was found to be in the 
insoluble fraction. Hence, the pelletwas dissolved in 40 ml IX binding buffer containing 
. . . . 
6M urea. On:e hundred micro liter of this insoluble fraction was mixed with 100 µl of 2X 
SDS sample buffer and stored. The urea-solubilized proteins were then filtered through 
a 0.45µ filter {Nalgene). The volume was made up to 100 ml with the same buffer and 
us.ed to load the affinity column. One hundred microliter of this filtered insoluble 
fraction was mixed with 100 µl of 2X SDS sample buffer and stored. · 
. . 
To purify the protein from the soluble fraction, a two liter or a four liter culture 
. was used, as the amount ofinduced target protein in the soluble fraction was very low . 
. The protocol described above was followed to obtain the soluble fraction (200 ml) and 
this fraction was filtered before loading the affinity chromatography column. As before 
. . . 
samples obtained during the purification process were stored for SDS-P AGE arid 
methyltransferase assay. 
· Affinity Chromatography 
To prepare the column, the resin (His. Bind metal chelation resin) was poured 
into a clean column and allowed to settle by gravity. The column was equilibrated with 
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seven column volumes of IX charge buffer (50 mM NiS04). The column was 
equilibrated with three column volumes of IX Binding buffer with 6M Urea. The 
prepared extra.ctwas loaded in the column and the column was washed with 10 volumes 
of IX binding buffer with 6M urea. The flow rate was maintained at 10 colu~ volumes 
per hour. One hundred microliter of the unbound sample was mixed with 100 µl of · 
sample bufferto check for efficiency of binding. The bound protein was eluted using a 
gradient ofimidazole, formed with IX binding buffer with 6M urea and IX elute buffer .· · 
(1 M imidazole, 0.5 MNaCl, 20 mM Tris-HCI pH7.9) with 6M urea. Ten microliter of 
each of the fraction was used to perform a Bradford assay to determine the 
.·: •' . ·. . . . . . 
concentration of purified protein in the fractions. 15 µl of each of the samples collected 
during the course of the process and the different fractions were loaded on a 12% SOS-
. . 
PAGE gel to check the efficiency of expression and purification and to check for the 
presence of the protein. 
· The procedure for affinity chromatography of the soluble fraction was essentially 
the same as for the insoluble fraction except that the proteins were eluted with the elute 
buffer that did not contain urea. In some cases· elute buffer. containing 200mM, 400mM 
or IM imidazole was used to elute the resin bound prnteins: 
. . . 
Processing the purified sample 
The fractions containing the protein peak were pooled and dialyzed to 
concentrate the protein as follows: The protein containing fractions were transferred to a 
dialysis bag and dialyzed overnight against 41 buffer [20 mM Tris-HCI (pH 8.0), 100 
78 
mMNaCI, 50 mMKCI, 1 mMEDTA, 1 mM ~-mercaptoethanol, lµMPMSF, 0.1% ·. 
triton-X-100, and 0.05% sarkosyl) containing 5 M urea. After overnight dialysis, the. 
process was repeated with buffer containing 4M 'urea for 6 h, and every 6 h, the dialysis 
buffer was changed with a fresh buffer con~aining less urea until almost all of the urea 
was dialyzed out The sample recoveredwas centrifuged at 10,000 rpm for 30 min at 
. . . 
4°C to remove the precipitates, ifany. The sample was dialyzed against 21 of the same 
buffer containing 50% glyc~rolbiltwithout any urea at 4°C overnight. The proteinwas 
stored at ~80!>C for further experimentation. · 
. . 
The fractions obtained while purifyingthetarget protein from the soluble fraction 
were either dialyzed against a buffer containing 10 mM Tri~-HCl(pH 7.4), 25 mM KCI, 
1 mM OTT, 10 µM AEBSF [4,-(2 .. Aminoethyl)-Benzenesulfonyl Fluoride 
. . . 
Hydrochloride] and 50% glycerol or a buffer containing so·mM Tris-HCl (pH7.4)~ 200 
mM KCI, 10 mM EDTA, 1 mM OTT, and 50% glycerol, prior to storage. 
HPLC Analysis 
Some of the fractions obtained while purifying the target protein from the soluble 
:fraction were sent to the Recombinant DNA/Protein Resource facility of Oklahoma State 
University for gelfiltraticm an~ly~is.using HPLC.· The proteins were eluted from the gel 
filtration column using either the elute buffer containing 200 mM imidazole or a buffer 
containing 50 mM Tris.;HCI (pH 7.4), 200 mM KCI, 10 mM EDTA, l mM OTT, 0.1 % 
triton-X-100 and 0.05% sarkosyl. 
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Extract Preparation for Methyltransferase assay 
Total extracts from E. cpli XL 1.:. J3lue MR.A cells or those harboring various 
. . 
plasmids, E.coli ceHs that served as the expression hosts or those harboring plasmids, 
and S. pneumoniae cells with or without plasmids were obtained for use in the 
methyltransferase assay. 
Total protein extract preparation from S.pneumoniae . 
Appr~priate S. pneunioniae cells were grown'in CATPG broth supplemented 
. . 
with 0.001% choline chloride to an ODssonm of0.2 (2x 109 CFU/rttl)and 4x109 cells were 
centrifuged at 11,000 x g for 10 min at 4°C. · The supernatant was discarded and the 
pellet was maintained at 0°C. The pellet was washed in 1 mi ofbuffer containing 10 mM 
Tris-HCI (pH 7.4), 25 mM KCl, arid lmM DTT and transferred to a microfugetube at 
0°C. This suspension was centrifuged at 14,000 rpm for 2 min, the pellet resuspended in 
. . ' 
180 µlo.fthe same buffer, and maintained at 0°C._ .. To this, 20 µl of 10% triton-X-100 
. . 
was added and the mixture was transferred to 37°C until clear. Immediately after lysis, 
. . . : . . 
the lysate was transferred to 0°C and was passed through a 21 gauge needle 15 times to 
shear the DNA. Then an eqttal volume of bNase free glycei-ol was added and the extract 
stored at -20°C until needed. 
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Total protein extract preparation from E.coli XLl-Blue MRA cells 
Appropriate E. coli XLl-Blue MRA cells were grown overnight at 37°C with 
shaking. 50 ml of the cells were centrifuged at 11,000xg for 10 min at 4°C. The pellet 
was resuspended in 500 µ1 of the buffer containing 10 mM Tris-HCl (pH 7.4), 25 mM 
KCl, lmM DTTand 100µM PMSF, and maintained at 0°C. The suspension was 
transferred to a microfugetube maintained at 0°C andthen centrifuged at 11, 750 x gfor 
2 min. The pellet was resuspended in 3 00 µ1 of the same buffer and sonicated at 0°C ten 
times at 12 sec pulses. Then it was centrifuged at 11, 750 x g for 5 min and the 
supernatant was tfansferred to a fresh microfuge tube at 0°C and centrifuged once more. 
To the clear supernatant, an equal volume ofDNase free glycerol was added and stored 
at -20°C until use. 
Preparation of Soluble protein fraction from E.coli expression host 
As mentioned in the large scale protein purification procedure, a glycerol stock of 
the appropriate expression host strain was streaked on agar plate with appropriate 
selection and incubated overnight at 37°C. An isolated colony was inoculated in 5 ml 
rich broth with appropriate selection and. grown to an OD5sonm of O. 6 and then stored at . 
4°C overnight. One and eight-tenth milliliters of this culture was centrifuged at 11,750 x 
g for 1 min and resuspended in 500 µl of fresh rich broth. This resuspended mix was 
used to inoculate 90 ml ofrich broth with appropriate selection and 2. 5 mM betaine-
HCl. The culture was incubated with shaking at 37°C until an OD5sonm of 0.6 was 
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reached.. At this time point. lmM IPTG was added to the culture and the cells were 
incubated at room temperature for 3.h with shaking. The cells were centrifuged at 8,000 
rpm for 10 min and the pellet was resuspended in 5 ml of lX binding buffer. To the 
resuspended cells, 0.1%triton-X-100 was added and siored at -20°C overnight. The 
. . ',. . . . . . 
cells were thawed in an ice-water bath and 0.05% Sarkosyl and 100 µM PMSF were 
added. The c.ells were sonicated at 0°C for 4 min with 20 sec pulses. The cells were · 
centrifuged at 15,000 x g for 30 min and the supernatant was collected and filtered 
through a 0.45µfilter. To this filtered fraction an equal volume of~Nase free glycerol 
was added and stored at -20°C until needed for the assay. 
Protein Coricentration Determination 
· Bradford Assay 
The Bio-Rad Protein Assay, based on the method of Bradford (19), was the 
method of choice for determining protein concentration. A standard curve for the assay 
. . 
. was plotted based on :known concentrations of bovine serumalbumin:. Protein assay 
samples were prepared by mixirtg 10 µl of the protein fraction, 790 µlof ddH20, and 
200 µl of the dye n~agent concentrate. After vortexirig thoroughly, the mixture was 
allowed to incubate at room temperature for at least 5 min. The samples were then 
transferred to disposable polystyrene cuvettes (Bio-Ra,d) and the absorbence measured 
using a spectrophotometer (Spectronic 1001, Milton Roy Company) set at 595 nm. 
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. Comparison to the standard curve provided a relative measurement of protein 
concentration. 
Methylation Activity Assay 
The standard methylase assay mixture contained 5 µg of substrate DNA and 
6 µg of protein extractin a total volume of 20-µl reaction buffer containing 50 mM Tris-
HCl (pH 7.4), l O mM EDT A, 0. 5 mM DTT, and 1 µM [ methyl-3H]S-Adenosyl-:L-
methionine. After incubation at 37°C for 2 h, the assay mixtures were diluted to 250 µl 
. . 
with 10 mM Tris-HCl (pH 8.0), l mM EDTA, and extracted once with phenol: 
chlorpform-isoamyl alcohol (25 :24: 1) and precipitated :with ethanol, The precipitate Was 
resuspended in 20 µl 10 mM Tris-HCl (pH 8.0), 1 mM EDTA. Determination of the 
incorporated radioactivity in the samples was done as described (110, 164). 
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CHAPTER IV 
RESULTS 
Tn5253 was originally identified as a heterologous insertion in the chromosome 
of the cliriicalisolate ofS. pneumoniae BM600l (7, 177). Prior Work in our lab has 
demonstrated this transposon to be a composite site-specific conjugative transposon 
consisting oft~~ tranposons; Tn.5251 and Tn5252 (7). Tn5251 is 18 kb in size and 
. . . . . 
belongs to the Tn916 class of conjugativetransposons (7). Tn5252 is a 47 .5 kb 
. . 
.. . ., 
conjugative transposonthat ·carries the chloramphenicol resistance gene. SinceTn5252 
is the prototype of complex conjugative transposons, our lab has focused on 
understanding the biology of the streptococcal conjugative transposon Tn5252. 
. ·. . •. 
Previous studies have shown that Tn5252 is a site-specific transposon. The nucleotide 
s~quences of the right, the left, and the target site have been obtained (206). 
Comparison of these seqqences has shown clearly that a 3 5 bp core sequence was 
. . . ' 
adequate for the site-specific integration of the element (6). Studies to identify the 
transfer related regions of the transposon indicated that the ends ofTn5252 were 
important for transfer (97). Preliminary work on the left end of the element showed the 
presence of a regulator (188), a DNA relaxase (189), an integrase and an excisionase 
(97) and more recently a gene conferring resistance to UV radiation (142). 
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Work on an internal region (located near the right end) has .shown the presence of an 
operon like structure of many membrane-associated genes that have been implicated in 
· transfer in other systems (1). The present work was undertaken to gain a better 
understanding of the right end of the element includingthe structural organization ofthe 
gene( s) present and their role in the transfer process: · Fig. 2 · presents the restriction inap 
of Tn5252 for 11 different restriction endonucleases, with the region of interest 
highlighted. 
Cloning of the 3.27 kb.EcoRI frl)gment in E.coli: 
. . 
In order to construct the restriction map ofTn5252, Vijayakumar, et al. (208) 
. . 
introduced an E. coli vector, p V A891, at various sites in the transposon and generated 
various E. coli plasmids carrying flanking DNAs from the insertion mutants. One such 
plasmid, pVJ164 (207), contained a 3.27 kb EcoRI fragment forming the right junction 
fragment. The 3 .27 kb EcoRI fragment 'Yas electroeluted from this plasmid for cloning 
purposes. Our initial attempts to clone this fragment in its entirety in several commonly 
. . 
used. high copy number vectors such as, pBluescript SK+ and pUC8 were unsuccessful 
suggesting that the passengerD~A might be unstable in high copy numbers. To 
overcome this problem, attempts were rtiade to clone the.fragment into pACYC184 and 
pVA891, which have a copy number of 18 (31) and 15 (126) respectively and these were 
also unsuccessful. This suggested that there might be some product encoded by 
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Figure 2. The rest.-iction map of Tn5252, with the region of interest highlighted. 
The asterisks mark the end of the transposon. The location of the cat { chloramphenicol 
acetyl transferase) gen~ is indicated, 
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the passenger DNA that either might be toxic or might be unstable even in low copy 
numbers. The cloning attempts were repeated using a variety of E. coli hosts like 
HBlOl, JM109, C600, XL-1 and XL-1 Blue l\1RA (89). These attempts were also 
unsuccessful. In spite of our inability .to clone this j .27 kb EcoRI fragment in its entirety 
in E.coli, we were able to clone smaller fragments of thisI>NA in high copy 
number vectors.This strongly suggested that the passenger DNA encodes some gene 
product( s) that might be toxic to E. coli cells. 
. Cloning in S. pneumoniae 
The inability to clonethe 3.27 kbEcoRI fragment inE. coli led us to clone this 
fragment in S. pneumoniae. This cloning would ~e helpful in understanding the structural 
and functional characteristics of this region, as the right end of the transposon has been 
shown to be important for transfer (97). The vector chosen for this purpose was pLS 1, a 
streptococcal 4.4 kb plasmid that has been shown to replicate in rec+ E. coli. It has a 
copy number of 4 and 24 in E. coli and S. pneumoniae, respectively. The pneumococcal 
host strains used for cloning were Rxl and SPlOOO (Stf Rxl::Tii,5252). A recombinant 
plasmid, pSJ107 contJining the 3.27 kb Ec~Rl rightjimcfon fragment as insert was 
established in SPlOOO.but not in Rxl. . This observation was in agreement with the 
report of Lopez, et al. (125) showing that the plasmid establishment inS. pneumoniae 
•, . . 
was increased 10 fold when the plasmid carried a segment of DNA homologous to the 
host chromosome. 
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Spontaneous Deletion of the cloned 3.27 kb EcoRI fragment in E. coli 
To test our earlier hypothesis that the insert DNA specified a protein that might 
. be toxic to E. coli cells, pSJ107 was introduced by transformation into competent E. coli 
. . . . . ".. . . ··: . . 
' . . . ·" 
cells and pLS 1 was used as the control. As pLS 1 can replicate only in rec+ E. coli hosts, 
.. . . 
E. coli C600 and XLl-Blue MR.A were chosen. The plasmid DNAs from single colony. 
. . 
isolates were isolated. The resul~s (Fig. 3) clearly indicated that pSJ107 suffered no 
deletion in XLl-Blue MRA a~ the 3.27 kb EcoRI insert was detect.ed whereas in C600 
cells several deleted forms of the plasmid·were evident (lanes 5 and 6). The major 
difference in the genotype between the two host ceHs is that C600 is McrA· and XL 1-
Blue MRA is McrA", McrBC-, Mrr" and hsdSMR". It has been shown that restriction of 
methylated ormethylase-encoding DNAbyE.coli depends on the products ofmcrA 
. . . 
gene, the .mcrBC operon and the m1T gene (143). The specificities of the McrA, McrBC 
and Mrr restriction activities for smc containing DNA have been shown to be partially 
overlapping (143). Thus, depending on the modification pattern, the invading DNA may 
be subjected to restriction by one or several of these systems. Thus, restriction of pSJ107 
: . . .·, 
by E. coli C600 indicated that the insert DNA contained a modification recognized by 
the host cells for restriction. 
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Figure 3. Restriction digest of the plasmids isolated from E.coli XL-1 Blue MRA 
and E. coli C600. Lane M, the 1 kb ladder. Nominal molecular masses are indicated. 
Lanes 1 and 2, pLSl from S. pneumoniae (control); lanes 3 and 4, pLSl from C600; 
lanes 5 and 6, pSJ107 from C600; lanes 7 and 8, pLSl from XLl Blue MRA; lanes 9 and 
10, pSJ107 isolated from XLl Blue MRA; lanes 11 and 12, pSJ107 from 
S. pneumoniae ( control). Odd numbered lanes contain uncut plasmid DNA and even 
numbered lanes show EcoRI digested plasmids. pLS 1 (the vector) is 4.4 kb in size and 
the insert is 3 .27 kb in size. 
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Nucleotide sequence determination 
To gain a better understanding of the possible protein products encoded by this 
segment of DNA, subclones c6ntaining segments of this fragment were generated. The 
restriction map of the 3.27 kb EcoRI fragment is shown in Fig. 4. The ClaI site is within 
the transposon and the right EcoRI is in the host chromosomal DNA about 400 bp away 
from the attR ofTn5252 (206). The recombinant plasmids generated contained the 0.5kb 
EcoRI/XbaI fragment (pVJ430/431), the 1.8 kb XbaI fragment (pVJ419/442), the 1.1kb 
Kpnll EcoRI fragment (pSJl 14) and the 0 .. 3 kb EcoRI/ClaI fragment (pSJ132) from this 
region. A nested set of deletion derivatives usingExonuclea:se III and S 1 nuclease were 
generated from pVJ419, pVJ442 and pSJl 14; The nucleotide sequence was obtained 
from all the subclones and the deletion derivatives. The 2.3-kb sequence from the right 
most EcoRi: site to the left most X'baI site·was obtained by Dr. Vijayakumar (personal 
communication). From these sequence-specific primers were designed for further 
sequencing reactions. The physical organization of the 3. 5 kb fragment and the 
sequencing strategy used are shown in Fig. 5. The sequence between the Xbal and KpnI 
site was obtained using pSJl 07 as the template. The-data obtained from all the 
subclones were manually assembled to form a contiguous sequence. Except for a 50-bp 
. . . 
region to the left oftheKpnI site,.the sequence was determined from both strands. 
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Figure 4. Restriction endm:mclease map of the 3.5 kb fragment spanning the right 
end of Tn5252. The asterisk adjacent to theXbal site marks the end of the transposon. 
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ORF42 
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ORF6~ 
... 
ORF6a. ORF41 
.._ 
2 3 4kb 
I· 
Figure 5. The restriction map of the 3.5-kb EcoRI fragment. The sequencing 
strategy and the different open reading fram~s (ORFs) are shown. For maximal 
.· . ' ' . .· 
confidence, both the strands of the DNA were sequenced. The arrows at the bottom 
show the sequencing strategy used. ORF6~ is transcribed in an alternate reading frame 
and is within the ORF6q.. The 5' end of0RF42 overlaps withthe 3' end of0RF6a.. 
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Structural analyses of the nucleotide sequence obtained 
The DNA segment was 3565 hp long with a GC content of36%. Computer 
analysis of the primary sequence data revealed the presence of four open reading frames 
(ORFs), designated-ORF6cx., ORF6f3, ORF41, and ORF42. !he predicted transcriptional 
map is shown in Fig. 5. The annotated nucleotide sequence of the DNA segment is 
shown in Fig. 6. All except ORF41 Were preceded by an appropriately spaced consensus 
Shine-Dalgamo sequence. All were transcribed in the same orientation. ORF6cx. (nt 
1704-3062) could specify a polypeptide of 453 amino acids of 50. 7 kDa. ORF6f3 
(ntl 759~2277) localized within the region of ORF6cx. but in an alternate reading frame 
could encode a polypeptide of 173 amino acids with an apparent molecular mass of 20.1 
kDa. ORF41 (nt 1320-1604) and ORF42{nt 3046 .. 3495) are presumed to encode . 
polypeptides of95 (11.3 kDa) and 150 amino acids (17.5 kDa) long, respectively. The 
5'-end ofORF42 was also found to overlap with the 3'-end ofORF6cx.. Estimation of the 
net charge and isoelectric point (pl) showed the gene products of ORF6cx. and ORF6f3 
to be basic polypeptides of9.7 and 8.2, respectively. On the other hand, the estimated 
pls ofORF41 and ORF42 polypeptides are 5.2 and 4.2 respectively. Upstream of 
ORF41, aregion carrying 9-bp imperfect inverted repeats, IR2 (nt 1219-1227 and nt 
1246-1256), th~t could form a stem-loop structure with a AG = - 14.9 kcal/mol 
follwed by three nearly perfect 12-bp repeats, DR3 (nt 1269- 1281; nt 1284- 1295 and nt 
1298- 1309), was observed. A promoter-like region 
showing consensus -10 and-35 sequences was present between the direct repeats 
93 
Figure 6. The nucleotide sequence of the 3.5 kb right junction fragment. The 
deduced amino acid sequences of the 4 ORFs (ORF41, ORF6a, ORF6f3 and ORF42) 
are also shown. The 10 base imperfect Inverted repeat (IR2) is present at the right most 
end of the transposon. ORF41 is flanked at the 5'end by a perfect 12 base repeat (IRl) 
and three nearly perfect 12 base pair Direct repeats (DR). The -10 and the -35 regions, 
the ribosome binding sites, and few of the restriction sites within the sequenced region 
are shown. 
EcoRI 
l GAATTCCTACTGATAATGAAGTAAGTTATGCTCTTATTTATCAGCAGGAAACTCTTCCTG 
61 CAACAGGTTCATCAACTTCTGAGCTTACAGCTTTAGGCCTATTAGCTGTTGGTAGTTTAG 
121 .TTCTTTTGGTTCATAATATGACGGGAACAGTTTTTTGCTCCCTCTGAAAAGTCATCATTT 
DRl DRl 
----~----> ---------> 
181 GATGGCTTTTTCTATATAGGGTTAAAGATAGGCTAAAGATAGGGTAAAGGCTATCATCGA 
241 CAAAATAAAGAAGGCATGATATAATATAAAGTAGATTTCTATGTCATAAAAACAAGAACT 
301 ATTTGGACATCATTCATTTGAAAACTCTCTATGTTCAAACTATAGTAAAATAAAATAGGG 
361 GATCTAAATCCTTGCTACGAGAAGGAAAAAAACTCAATGGCTACTATTCAATGGTTGGTC 
IRl 
XbaI . . . . ------------>< 
421 TAGAAGATTTAAAATAATAAAACATTGTGAAGTAGAATAAATACTTAAAACCCTTGAAAT 
IRl 
<----------
481 TCAAGGGTTTTTATTGGTTTAGATTTTAATTATTCACATTGTTATATGTGCTTGATTGAG 
DR2 DR2· 
--~----> -------> 
541 .CAATAATCATCAATAAAAACATTTTTTTGGTGTTGAGTTTGGTGTTCAAATATTTATTAT 
601 GTTACGGAAAGGAATTTCACAATCTTTCCGTTTTTTTATTTTCTGGAGGAAAAATGACAA 
661 AAGAATTACAATCATCACGCTATATTGTCATTTCATTTTTAGTACGTGAAATGGGAATTG 
·721 ATATTGTTGAGGCCATATCTCTTATGGCTGAATTAGAAAAAAGTGGCTTGGTTCGCTTCG 
781 AATCAAGTGGAGATTTAATACTCAAAGAACTTGGAGGAACGCTATGAAACGAATTACCGC 
841 AAATCAATACCAAACTTACGAACGGTATTACAAATTACCTAAATTCTTTTTTGAGGGATG 
901 AGAAATATATGGATATGAAACTAGAAGGTAAAGGTGGCTTATTCTATTTTAAAAGATCGT 
961 'l:'TAGAATTATCTCTCAGTC9TGGTTGGATAGA'l'GAAGAGGGACGGTCTATTTAGTATTTC 
1021 TAATTCTAAACTGATGAAGCTATTAGGTTGTTCGAAGTCAAAATTACTGTCCATCAAAAA 
. ., . 
1081 AAACTCTTAAAGAATATGAC'l'TAATTGATGAAGTTCAACAGTCTTCAAGTGAGAAAGGAA 
1141 GACTAGCTAATAAGATTTATTTAGGGGAATTA'i'CTTCTACCCCAGTAGCTAATTCAAACA 
IR2 IR2 
---------> <---------
1201 GGCCATAGTGTTAAAAAAAGACTAGGGCAGGGTGAAAATGAAACGGCCCCCGTCTCACAT. 
-35 
DR3 DR3 
-10 
DR3 
--- - -----> -----------> -----------> 
1261 TCAGCCCCTAGTGAGACTGAAGTTAGTGAGACTAATATAGTGAGACTGATTCTTTATTT 
94 
1320 ATT GAG GAT GAG GAG GAG AGG GAT ACT CAA CCT ATC TTG AAA AGA . 
. ORF41> I E D E E E R D T Q P I L K R 
1365 AAA GTA GAA AAG GTC ACA AAA TAT GAT CGA GAT TAT ATT TGG GGA 
K V E K V T K Y D R D Y I W G 
1410 TTG GTG CAA GAT CAA TTT AG.A CGA GAG GGG TTT TCT GAA ACA GCC 
L V Q D Q F R R E G' F S E T A 
1455 AGT GAA ATT GCT ATG ACT GAT TTT GAG AGA ATC TAT CAG TAT GCT 
S E I A M T D F E R I Y Q Y A 
150.0 CTT GAC AAT GTT CGC TTT GTT AGA CGA GCG GAA·GTA CTT GCT GAA 
L D N V R F V R R A E V L A E 
1545 TTT GTG TTT AAT GGC TTG TAr TCC GTT TGG.AAC AAC CGT GTT AGA 
F V F N G L Y S V W N N R V R 
1590 AAA GGA GGT GGT TAA ATGTCGCCAATCGAGTGGATATTAGTTATGCTTCATTGTC 
K G G G * 
SD 
1645 ATTTCAA~TGGAGTGACAGTTCTGACAATGATAGTCGATAAGAAAGGGGTGATAAAGAA 
1704 ATG AGA TTT ATT GAT TTA TTT TCA GGT ATC GGT GGC TTT CGA CTA 
ORF6a>M R F I D L F S G I G. G F R L 
SD 
1749 GGA ATG GAA AGT GTC GGA CAC GAG TGT ATT GGA TTT TGT GAG ATT 
G M E S V G H E C I G F C E I 
ORF6P> V S D T S V L D F V R L 
1794 GAT AAA TTT GCT AGA GAA TC'!' TAT AAG TCC ATT TTT CAA ACG GAA 
D K F A R • S Y K $ I F Q T E 
I N L L E N L I S P F F K R K 
1839. GGA GAA ATT GAA TTT CAT GAC ATA CGA GAT GTT TCA GAT GAC GAA 
G .E I · E F H D I R D V S D D E 
E K L N F M T Y E M F Q M T N 
18.84 TTT 'AAA AAA CTT AGA GGG. AAA GTC GAT GTC ATC TGT GGA GGA TTC 
F K K L R G K v· D V I C G G F 
L K ·.' L E G K S M S S V E D S 
1929 CCT TGT CAAGCA TTT TCA ATC GCA GGA AGA CGA TTG GGA TTT GAA 
P C Q· A F S · I A G R R L G F E 
L V K H F Q S Q E D D W D · L K 
1974 GAT ACT AGA GGA ACT TTA TTC TTT GAA ATT GCT CGA GCG GCC AAA 
D T R G T L F F E I A R A A K 
I L E E L Y S L K L L E R P N 
95 
2019 CAA ATC CAA CCA CGT TTT CTT TTT CTT GAA AAT GTT AAA GGC CTA 
Q I Q P R F L F L E N V K G L 
K s N H V F F F L K. M L K A Y 
2064 CTC AAT CAC GAT AA.G GGA CGG ACG .TTC ACC ACA ATC CTT ACC ACG 
L N .H D K G R T F T T I L T T 
S I T I R D- G R S P Q S L P R 
2109 CTT GAT GAA TTG GGG TTT GAT GTT GAG TGG CAG ATG CTT AAC AGT 
L D E t G F D V E W Q M L N S 
L M N W G L M L S G ,R C L T V 
2154 AAG GAT TTT GGC GTT CCC CAA AAC AGA GAG AGG GTG TTT ATT ATC· 
K D F G V P Q N R E R V F I I 
R I L . A F p· K T E R G C L L S 
XbaI KpnI 
2199 GGA CAT TCT AGA AAG AGA GGT ACC AGA CTC GGA TTT CCT TTC AGA 
G H S R K R G T R L G F P F R 
D I L E R E V P D S D F L S D 
2244 CGA GM. GGT CAA GCA ACT·AAC CCT GAG ACT TTA AAA ATA TTA GGG 
R E .G Q A T N P E T L K I L G 
E K ·. V . .K . Q L T L R L '* 
2289 AAT TTG AAT CCA TCA AAA AGT GGA ATG AGT GG'i'. AAA GTC TAT TAT 
N L N · P S K S G M S G K V Y Y 
2334 TCA GAA GGT CTT GCG CCA ACC TTA GTT CGT GGA AAA GGA GAA GGA 
S E G L A ~ T L ·v R G K G t G 
2379 TTT AAA ATT GCG ATT CCT TGT ATG ACA CCA GAC AGA TTA GAC AAG 
F K I A I P C M T P D R L D K 
24'24 AGA CAA AAT GGT AGACGT TTC AAG GAT AAT CAA GAG CCA ATG TTT 
R Q N G R R F K D N Q E P M F 
2469 ACT TTA.AAT ACT CAG GAT CGC CAT GGT ATT GTC GTT GTT GGA GAT 
T L N .T Q D R H G I V V V G D 
2514 TTA CCA ACT AGC TTT AAG GAA ACT GGT AGA GTC TAT GGA AGT GAG 
L P T ·s. F K E T G R V Y G S E 
2559 GGC TTA TCT CCA ACA CTG ACT ACG ATG CAA GGA GGA GAT AAA ATC 
G L S P T L T T M Q G G D K I 
2604 CCC AAA ATA CTG ATT CCA GAA CCA ATC CAA TTT CTA AAA GTC CGA 
P K I L I P E P I Q F L K V R 
2649 GAG GCA ACG AAA~ GGA TAT GCT CAA GCA GAG ATT GGG GAT TCA 
E A T K K G Y A Q A E I G D S 
2694 ATC AAT TTA GAA AGA CCA AGT TCT CAG CAT CGT CGT GGT AGA GTT 
I N L E R P S S Q H R R G R V 
96 
2739 GGA AAA GGT ATA GCT AAT ACG TTA ACA ACT AGT GGG CAA ATG GGA 
G K G I A N T L T T S G Q M G 
2784 GTA GTA GTG GCT AGC TAT GAA GGA GAA GAT AAA CAA GTT TAC CAA 
V V V A S Y E G E D K Q V Y Q 
2829 GTA GCT GGT GTT TTA ATA GAT GGA CAA TTT TAC CGT TTG AGA ATA 
V A G V L I D G Q F Y R L R I 
2874 CGA CGA ATC ACT CCT AAA GAG TGT TTT CGA TTG- CAG GGC TTT CCT 
R R I T P K E C F R L Q G F P 
2919 GAT TGG GCT TTT GAA GCT GCT AGA AAA GTC TCT AGT AAT AGT CAG 
D W. A F E A A R ·K V S S N S Q 
2964 CTC TAT AAA CAA GCT GGT AAT AGT GTA ACC GTT CCT GTG ATT GCC 
L Y K Q A G N S V T V P V I A 
SD 
3009 G.CA ATC GCA AAG AAA TTA. AAA 'GAA GTA GAG GAA AAA GAT GAA AGC 
A I A K K L K E V E E K D E 
ORF42> M K A 
3054 ATT AAA TAA AGAA TCA ATA CTA GAT TGT GAT GAA TTA GAA ACA 
I K * 
L N K E s I L D C D E L E T 
3097 GAA TTA CAT GAC GCA GAA ATC AAA CAG CTG GAT GAA CAA ATA TTT 
E L H D A E I K Q L D E .Q I F 
3142-TTG ATG CCC AAT TAT CCA TGT GAG. TTT GAG GTG .ACA TTT TTA GAT 
L M P N Y P C E F E V T F L D 
3187 GAT TAC CAT AAA AAA CAC AACTAC CCC CTA TTTTAC GAA TCC TAT 
D Y H K K H N Y P L F Y E S Y 
EaoRI 
3232 CTT CAA AAC·ATT ATG GAA TTC CTT GAA AGT CAG GAT ATA AAG AAC 
L Q N I M E F L E S Q D I K N 
3277 GGA GCT GAT GCC TTT GTA GAT GAT CAT CAG AAT CTT GTT TTT GTT 
G A D A F V D D H Q N L V F V 
3322 TTA TAT GGA CAA GGC TAT AGA GCT GAG GGA AAA GAG GGA ATA CTT 
L Y G Q G Y R A E G K E G I L 
3367 ACA ACC. CAA GTA ACT GTA AAA GCT TTT GAT GAA GAC AAG AAA CCG 
T T Q V T V K A F D E D K K P 
3412 ATT AAC TTC GCA AAT TTA TTA GAT TCC TTA ATC GTC TCA GAA TAT 
I N F A N L L D S L I V S E Y 
97 
3457 CAA ATG GAA CCG AAT CTT.TGG GAG GTC TCC CAT GAT TGA TCTCTATC 
Q M E P N L W E V S H D * 
Cl a I 
3504 TAAGTAAAAATAGCCAAAGAAATCAACTTCTTTTAGACTTCTTCCAAAACTATGGCATCGAT 
98 
(61, 160). Toward the very right end closer to the attR, another region of 12-bp inverted 
.. repats, IRl (nt467- 478 andnt 480- 491) with a &G = -16.6 kcal/mol was found. 
Sequence similarity search 
. . : 
The deduced amino acid sequences of the putative ORFs were analyzed for 
similarities to other protein sequences ip. the Genbank. Of the four ORFs, only ORF6a 
and ORF6~ · showed signif1c~nt sequence similarit~es to. other prote1ns. ORF6a showed 
similarities to a variety of prokaryotic smt-cytosine methyltransferases. Multiple 
alignment of ORF6a with other smc:..cytosine methylases is shown in Fig. 7. The 
deduced amino acid sequence of ORF6a exhibited the same pattern of 10 conserved 
motifs that have been observed in all known smC-DNA methylases (116, 143, 147,202). 
The presence of the highly conserved sequence, PCXXXS within motifIV, containing 
the cystein.e thought to form a transient, covalent complex with the cytosine to be 
methylated and the putative S-Adenosyl-L-Methionine (SAM, also called as AdoMet) 
binding site, (F,G)XGXG, in motifl provide compelling support for the suggestion that 
the ORF6a product ce>uld be. a smC-DNA methylase. • The deduced amino acid sequence 
. ' . ' . . . . 
· of ORF6a shares 72%: similarity to a smC-cytosine methylase present in the SPR phage 
of Bacillus subtilis (M. SPR). In addition to the 10 conserved motifs, significant 
. . . . 
sequence similarities between ORF6a and SPRphage methylase were also observed in 
the region located between the conserved regions VIII and IX. Fig. 8 shows the 
alignment of this variable region ofORF6a with that of the SPR phagemethylase. 
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Figure 7. Multiple alignment of ORF6a. with other smC-cytosine methylases. The 
10 conserved domains (I to X), found in all smC-cytosine methylases are shown. The 
catalytic center is presumed to reside in the pro-cys dipeptide is highlighted. Amino 
acids represented in lower case indicate a gap. Gaps were introduced to maximize the 
similarity. 
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1 50 
MRFIDLFSGI GGFRLGMESV GHECIGFCEI DKFARESYKS IFQTEGEIEF 
LRVMSLFSGI GAFEAALRnv GYELVGFSEI DKYAVKSFCA IHNVDEQLNF 
YKMIDLFAGI GGTRLGFHQT EkkSVFSSEI DKFAIKTYKA NFGDegDITK 
FTFIDLFAGI GGFRIAMQNL GGKCIFSSEW DEQAQKTYEA NF ••• GDLPY 
YRMIDLFAGI GGTRLGFHQT NAVNVVfsEW DKFAQKTYHA NYGddGDITK 
. ; . 
LKFIDLFAGI GGMRIPFEEL GGKCVFSSEI DKHCQRTYEA N.F ••• GEMPT 
LRVMSLFSGI .GAFEAALRNI gyELIGFSEI DKYAIKSYCA IHNVSETLNV 
LTFIDLFAGI GGIRLGFEDK YTKCVFSSEW DKYAAQTYEA NY ••• GEKPH 
LRVMSLFSGI GAFEAALRNI gyELVGFSEI DKYAIKSYCA IHNADEQLNF 
LRFIDLFAGL GGFRLALESC GAECVYSNEW DKYAQEVYEM NFGEKPEGDI 
LRVMSLFSGI GAFEAALRNI.gyELIGFSEI DKYAIKSYCA IHNVSETLNV 
·. MNLISLFSGA GGLDLGFQKA GFRIICANEY DKSIWKTYES NHS •• AKLIK 
FRFIDLFAGI GGIRRGFESI .GGQCVFTSEW NKHAVRTYKA NHYCDPATHh 
FRFIDLFAGI GGIRKGFETI GGQCVFTSEW NKEAVRTYKA NWFNdrEVTL 
MKIISLFSGC GGLDLGFEKA GFEIPAANEY DKTIWATFKA NHPKTHLIE. 
I II 
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HDIRDVSDDE •FKKLRGKVDV ICGGFPCQAF S.IAGRRLGFE DTRGTLFFEI 
GDVSKID ••• .KKKLPEFDL LVGGSPCQSF SVAGHRKGFE DTRGTLFFQY 
IDEKDIPDH. ••.• ~ •••• DI LVGGFPCQAF SQAGKKLGFD DTRGTLFFEI 
GDITLEETKA F •• IPEKFDI LCAGFPCQAF SIAGKRGGFE DTRGTLFFDV 
.. IDEKDIPDHE • • ~ • .. • • • I LVGGFPCVAF SQAGLKKGFN DTRGTLFFDI 
GDITKLSADS IPY •••• HDL LLAGFPCQAF ~QGGRKQGFQ DERGQLFFQV 
GDISKAKKDN IPYF •••• DL LTSGFPCPTF SVAGGRDGmk DERGTLFFET 
.. GD!TKINEND IPDQ •••• DV LLAGFPCQPF SNIGKREGFA HERRNIIFDV 
GDVSKID ••• .KKKLPEFDL LVGGSPCQSF SVAGYRKGFE DTRGTLFFQY 
TQVNEKTIPD .H ••.••••• DI LCAGFPCQAF SISGKQKGFE DSRGTLFFDI 
GDISKAKKDN Ii?fF •••• DL LTSGFPCPTF SVAGGRDGME YKCSNCSHEH 
GDISKISSDE FPK •••• CDG IIGGPPC:QSW SEGGSLRGID DPRGKLFYEY 
.eDIRDitaEH IRQHIPEHDV LLAGFPCQPF SLAGVSKKNs dTQGTLFFDV 
SDKPEVPENd iNEHVPDHDV LLAGFPCQPF SLAGVSKKNs eAQGTLFFDV 
GDIRKIKEED FPE ••• EIDG IIGGPPCQSW SEAGALRGID DARGQLFFDY 
III IV V 
101 150 
ARAAKQIQPR FLFLENVKGL LNHDKGRTFT .TILTTLDELG FDVEWQMLNS 
VETLKEKQPK FFVFENVKGL INHDKGNTLN VMAEAFSEVG YRIDLELLNS 
ARIIKEKRPK AFLLENVKNL KTHDKGRTFK TILNTLEELD YEVHTALFKA 
AEIIRRHQPK AFFLENVKGL KNHDKGRTLK TILNVLRegY FVPEPAIVNA 
ARIIKEKKPH AFLLENVKNL LGHOKGRTFS IIKNTLEELN YTVYYNIFAA 
AKILNDHRPQ AI!iLENVKGL RGHDKGRTLQ MILYVLEKLN YWSWKil:SA 
ALLAEEKKPK FVILENVKGL INSGNGQVLR IISETMNNIG YRIDLELLNS 
LRILKKKQPK MFLLENVKGL LTNDNGNTFR VILDNLKSLG YSVFYEVMDA 
IDTLKEKQPR.YFVFENVKGL INHDKGNTLN IMAESFSEVG YRIDLELLNS 
ARIVREKKPK WFMENVKNF ASHDNGNTLE WKNTMNELD YSFHAKVLNA 
LITYEDYKKG VKCPKCEAVS KAKDERGTLF FETALLAEEK KPL ••• MVGH 
IRILKQKKPI FFLAENVKGM MAQRHNKAVQ EFIQEFDNAG YDVHIILLNA 
VRIIDARRPA MFVLENVKNL KSHDQGKTFR IIMQTLDELG YDVAdpKIID 
ARIIRAKKPA IFVLENVKNL KSHDKGKTFK VIMDTLDELG .. YEVAdpKVID 
IRILKSKQPK FFLAENVSGM LANRHNGAVQ NLLKMFDGCG YDVTLTMANA 
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KDFGVPQNRE RVFIIGHSRK RGTRLGFPFR REGQATNPET LKILGNLNPS 
KFFNVPQNRE RLYIIGirqKG KQRlsFNFR WTAQSAATKR LKDlgNINPS 
RDFGLPQNRE RIYIVGFDRK SISNYSDFQM PTPLQEKTRV GNILESVVDD. 
KNFGVPQNRE RIYIVGFHKS .. TGVN. SFSYP EPLDKIVTFA DIREEKTVPT 
KDFGVPQNRE ·· RIYIVGFNKE KVRNHEHFTF PTPLKTKTRV GDILEKSVDN 
TDFNLPQKRE RIFIVGFQDK.NNKNLIFDFP KPIELT.AKV GDLLEKEVDE 
KFFNVPQNRE RVYIIGiRED LVENEQWVVG QKRNDVLSKG KKRLQEINIK 
QNFGLPQRRE RIVIVGFHPD LG •• INDFSF PKGNPDNKVP INAILEHNPT 
KFFNVPQNRE RIYIIGVRED . L.IENDEWVVE KGRNDVLSKG KKRLKELNik 
LDYGIPQKRE RIY.MICFRND LNIQ.NFQFP KPFELNTFVK DLLLPDSEVE 
VDLKGHDAIK RVYSPEGLSP TLTTMGGGHR EPKIAEKQKE VRAV.~ •••• 
NDYGVAQDRK RVFYIGFRKE.LNINYLPPIP HLil<PTFKDV IWDLKD •••• 
GKHFLPQHRE RIVLVGFRRD LNLKADFTLR OISE •••••••••••••••• 
GKHFLPQHRERIVLVGFRRD LNIHQGFTLR DISRFYPEQ ••••••••••• 
KDYGVAQERK RVFYIGFRKD t.EIKFSFPKG STVEDKDKIT LKDV •••••• 
VIII TRD-I 
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KSGMSGKVYY SEGLAPTLVR GKGEGFKIAI PCMTPDRLDK RQNGRRFKDN 
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F · •.• • • • • • • ~ 
I .. • ~ ..... ··. •••••• PDDG 
KYTLSDALWN GHQRRKLVNA AAGKGFGYGL F ••••••••••••••••••• 
KYTITDRMWE GHQNRKKAHR KRGNGFGFSt V ••••••••• ······~··· 
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QE:PMF'l'.LNTQ DRI:IGIVVVGD LPTSFKETGRVYGSEGLSPT LTTMQGGiiKI 
GEPAFTVNTI DRHGVAV ••• ........... 
•••••••••• ••••••••• N QDSEYTNTLS ARYYKDGSEI LIEQKNKNP. 
IANAIVVGGM GRERNLVIDH RITDFTPTTN . • • • • • • • • • • • •• • •••••• 
• • • • • • • • • • • •••••• · •• N · ENSPYTNTIS ARYYKDGSEI LIEQKGSNP. 
••••••••••••••••••• N RNSSYTRTIS ARYYKDGSEV LVEQANKNP. 
LGT~PLQKQE VREPLmTGHV DLKGHiiAIKR VY'SPEGLSPT LTTMGGGHRE 
•••••.•••••.•••.•••• Iii • • • • • • • • • • • • • • • • .• • • • • • • ••••• • •••.• 
NGIATTLTSQ SVGGLGGQTS llKGHDAIKR VYSPDGVSPT LTTMG~GHRE 
.......... ••••• GQGER IYSTRGIAIT LSAYGGG ••• 
GEPAFTVNTI DRHGVAI ••• 
.......... 
••••• YFIGS YSTIFMSRNR VRQWNEPAFT VQASGRQCQ. 
• • • • • • • • • • • • • • • • • • • • • • CFPAQRVT LAQLLDPMVE 
•••••••••• ••••••••••••• RPSFGEL LEPVVDSKYI 
~· ~· ~· ~· ~· ~· ~· -·· ~· ~· _. ~· ~·~·~·~·~·~·~· . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 
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ORF6cx. 
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PKILIPEPIQ FLKVREATKK GYAQAEIGDS INLERPSSQH RRGRVGKGIA 
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LTPKLWEYLY NY~G NGFGFGLVNP ENKESIARTL SARYHKDGSE 
•••• IWDLQD TAVPSAPQNK T.NPDAVNNNE YFTGSFSPIF MSRNRVKAWD 
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NTLTTSGQMG VVVASYEGED KQVYQVAGVL 
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RRITPKECFR 
RRLTPLECFR 
RKITPREAAR 
RKMTPREWAR 
RKITP:REASR 
RVLTPRECAR 
RKLSPLECWR 
RLFSELELKR 
RKLTPLECWR 
••••• ~IFAK TGGYLVNGKT RKLHPRECAR 
•••••••••••• GEYPKYKI RKLSPLECWR 
DGAEILIDRG WDMATGEKD. • • • • • • • • • F 
••• • •• , HLY . RRL.TVRECAR 
DDPLNQQHRP RRLTPRECAR 
ILIDRGWDMA TGETDFANEE NQAH •••••••••••••• RP RRLTPRECAR 
EQGFTVQASG RQCQLHPQAP KMEKHGANDY RFAAGKETLY RRMTVREVAR 
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·oRF6cx.·· LQGFPDWAFE AARKVSSNSQ LYKQAGNSVT VPVIAAIAKK LKEVEEKDES IK 
M.SPR LQAFDDEDFE KAFAa;i.SNSQ LYKQTGNSIT V'.l:'VLESIFKE LIHTYINKES E. 
M.ScrFIA LQGFPENFII.PV.~ •• SDTQ AYKEFGNSVA VPTIHAIAEK.Ml;.,EVLE:KSKK 
M.HpaII LQGFPDSYVI · PV •• •. SDAS. AY;QFGNSVA VPAIQATGKK ILEKLG.NLYD 
M.Ssol;I LQGFPSDFII PV •••• SDTQ AYKQFGNSVA VPVINAIAEK IISTLDS ••• 
M.DsaV LQGFPESFVI PV ••• ·.spcQ· AWRQFGNSVP VSVIRAIAQK MLSYIDLTEQ QK 
M.phi3TI .LQAFDDEDFE KAFAaiSNSQ LYKQAGNSIT VSVLESIFQE LIHTYVNKES E. 
M.BsuFI LMGFPVDF •••• KVPVSRTQ MYRQFGNSVA.VPMIKAVAGA MKERLLLAEM •• 
M.BsuRI LQAFDEEDFE KALSviSNSQ LYKQAGNSIT VTVLESIFKE LIHTYVNEES E. 
M.Hhal VMGYPDSY •••• KVHPSTSQ AYKQFGNSVV INVLQYIAYN IGSSLNFKPY 
M. Sp~ LQAFDDEDFE· l(A. • • • • • • • • • • • • • • • • • • • • • • • • • • • • ••••••••• 
M.HaeIII VQGFPD ••• D FIFHYESLND GYKMIGN.AVP VNLAYEIAKT IKSALEICKG N. 
M.Dcm LMGFEAPGEA KFRIPVSDTQAYRQFGNSVV VPVFAAVAKL LEPKIKQAVA LR 
M.EcoRII LMGFEKVDGR PFRIPVSDTQ SYRQFGNSVV VPVFEAVAKL LEPYILKAVN AD 
M.NgoPII IQGFPD ••• N FKFIYQNVND AYKMIGNAVP VNLAYEIAAA IKKTLER ••••• 
IX X 
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ORF-6a. GNLNPSKSGMSGKVYYSEGLAP.TLVRGKGEGFKIAI ••••• ~ .•••••• 
ll=lll·-1·1.1.11 1-ll-•11=· -1111=111= 
M.SPR GNINPSGNGMNGNVYNSSGLSPTITTNKGEGLKIAVEYSRKSGLGREL 
TRD-I 
ORF-6a. ••• • •• ·~ •••••••••••••••••••• PCMTPDRLDKRQNGRRFKDNQ 
. 1-=ll=I =LIJIIIIIII=· 
M.SPR AVSHTLSASDWRGLNRNQKQNAVVEVRPVLTPERGEKRQNGRRFKDDG 
TRD-II 
ORF-6a. EPMFTLNTQDRHGIVVVGDLPTSFKETGRVYGSEGLSPTLTTMQGGDK. 
11 11 = 11 1111 = - I . 
M. SPR ·EPAFTVNTIDRHGVAV ••••• •. ~ ••• • •••••••••••••••••• ,, ... 
TRD-III 
ORF-6a. IPKILIPEPIQFLKVREATKKGYAQAEIGDSINLERPSSQHRRGRVGK 
M.SPR ..................................................... • . 
ORF-6a. GIANTLTTSGQMGVVVASYEGEDKQVYQVAGVLID. 
M.SPR 
Figure 8. Alignment of variable region of ORF6a. with that of the 
methyltransferase encoded·by Bacillus subtilis phage SPR. Vertical bars represent 
identical amino acids and dots show conserved substitutions. Gaps were introduced to 
maxilllize the sirnilaritf The overall similarity between ORF6a and M. SPR is 72% and 
identity is 52%. Each ofthetarget recognition domains (TRDs}, TRD-1, TRD:..11, TRD-
. ' 
III, of the phage SPRmethylase have:beefl showiby others (66) to be responsible for 
the recognition of target regions, EcoRll, Mspl, .and Hae III restriction endonuclease 
sites correspondingly for methylation. Regions similar to TRD-1 and TRD-111, are 
present in ORF6a. 
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The SPR phage methylase has been shown ( 66) to contain three target-recognizing 
domains {TRDs ), that are responsible for recognizing three different target sequences. 
TRDI has been shown to recognize the EcoRII site; TRDII, the Mspl site and TRDIII, 
the HaeIII site (9, 204, 214). Based on the alignment, ORF6a. was found to have 
regions corresponding to TRDI and TRDIII, but not TRDII. Fig. 9 shows the alignment 
of the TRDI ofORF6a. with the corresponding domains of the multi-specific methylases 
SPR, <l>H2, (j>3TI, (j>Sp~, and (j>pllsl. The TRDs ofM.EcoRII, M.Dcm both of which 
recognize the sequence CCWGG, the TRDs ofM.SsoII, M.NlaX and M.ScrFI all of 
which recognize the sequence CC:NGG, and the TRD of M.DsaV which recognizes the 
sequence CCTGG are also aligned. As evident from the figure, the multi-specific 
methylases of the B. subtilis phages and the ORF6a. methylase group together and share 
a common domain structure whereas the mono-specific methylases form a separate 
group and share a common structure. Similar reports have been published {143,203). 
This structural difference between the multi-specific and the mono-specific methylases 
recognizing the same target site indicates that there might be distinct requirements for 
mono-specific and multi-~pt;:'cific methylases. Walter, et al. (212) have shown that the 
multi-specific methylases could not be endowed with novel specificities by integrating 
TRDs of mono-specific methylases. · This suggests that in the case of multi- and mono-
specific methylases, the interaction of the TRDs with their core ·sequence is different. 
<J>H2, and (j>pl 1 have been shown not to be able to methylate the EcoRII site (CCWGG) 
in spite of sharing significant amino acid similarity with the 
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cj>3TI 
cj>Sp~ 
cj>H2 
cj>pllsI 
cj>SPR 
5252I 
Dem 
EcoRII 
NlaX 
ScrFIA 
SsoII 
Dsa.V 
___________________ _: ______________ GHVDLKGHDAIKRVYSPEGLSPTLTTMGGGHREPKI 
----------------..:.--..,::._ _____ :._ __ ..;. ____ Gf!Vi:>LKGHDAIKRVYSPEGLSPTLTTMGGGHREPKI 
----------------..;_..; _______________ GNINPSGEGMNGQVYNSNGLS.STLTTNKGEGVK!SV 
-,,-----------..;. ___ ..,: _________________ GNINPSGKGMNDQVYNSNGLSPTLTTNKGECNKISV 
----------------------------------GNINPSGNGMNGNVYNSSGLSPTITTNKGEGLLIAV 
_____________________ :._ __________ ,,_i..LGNLNPSKSGMSGKVYYSEGLAPTLVRGKGEGFKIAI 
DPMVEAKYILTPVL ... YLYRYAKKHQARGNGFGYGMVY .. 
EPVVDSKYILTPKLWEYLYNYAKKHAAKGNGFGFGL-,,-
EAYPDEKYTISDKJ.,WQGYQRRKAENRAAGKGFGYGL--
ESVVDDKYTISDKLWPGHQRRKTENKKNGKGFGYTL-~' 
EKSVDNKYTLSDALWNGHQRRLLVNAAAGKGFGYGL--
EKEVDEKYTITORMWEGHQNRKKAHRKRGNGFGFSL--
. . 
D~>G' (in cj>plls) 
. I I I 
S->P (in .cj>H2) S->A 
CCWGG · 
RECOGNITION' SITE 
+ 
·+ 
+ 
+ 
+ (CCNGG)• 
+ (CCNGG) 
+ (CCNGG) 
+ (CCTGG)' 
+ 
+ 
Figure 9. Alignment of.TRDI ofORF6cx. (525.ZI) with the corresponding domains of 
other, multi-specific and mono-specific methylases. The substitutions, inade in the 
pseudo domain of <l>pl hi and <l>H2 that made them active are also indicated (112). + 
indicates the. ability of an enzyme to recognize and methylate CCWGG and - indicates the 
· inability. ? indicates uncertainty' recognition and ~ethyl~tion. Domains responsible for 
recognizing other sites (CCNGG or CCTGG) are ind1cated. 
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TRDI (EcoRII target reconizirig domain) of <j>SPR (112). · These inactive domains 
(pseudo domains) have been activated by site.,specific mutations. Based on the alignment 
and the activating mutations made in the case of <j>pl 1. and <l>H2, the TRDI of ORF6a 
could be a functional EcoRII domain. Fig. 10 shows the alignment of TRDIII of ORF6a 
with the corresponding TRDs.ofmulti:-specific phage methylases, and mono-specific 
methylases that recognize the sequence GGCC. As in the case ofTRDI, here also the 
mono-specific methylases from a separate group compared to the multi-specific 
methylases. The alignment, showt1 in Fig. 11, ofa region next to TRDIII ofORF6a with 
that of other multi-specific phage methylases revealed a significant sequence the entire 
.. . 
Fnu4HI domain but only a portion ofit. This partial sequence similarity indicated that the 
sequence recognized by ORF6a might be similar to the sequence GCNGC, but not the 
same. In the case ofM.pllsl, theFnu4l:H dorn~in has been shown to be non-functional. 
The amino-acid sequence of the Fnu4HI recognizing domain of <j>H21 and <pp l lsl are 
identical except for one.amino acid difference (112) and conversion ofthis Glutamic acid 
to Glycine by site-specific mutation has been shown to restore the methylation potential 
of <j>pllsl. In the case of ORF6a, the homologous position is occupied by Gl)'cine, which 
could mean that the domain is. functional. 
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~3T AVLTPEREEK RQNGRRFKEN GEPAFTVNTI DRHGVAI 
~Sp~ AVLTPEREEK RQNGRRFKEN GEPAE'.TVNTI .· DRHGVAI 
~H2 PVLTPEREEK RQNGRRFKED DEPAFTVNTI DRHGVAI 
~pllsI · PVLTPEREEK RQNGRRtKED DEPAFTVNTI DRHGVAI 
~SPR PVLTPERGEK RQNGR:RFKDD GEPAFTVNTI DRHGVAV 
ORF6cx PCMTPD~DK RQNGRRFKDN QEPMFTLNTQ DRHGIW 
FMSRNRKKKW TDQSFTIQAS GRQAPIH 
YMSRNRKKSW .DQSFT:i:QAS GRQAPtH 
HaeIII EYFTGSYSTT FMSRNRVRQW NEPAFTVQAS GRQCQLH 
. NgoPII · EYFTGSFSPI FMSRNRVKAW DEQGFTVQAS GRQCQLH 
BspRI 
BsuR:i: 
PYFTGSYSTI 
PYFTGSYSST 
GGCC 
RECOGNITION 
+ 
+ 
+ 
+ 
+ 
? 
+ 
+ 
+ 
+ 
Figure 10. Alignment of the TRDID of ORF6a. with the corresponding domains of 
multi..:specific and niono~s.pecific methylases. + indicates the ability to recognize and 
methylate GGCC, - indicates the inability and ? indicates uncertainty. 
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GCNGC 
RECOGNITION 
q>H2 VEDPIMIGHIDLI<GHDAIKRVYSPDGVSPTLTTMGGGHREP + 
cppllsI VEDPIMIGHIDLI<GHDA!I(RVYSPDGVSPTLTTMGEGHREP 
cp3T ' VREPLMVG1:IVDLI<GHDAIKRVYSPEGVSPTLTTMGGGHREP + 
ORF6cx. . -: - - - - -VGDLPTSFKE;.T. GRVYGSEGLSP'l'LTTMQGGDKIP ? 
I 
I 
I 
E,+G (in cppl lsl) + 
Figure 11. Alignment of a region next to TRDID of ORF6a. with the 
corresponding domains of multi-specific inethylases. + indicates the ability to 
. . . 
recogniz~ and methyl~t¢ the GCNGC site and...., refers to the inability to do so. A site-
specific mutation madein:.<l>p;l lslto make the domain active is also shown (112) . 
. ? refers to the uncertainty in the recognition site. 
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ORF6(3 homology 
ORF6J3 showed significant similarity to J3 sub-unit of MBcoHK311. Methylation 
of a substrate DNAby M.EcoHK3 ll has been shown to r~quire two proteins, ex. and p. 
One of the proteins has been shown to be translated in an alternate reading frame within 
the other. Nine of the ten conserved motifs found in the smc-methylases were found in 
··. the M.EcoHK31 lcx. polypeptide. MotifIX was found to be present in the J3 polypeptide 
(122). Fig. 12 shows the alignment of ORF6J3 with the J3 sub-unit ofM.EcoHK311. 
However, the region of similarity betweeri the two polypeptides does not span the 
conservedmotifIX and no conserved motif was detected in ORF6J3. 
Protein Modeling 
The crystal structure.of four type II methyltransferases, M.Hhal(34), M.Haelll 
(155), M.Taql (108) and M.Pvull have been resolved (129} Of these four, M.Hhal and 
M.Haelll are both smC-cytosine methyltransferases, M.J;'aqI a 6~-adenine methylase 
and M.Pvull is a 4~-cytosine methylase~ Presence ofa bilobal structure has been 
established by comparing the structures of these 4 DNA methylases (129). One lobe 
consists of the.catalytic domain with both activesitefor methyl transfer and the AdoMet 
binding site and the other lobe contains the target recognition domain.· Comparison of 
small molecule methylases, catechol-0-methylase, DNA methylases, and other 
109 
ORF6f3 LLERPNKSNHVFFFLKMLKAYSITIRDGRSPQSLPRLMNWGLMLSGRCLT 
= : ••• 1 •• ==IIJ: •• :J ..•. 1 1-· 1 I= 1-1=. =·I=.= 
EcoHK31lfl MQNSSKKESLNGLLLKMFPDCSTATMDKTSKLSSIRWSNSGMAFRGEYWM 
ORF6fl VRILAFPKTERGCLLSDILEREVPDSDFLSDEKVKQLTLR 
• • 1 • 1 • .1 · = I 11 = = 11 - I ·• -11 • -1 • = • 1 • I 
EcoHKJUfl QNTLEHPSVEEECTLSQVLETCAPLESFLNPEQLESLINR 
· Fig. 12. Alignment of the predicted protein product of ORF6P with. the P-subunit 
ofM.EcoHK311. Vertical bars represent identity and dots represent similarity. The 
overall similarity is 46% and identity is 29%. 
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. . 
methylases has revealed a similar three-dimensional folding of the catalytic domain in all 
these enzymes (129). Significant similarity between the putative catalytic domain of 
ORF6a. and M.Hhal and M.Haem was observed (Fig. 7). Hence homology-based 
protein modeling was done using these known structures as templates. Due to the lack 
of homology between the target reqognition domain of ORF6a. and the other methylases, 
. ·. 
this domain has.not been modeled. The.model thus developed is shown in Fig. 13. The 
catalytic domain is dominated by a/f3 sheet structure that is very similar to those of other 
DNA methylases. The main feature is a seven stranded J3-sheet ((iJ:. 7t5J:. 4J:. U 2J:. 3J:.) 
formed by five parallel J3-stiands and an antiparallel J3-hairpin. The J3.;sheet is flanked by 
six parallel a-helices, three on each side. The AdoMet binding site is located at the C-
terminal ends of J3 l and J32 and the active site is at the C-terminal ends of strands f34 and 
J35 and the N-terminal end of (37 .. 
· In vitro Transcription and Translation 
In order to analyze the protein products encoded by the 3.27-kb EcoRI fragment, 
pSJ107 and pLS 1 were added in vitro to an E. coli S3 0 extract. The radioactively 
. . . 
labeled polypeptides were resolved on a 12% polyacryl~mide gel under denaturing 
conditions. As shown in Fig. 14, four polypeptides of apparent molecular masses of 46, 
42, 21 and 19.5 kDaunique to pSJ107 were identified. The molecular masses of 
two of these, 46 and 21 kDa, were in reasonable agreement with the molecular masses of 
ORF6a. and ORF6J3 proteins deduced fromthe nucleotide sequence data. The 
Ill 
Figure 13. Homology-based modeling of the catalytic domain of ORF6a. The 
modeling was done using the SWISS-MODEL and is based on the structure of M.Hhal 
methylase. The Pro-Cys dipeptide that forms the active site is shown using the spacefill 
model. The f3-sheets and a-helices are also shown in the model. 
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MAB 
q .. : 
Figure 14. In vitro Transcription and Translation using the E.coli S30 Extract 
with pLS1 and pSJ107 as templates. pLSl and pSJ107 plasmid DNA were added to 
E. coli S30 extract and the protein products made were electrophoresed on a 12% SDS-
PAGE. Lane (A), pLS l ; (B), pSJ107 and (M). Molecular weight standard, the sizes of 
the molecular weight markers indicated are in kilodaltons. The 46 kDa band and the 21 
kDa band in lane (B) corresponds to ORF6a and ORF6f3 proteins respectively. 
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expected sizes for ORF6a. and ORF6P were 50. 7 kDa and 20.1 kDa respectively. It was 
assumed that the 42~kDa polypeptide was the result of fusion between the amino 
termirial portion of the truncated ORF42 and the ORF-D protein of the ve~tor (109). It · · 
is not clear at present whether the 19 .5 kDa band was the product of proteolysis or 
translation from an alternate start site. No product resembling the predicted polypeptide 
of ORF41 ( expected size of 11.3 kDa) could be observed due to the presence of 
radioactivity at the expected position inthe control sample containing the vector. 
Construction of pSJl 17 
In order to mutate ORF6 in pSJ107 and to check its effect on the methylase 
activity, the central four bases within the unique.Kpnl site in pSJ107 was removed by 
Kienow treatment. The plasmid, designated pSJl 17, was generated in E.coli XLl-Blue 
MRA. This plasmid was expected to produce a truncated methylase protein due to the 
frame shift mutation introduced: Efforts to generate pSJl 17 from E.coli C600 were 
unsuccessful, indicating that the truncated methylase produced from the plasmid was still 
activ~. To confirm the loss oftheKpnI site, pSJI17was subjectedto restriction 
digestion; Fig. 15 shows the restricti9n digestion ofpSJ107 and pSJ117along with 
pBluescript SK+. The nucleotide sequence of pSJI 17 was also obtained using 3: newly 
. designed synthetic primer, which also confirmed the loss of the central four bases of the 
KpnI site. 
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Figure 15. Restriction digest showing the loss of the Kpnl site in pSJl 17. 
Undigested and digested DNA were run on a 0.8% agarose gel. pSJ107 and pBluescript 
SK+ digested with various enzymes served as the control. The molecular masses (lane 
M) in kilobases are indicated. Lanes 1, 5, pSJ107 uncut; lane 9, pSJl 17 uncut. pSJ107 
and pSJl 17 were digested with EcoRI (lanes 2, 10 respectively) ; HindI.11 (lanes 3, 11 
respectively) ; Kpnl (lanes 4, 12 respectively); Xbal (6, 13 respectively) . pBluescript SK+ 
was mixed with pSJ107 (lane 7) and pSJl 17 (lane 14) and the mix was digested with 
Kpnl (lane 8 and 15 respectively) . pBluescript SK+ uncut (lane 16) and Kpnl digest 
(lane 17). 
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In vitro Assay for Methyltransf erase activity 
To demonstrate directly the DNA methylase activity, crude extracts from E. coli 
and pneumococcal cells with or without pSJ107 were used in a reaction buffer 
containing [methyl-3H] S-adenosyl methionine (AdoMet) and E.coli GM2163 
chromosomal substrate DNA. Background numbers obtained· in the absence of extracts 
were subtracted .. The results are presented in Table V. Based on the incorporated 
radioactivity retained on the filters, it was evident.that the passenger DNA in pSJ107 · 
conferred DNAmethylase activity to E. coli and pneumococcal cells harboring it. 
Methylase activity of extracts of E. colt cells carrying pSJl 17 was found to he 30-fold 
higher. This result was not altogether surprising as the amino terminal half of smc-
cytosine methylases are known to methylate random sequences in the absence of target 
recognizing domains at the carboxyl end (67). Interestingly pneumococcal strain Rxl 
was observed to carry abundant methylase activity that did not significantly increase 
when copies oftn5252 methylase genes were added. This could possibly be due to 
down-regulation of expression in the native host, especially in the ,light of the various 
repeats found upstream of the gene. As Fig. 16 shows, the incorporation of radioactivity 
' .· 
was dependent on the concentration of the extract added. 
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Table V. Incorporation of [3H] AdoMet to Nonmethylated E.coli GM2163 DNA 
EXTRACT cpm 
E. coli XLl Blue MRA 19 
E. coliXLl Blue MRA (pLS1) 5 
E. coli XLJ Blue MRA (pSJ107) 521 
E. coliXLl Blue MRA (pSJl 17) 15249 
S. pneumoniae Rxl 1871 
S. pneumoniae Rxl (pLS1) 2661 
S. pneumoniae Rxl (pSJ107) 2160 
Six microgram of protein extract and 5µg of substrate DNA (GM2163 
chromosomal DNA) were used in each reaction under the conditions 
described. The values shown are the average of two independent 
experiments. 
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Figure 16. Graph showing the concentration dependence of the methylase activity. 
. . . . . 
Extract from E. coli XLl- Blue MRA cells c~rrying pSJ107 was used for the assay. The 
background radioactivity ~ncorporated in the absence of the m~thylase was.subtracted. 
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Over expression and purification of the methylase 
To purify the methylase protein and study its biochemical properties, ORF6cx.. 
was cloned into the expression vector, pMal-2 . 
. The pMal-2 system 
The pMal-2 vectors (pMalC2 and pMalP2) express the malE gene which encodes 
. . . ·. ... . . 
the maltose binding protein (MBP) of E. coli fused to the lacZa gene. Seven unique 
restriction sites are available between malE and lacZcx.. The gene of interest is cloned in 
the multiple cloning site and the insertion inactivates the lacZa resulting in no 
a-complementation. The vectors have a strong tac promoter and the malE translation 
initiation signals to give high:-level expression of the cloned gene (4, 54) and one step 
purification of the fusion protein using MBP' s affinity for maltose (96). The vectors 
carry the laclq gene coding for the Lac repressor which keeps the ex;pression from Ptac 
low in the absence ofIPTG. They also contain the recognition site for the site-specific 
. . . 
. protease,· factor Xa, just 5' of the multiple cloning sites. Thus, after purification the 
MBP can be cleaved off the fusion protein. The over"'.expressed protein, in the case of 
pMalC2, found in the cytoplasmic :fraction constitutes 20-40% of the total cellular 
protein. Due to the presence of the signal peptide, in the case ofpMalP2, the fusion 
protein is transported to the periplasm and it constitutes 5-10% of the total cellular 
protein. 
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Cloning ORF6a. hi pMalC2 
The template used for amplifying ORF6a. by PCR was pSJ107 linearized with 
Hindlll. PCR wa,s performed as described previously using the primers MET-F . 
(5'-ATGAGATTTATTGATTTATTTTCAGGT-3') and MET-R 
(5'-TTTATTTAATGCTTTCATCTTTTTCC"'.3'). The amplified product (1.4-kb) was 
gel purified and ligated to Xmnl digested pMalC2. E. coli JMI 09 cells were transformed 
with the ligation rriix and white colored transformants were selected on LB agar with 
ampiciUin and X-gal. These transformants were then replica.:.plated on LB agar 
containing ampicillin and X-gal or ampicillin, X-gal and IPTG; Colonies that remained 
white in the plates with X-gal and IPTG were chosen and the corresponding colonies in 
X-gal plates were used for making a mini plasmid preparation.· The plasmids were 
digested with Xbal to check the orientation of the insert, as there were two sites for this 
enzyme, one in the insert and one in the vector. The nucleotide sequences of three 
independent recombinant plasmids were also obtained. The restriction digest and the 
nucleotide sequence.information revealed the presence of the insert in the wrong 
orientation. The sequence also revealed the presence of 7-8 bp deletions. · This was 
assumedto be due to the:3'-5' exonuclease activity ofDeepVent polymerase. To avoid 
. .: " 
this problem, the dNTPs concentration was increased from 250 µM to 625 µM, 1.25 
mM and 2 mM and three independent PCR reactions were set up. After amplification, a 
sample was electrophoresd on the gel and it was observed that the non-specific 
amplification was reduced with an increase in the dNTP concentration. It was also noted 
that the specific product amplification reduced with the increase in dNTPs. The PCR 
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products obtained from the reaction using 1.25mM and 2mM dNTPs were chosen for 
further work. The amplified fragment was gel purified and used in ligations with pMalC2 
digested with Xmnl. The recombinant plasmids obtained from three of the clones were 
. . 
restriction digested and also sequenced. Both restriction digestion and the nucleotide 
sequecing revealed that the insert was in the. wrong orientation. However, unlike the 
previous experiment, no deletion in the insert DNA was.observed. One such plasmid was 
designated pSJ133. The observatio~ that the methylase gets cloned in the reverse 
orientation in pMalC2 indicated that the lyaky expression of the MBP-methylase fusion 
product might be toxic to the host ~ven ifthe expression is at a very low-level, in the 
absence of induction by IPTG. 
Cloning ORF6a. in pMaIP2 
The inability to clone the methylase in pMalC2 led me to try and clone the 
methylase in pMalP2 as it would be exported into the periplasm. The PCR product was 
gel purified and ligated to pMalP2 digested with Xmnl. The ligation mix was used to 
' . . . 
transform JM109, DHSa. and XLl-Bhie.MRF'. The recombinant plasmids obtained 
. from JMl 09. and DHSct contained. deletions butthe plasmid obtained from MRF' had the 
methylase in the correctqrientation. This was checkeµ by restriction enzyme digestion 
and confirmed by nucleotide sequencing. This plasmid was designated pSJ136 and was 
used for protein purification pilot experiments. 
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Protein purification using pSJl36 (pilot) 
Before the large-scale purification using. pSJ136, a pilot experiment was done to 
check the level and the duration of induction. The cells were grown to an OD6oorun of0.5 
(2 x 108 CFU/ml} and were induced. with IPTG for 3 h. Satriples for SDS-P AGE were . 
taken before the start of induction and after every hour during induction. After three h, · 
crude extract and osmotic shock fluid were collected. The crude extract was also mixed 
with the amylose resin, to check the amount of the induced MBP.:.methylase fusion 
protein bound t:o the resin. The bound fusion protein was released with maltose and was 
' ' 
run ori SDS-P i\GE .. As evident from the result shown in Fig .. 17, the induction of the 
fusion protein, the expected size of which is about 92 kDa (42 kDa of the MBP with50 
kDa of the methylase), was inadequate to purify the protein inlarge quantities. 
· Therefore, the methylase was cloned into another expression vector. 
The pET system 
The gene ofinterestis cloned into one of the pET plasmids and placed under the 
· control ~fa strong bactetjophage T7 transcription signal. The expression of the gene of 
. interest is achieved by providing the host cells with a source ofT7 RNA polymerase. 
The T7 RNA polymerase gene is under the control of the lacVVS promoter in 
the chromosome of the host and can be induced by the addition ofIPTG. After 
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Figure 17. Induction ofMBP-methylase fusion protein expression from pSJ136. 
The proteins were resolved on a 10% SDS-P AGE gel. Lane M, the molecular masses 
(in kDa) . Lane 1, the uninduced sample. Lane 2, 3 and 4 are the one, two and three 
hour induced samples; lane 5, the osmotic shock fluid; lane 6, the crude extract; lane 7, 
the crude extract bound to the resin and lane 8, the proteins released by amylose from 
the resin. 
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induction (upon addition ofIPTG), almost all of the cell's resources are converted to 
express the protein ofinterest, as the T7 RNA polymerase is very selective and active. 
As.much as 50% of the total cellular protein would be comprised of the protein of 
. interest within a few h ofinduction. The gene of interest can be maintained 
transcriptionally silent in the unind11:ced state. · Recombinant plasmids that are not stable 
in the host cart be stabilized by expressing the gene in hosts containing compatible 
plasmids that provide a small amount ofT7 lysozyme that has been.shown to be a natural 
. . . 
inhibitor of the T7 RNA polymerase (139, 195). The two plasmids that express the T7 
lysozyme are pLysS and pLysE. The expression ofthelysozyme from pLysS is lower 
. . 
when compared:to that ofpLysE. The low"'.leveloflysozyme produced by pLysS has 
little effect on the expression of the gene of interest following induction whereas the 
expression of the gene of interest is substantially decreased in the hosts carrying pLysE. 
Cloning ORF6a. into pET30b + 
The methylase gene was subcloned from pSJ136 as follows: pSJ136 was digested 
. . . . ,. ' . 
. . .. 
. . . . . . 
with Ecll 3 611 and HindIII and the 1. 4 kb frag~ent released was gel purified ~nd ligated 
to pET30b + digested with EcoRVand Hindlll .. The recon1.binant plasmid, designated 
pSJ137, was subjected to restrictio11 enzyme digestion to confirm the integrity of the 
plasmid. The nucleotide sequence ofpSJ137 was obtained and, as expected, the 
methylase gene was in frame under the control of the T7 promoter. 
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Expression of the (ORF6a) Methylase 
In order to optimize the over-expression of th,e methylase and select the host 
strain to be used, a pilot induction was done with three different hosts. pSJ137 was 
transformed into E. coli BL2l(OE3) cells and also into BL21(DE3) host cells carrying 
either pLysS or pLysE. The strains were grown as previously described and induced 
with lmM IPTG for three h and samples were taken at the end of every hour. The 
samples collected were electrophoresed on a SOS-PAGE and the expression of ORF6a 
was checked. As evident from the results, shown in Fig. 18, the expression was 
adequate neither in BL21(0E3) hosts nor the host carrying pL,ysE. Also, the level of 
expression increased and reached a maximum after 3 h of induction. So BL21(0E3) 
pLysS cells were chosen as the optimal host and 3 h ofinduction was taken to be the 
optimal time required. It was also observed that for reasons that are not clear at 
present, extended subculturing of the E. cQli cells led to a very low level expression of 
the methylase. Glycerol was also found to lower the expression level. These problems 
were overcome by growing an isolated colony in the broth and using the broth culture 
for inoculating while doing the large-scale protein purification. 
Protein purification from the inclusion bodies 
The large-scale protein purification was done as previously described. The SOS-
P AGE analysis of the fractions collected is shown in Fig. 19. It was observed that 
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Figure 18. Determination of the optimal expression host for expressing the 
methylase fusion protein by SDS-PAGE analysis. The nominal molecular masses in 
kilodaltons are indicated (lane M). Lanes 1 and 2, lysates from BL21(DE3) hosts 
containing pSJ137; lanes 3 and 4, lysates from BL21(DE3) hosts containing pSJ137 and 
pLysS; lanes 5 and 6, lysates from BL21(DE3) hosts containing pSJ137 and pLysE. The 
uninduced lysates from the three different hosts are in lanes 1, 3 and 5. Lanes 2, 4 and 6 
have the three hour induced lysates. The arrow shows the induced methylase. 
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Figure 19. Large scale purification of the methylase fusion protein from the 
insoluble fraction. Lane M, the molecular marker and the masses indicated are in kDa. 
Lane 1, the uninduced lysate; 2, the three-hour induced lysate; 3, the soluble fraction; 4, 
the insoluble fraction; 5, the filtered insoluble fraction, 6, the column unbound fraction. 
Lanes 7, 8 and 9 are 8 µg, 20 µg and 40 µg, respectively of the pooled fractions 
containing the methylase. 
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about 6% of the total cellular proteins in the induced cells was made up of the methylase 
fusion protein product. However, most of the ORF6a fusion protein was insoluble. 
From 11 ofinduced cells, approximately 4 mg of the ORF6a fusion protein carrying the 
His-Tag sequence was isolated using affinity column chromatography with charged His-
Bind metal chelation resin under denaturing conditions in 6M urea. The purified protein 
fractions were pooled, renatured by step dialysis, and stored. The stored fusion protein 
was later used in methyltransferase assay along with the crude extract from the host 
strain harboring pSJ137. Surprisingly, the purified protein fraction was found to lack 
enzymatic activity (Table VI) although the total soluble protein extract of the cells 
carrying pSJB? was capable of methylating DNA. 
Cloning of ORF6j3 in an expression vector 
ORF6j3 was amplified by PCR using ORF6j3 and JRRKl-6 primers. The 
template used was pSJ107 linearized with Hindi.II. The blunt ended fragment obtained 
was purified from the gel and ligated to EcoRV digested pET30a+. The ligation was 
transformed into E. coli JMl 09 competent cells and the colonies obtained were used for 
mini plasmid DNA preparations.. It was observed that in most cases there were deletions 
that spanned even the vector plasmids. As in the case ofORF6a cloning, XLl-Blue 
MRA cells were used as the host and transformants were replica-plated and used for 
colony hybridization experiments using PCR amplified ORF6j3 as the probe. 
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Table VI. Methylase assay using the fractions collected during the purification of 
the methylase from the inclusion bodies. 
PROTEIN cpm 
Filtered Soluble Extract 354 
E. coli XLI Blue MRA (pSJ107) 521 
Purified methylase 11 
Six microgram of the extract or 1 µg of the purified protein wa,s added and 
the substrate DNA (chromosomal DNA ofGM2163)used for the 
assay was 5 µg. 
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The probe failed to hybridize to any one of the colonies indicating that there were no 
colonies that contained the insert. The cloning attempts were repeated, but ORF6f3 
could not be cloned in the expression vector. 
Production of anti-ORF6a. antibody 
The methylase obtained from the insoluble fraction was used to generate 
polyclonal antibodies. The antibodies were raised in mice and the process was carried out 
by the Hybridoma Center of Oklahoma State University. 
Optimization of the production of methylase 
As most of the induced protein was present in the insoluble fraction, the optimal 
concentration of IPTG needed for adequate induction of the· methylase and for the 
presence of maximal amount of the methylase in the soluble fraction was determined. 
Fig. 20 shows the SOS-PAGE analysis of the soluble fraction obtained from cells 
induced with varying amounts ofIPTG for various lengths of time. The methylase assay 
was also performed using these fractions obtained (Table VII). It was evident that the 
activity of the soluble fraction increased as the concentration ofIPTG is increased. The 
maximum activity was observed after 3 h induction with lmM IPTG. Fig. 21 shows the 
western blot analysis of the soluble fractions obtained from cells induced with 0.5mM 
IPTG and 1 mM IPTG for 1 h, 2 h and 3 h. The unpurified polyclonal antibodies raised 
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Figure 20. SDS-PAGE analysis of the soluble fraction obtained from pSJ137 
carrying cells induced with varying amounts of IPTG. The molecular masses 
indicated (in kDa) correspond to the proteins present in lane M. Lanes 1 and 8, the 
uninduced lysates; lanes 1-7, lysates from BL2l(DE3) containing pSJ137 and pLysS 
cells that were induced with 0.05mM IPTG; lanes 8-14, lysates from BL21(DE3) 
containing pSJ137 and pLysS cells that were induced with lmM IPTG; lanes 3, 5, 7,10, 
12 and 14, the soluble fractions obtained from different induced samples. Lanes 2, 3, 9 
and 10, one hour induced samples; 4, 5, 11 and 12, two hour induced samples; 6, 7, 13 
and 14, three hour induced samples. The arrows show the induced methylase. 
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Table VII. Methylase assay using the soluble fractions obtained from expression 
hosts carrying pSJ137. 
IPTG USED FOR 
INDUCTION HOURS OF INDUCTION cpm 
(mM) 
0.003 1 0 
2 0 
3 20 
0.006 1 6 
C 
2 41 
3 0 
0.01 1 13 
2 0 
3 7 
0.05 1 419 
2 458 
3 1456 
1.0 1 1715 
... ; 
2 2638 
3 2999 
1.0 (pET30b) . 3 0 
Six microgram of the extract was used with 5 µg of the substrate DNA (GM2163 DNA) 
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Figure 21. Western Blot analysis of the soluble fraction obtained from cells 
carrying pSJ137, induced with 0.05 mM and 1.0 mM IPTG. M, the prestained 
molecular weight standard. Lanes 1-4, the lysates from BL2l(DE3) containing pSJ137 
and pLysS cells that was induced with 0.05 mM IPTG; lanes 5-8, lysates from the same 
host cells but induced with I mM IPTG. Lanes I and 5, the uninduced sample; 2 and 6, 
soluble fraction from cells induced for I hour; 3 and 7, soluble fractions from cells 
induced for 2 hours; lanes 4 and 8, soluble fraction obtained after inducing the cells for 3 
hours. The arrow shows the induced methylase. 
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against ORF6a cross-reacted with a number of othr proteins. To eleminate the non-
specific antibodies, the polyclonal antibodies obtained was mixed with the crude lysate of 
over expressed E. coli host cells (BL210E3 pLysS) containing the vector pET30b +. 
Purification of the methylase from the Soluble Fraction 
As the purified protein obtained from the insoluble fraction was found to be non-
functional, attempts were made to purify the protein from the soluble fraction. Using the 
optimized conditions, the soluble fraction was obtained from a 4 l culture and used for 
affinity chromatography using His-Bind metal chelation resin. The protein content of the 
fractions obtained was analyzed and a SOS-PAGE was performed (Fig. 22). The 
maximum amount of ORF6a protein wa~ found to be in fractions 3, 4 and 5. These 
fractions were dialyzed overnight in a buffer containing lOmM Tris-HCl (pH 7.4), 25mM 
KCl, lmM OTT, lOµM AEBSF and 50% glycerol. The next day a significant amount 
of precipitate was observed in the.dialysis bags. The supernatant fluid was taken and 
stored. As evident from the SOS-PAGE analysis, most of the methylasewas lost during 
the precipitation. Nevertheless, the fractions obtained before and after dialysis were used 
in the methylase assay (Table VIII). Fraction 3 showed higher activity than fractions 4 
and 5 after dialysis. This decrease in the activity of fraction 4 and 5 was also· evident 
from the SOS-PAGE gel (Fig. 22) as there was only a very faint band corresponding to 
the methylase. The increase in the· methylase activity of fraction 3 after dialysis could be 
due to the removal of NaCl and other substances (such as Imidazole) present in the 
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Figure 22. SDS-PAGE analysis of the fractions collected during the purification of 
the methylase from the soluble fraction.Mis the molecular weight standard and the 
weights indicated are in kiloDaltons. Lane 1, the uninduced sample; 2, the 3 hour 
induced sample; 3, the insoluble fraction; 4, the unfiltered soluble fraction; 5, the filtered 
soluble fraction; 6, the fraction unbound to the column; 7, the column wash; 8, the 
purified but inactive methylase. Lanes 9, 11, 13, the fractions 3, 4 and 5 respectively 
after dialysis; lanes 10, 12, and 14, the precipitates obtained from fractions 3, 4 and 5 
respectively during dialysis. Lane 15, the extract from XLl Blue MRA cells carrying 
pSJ107. 
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Table VIII. Methylase assay using the fractions collected during the.purification 
of the methylase from the soluble fraction. 
PROTEIN.· cpm 
Filtered Soluble Extract · 7466 
UnbOund 2836 
·. 
'. 
Fra~tion #3 before dialysis 4439 
. Fraction #3 after dialysis 9813 
Fraction #4 before dialysis 3984 
Fraction #4 after dialysis 446 
,,. 
Fraction #5 before dialysis .1569 
Fraction #5 after dialysis 673 
E.coli XLl BlueMRA (pSJ107) 798 
., 
· ' Inactive m~thylase 4 " 
Six microgram of the extract or 1 µg of the purified fraction was used for the 
assay with.5 µg of the substrate(GM2163)DN.t\.; Inactive methylase refers 
.· . . 
to the purified methylase obtained from the insoluble fraction. The fractions 
obtained were eluted from the column using the lx elute buffer containing 1 M 
imidazole. 
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elution buffer. The protein was purified again from a 2 1 culture, using His-bind affinity 
chromatography with the intention of running an ion exchange chromatography using a 
DEAE-Sepharose column. A Bradford assay (19) was run on the fractions collected 
. . 
from the affinity column. Some of the fractions collected were run on SDS-P AGE (Fig. 
23) and were also used to check for the methylase activity (Table IX} Fraction 3, which 
showed the maximal methylase activity, was dialyzed overnight jn DEAE starting buffer 
containing 20 mM Tris-HCI (pH 7.4), 5 mM NaCl, 1 mM EDT A, 1 mM OTT and 1 µM 
AEBSF. 'The next day even in this case a significant amount of precipitate was observed. 
. . . . . . 
Unlike the previous cases, a Bradford assays revealed that there was no protein present 
in the supernatant fluid: The problem of precipitation was ;olved by dialyzing the 
protein fractions in a buffer containing 50 mM Tris-HCl (pH 7.4), 200 mM KCl, 10 mM 
EDT A, 1 mM OTT and 50% glycerol. The fusion protein was purified again from 2 1 
culture using affinity chromatography and the bound protein was eluted with elution 
buffer containing 500 mMNaCl, 20 mM Tris-HCl (pH 7.9) and varying amounts of 
imidazole, 200 mM, 400 mM, or 1 M. ABradford assay was done on fractions collected 
and soine of the fractions were run on SOS-PAGE (Fig. 24).. The ·same fractions were 
. also used for methylase. assays (Table X) and surprisingly the methylase activity was 
observed in fractions eluted with all the differentconcentrations ofimidazole. Two 
fractions that shciwed the highest jncorpo~ation were pooled and concentrated using. an 
Amicon column: This fraction was given to the DNNProtein Recombinant 
DNNProtein Resource facility of Oklahoma State University for purifying the protein by 
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Figure 23. SDS-PAGE analysis of the different fractions collected during the 
purification of the methylase from the soluble fraction for the second time. 
M, the molecular weight standard and the weights indicated are in kilodaltons. Lane 1, 
the uninduced sample; 2, the 3 hour induced sample; 3, the unfiltered soluble fraction; 4, 
the filtered soluble fraction ; 5, the insoluble fraction; 6, the fraction unbound to the 
column; 7, the binding buffer wash; 8, the column wash. Lanes 9-13, the fractions #2, 3, 
4, 5 and 8 collected respectively; lane 14, the purified but inactive methylase; lane 15, 
the previously purified active methylase. Arrow points to the methylase protein. 
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Table IX. Methylase assay using the fractions collected during the .second time. 
PROTEIN cpm 
,Unfiltered Soluble Extract 372 
Filtered Soluble Extract 426 
Unbound Extract 0 
Wash 822 
Fraction #2 257 
Fraction #3 1216 
· Fraction #4 166 
Fraction #S · 81 
Fraction #8 125 
Active methyfase 14356 
Inactive methylase 0 
Six microgram of the crude protein extract or 1 µg of the purified fraction 
was used for the assay with 5 µg of the substrate (GM2163) DNA. Active 
. . . . 
methylase refers to the protein purified from the soluble fraction (fraction 3 
of the first isolation) that was given for HPLC analysis and the inactive 
methylase refers to the protein purified from the soluble fraction. The fractions 
were collected using 1 x elute buffer containing 1 M imidazole. 
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Figure 24. SDS-PAGE analysis of the fractions collected during the methylase 
purification with step gradient. M, the molecular weight standard and the weights 
indicated are in kiloDaltons. Lane l ,the uninduced sample; 2,the 3 hour induced sample; 
3, the unfiltered soluble fraction ; 4, the filtered soluble fraction; 5, the insoluble fraction; 
6, the fraction unbound to the column; 7, the binding buffer wash; 8, the column wash. 
Lanes 9-12, the fractions collected using 200 mM Imidazole; lanes 13-15, the fractions 
collected using 400 mM Imidazole; lanes 16 and 17, the fractions obtained using 1 M 
Imidazole; lane 18 is the purified but inactive methylase. Arrow points to the methylase 
protein. 
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Table. X. Methylase assay using the fractions obtained during the step gradient 
purification •. 
IMIDAZOLE 
' 
CONCENTRATION PROTEIN cpm 
200mM Fraction #2 6160 
200mM Fraction #6 14425 
,, 
200mM Fraction#? 11364 
200mM Fraction #8 · 12388 
400mM Fraction #1 3912 
400mM Fraction. #3 11672 
400fuM Fraction #4 4344 
400mM Fraction #8 5998 
lOOOmM Fraction #5 9600 
lOOOmM Fraction #7 11159 
---
Active methylase 18107 
. --- · Inactive methylase 0 , . 
. . 
One microgram of the purified fraction was used for the assay with 5 µg of the 
'. . . . . . . . •. 
substrat~ {GM2163) DNA Active rnethylase refers to the purified farction. 
(:fraction 3 of the first isolation) obtained from the soluble fraction that was 
given for the HPLC analysis. Inactive methylase refers to the protien purified 
from the insoluble faction. 
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gel-filtration uisng HPLC. HPLC analysis using the Biorad Superdex-75 column was . 
done and the proteins were eluted using the same buffer that they were stored in but 
without the 50% glycerol. The fractions were collected and the absorbance was 
measured simultaneously {Fig~ 25). The profile· shows a: peak at fraction 6 and by 
comparing this peak with the standard, th~ size of the protein in the peak was estimated 
to be above l 00 kOa, which is much larger than that expected for ORF6a.. The fractions 
' ' 
. . ' .. 
collected were checked for their protein content.and used in methylase.assays. It was 
foundthat them was no m¢thylase activity (Table XI). Some of the HPLC fractions 
collected were also electrophoresed on.~ SOS-PAGE (Fig. 26). Analysis of the SOS-
' ' 
PAGE gels showed a very low <;oncentration, of a protein band corresponding to that of · 
ORF6a in some fractions. The presence of a peak of about 100 kDa in the HPLC was 
assumed to be due to hydrophobic interactions which resulted in the aggregation of the 
ORF6a. so the HPLC analysis was performed again using a different fraction of purified 
protein. The elution buffer used was 50 mM Tris-HCl (pH 7.4), 10 mM EOTA, 0.5 mM 
OTT, 0.1 % Triton-X-100 and 0.05% Sarkosyl. The .elution buffer used was the same as 
in the previous HPLC analysis except Triton and Sarkosyl were incorporated to 
. . ' . ' . 
overcome the hydrophobic ·interactions. The analysis revealed a peak corresponding to a 
protein of over IOff kDaa~d ~ smaller peak corresponding to a protein of about 70 kDa 
was also observed (Fig. 27). · The fractions were che<;kedfor activity and as before no 
activity was observed (Table XII). Although the purified protein fraction used for HPLC 
was active, for reasons not known at present the HPLC fractions collected were not. 
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-----··-- j oh.:n1: 1_UV1~280nm 
j oh.:n1: 1_Fra.ctions 
rnAU 
1000 
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0 
joh.n1:1_UV2_254nrn 
joh..n.1:1_Inject 
Figure 25. UV absorbance during the purification process by HPLC. The 
1.0 
O.B 
absorbance at 280nm and 254nm were measured and recorded along with the fraction 
numbers. 
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Table XI. Methylase·assay using the HPLC fractions. 
PROTEIN cpm 
Purified Active methylase 451 
Fraction 5 of HPLC 0 
Fraction 6 of HPLC 0 
Fraction 7 of HPLC 0 
Fraction 8 of HPLC 26 
Purified Inactive methylase 0 
One tenth microgram of the purified methylase or fraction was used 
· with 5 µg or'the substrate DNA. The purified active methylase was 
given for HPLC analysis. Active methylase refersto the purified 
... " . . .. 
fraction obtained from the soluble fraction that was given for the 
·.··. . . . ' '. : 
HPLC analysis: Inactive methyl~se refers to the protein purified frorri 
. the insoluble faction. 
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M 1 2 3 4 5 6 7 B 9 10 11 12 13 14 15 1B M 
-83 .0 
- .... 
-s2.o 
-47 .6 
-32 .6 
- 26 .0 
-16.6 
-6 .6 
Figure 26. SDS-PAGE analysis of some of the HPLC fractions. Mis the Molecular 
masses (in kDa) . Lane 1, the uninduced sample; 2, the 3 hour induced sample; 3, the 
filtered soluble fraction . Lanes 4-14, the different fractions (#5, 6, 7, 8, 9, 10, 11, 12, 
14, 15, and 17) collected during HPLC; lane 15, the methylase that was given for HPLC 
and lane 16, the purified but inactive methylase. Arrow points the methylase. 
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ml 
Figure 27. UV absorbance of the HPLC fractions collected using an elution buffer 
containing 0.1 % Triton·and 0.05% Sarkosyl. DV absorbance at 280nm and 254nm 
were measured and recorded. The graph also shows the fractions numbers and the 
arrow points to the rtew peak that was observed. At 280nm, for reasons not known at 
present a significant level of noise was observed. 
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Table XII. Methylase assay using the HPLC fractions collected using the buffer 
with 0.1 % Triton·and 0.05% Sarkosyl. 
PROTEIN cpm· 
.· 
Purified.Active methylase 1434 
Fraction 5 of HPLC 0 
Fraction 6 of HPLC 0 
Fraction 7 of HPLC 0 
Fraction 8 of HPLC 0 
Fraction 9 of HPLC 0 
Purified Inactive methylase 0 
Two tenths microgram of the purified methylase or fraction was used 
with 5 µg ofthe substrate DNA. The active methylase purifed from the 
soluble fraction used was given for HPLC analysis. The inactive 
methylase was obtained from the insoluble fraction. 
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Site of Methylation 
.Using one of the pudfied fractions that was active, pBR322 was methylated in 
vitro using non-radioactive s:.adenosyl methionine. After overnight incubation at 37°C, 
the plasmid was cleaned and digested with several different restriction endonucleases 
(Fig. 28). BstNI is an isoschizomer ofEcoRII but it restricts DNA irrespective of the 
methylation pattern. Comparison of the BstNI and EcoRII digests revealed that the 
EcoRII sites were protected by methylation. As evident, Haelllsites and the Sau3AI 
sites present in pBR322 were also protected by the methylation. Thus, the methylase 
methylates the cytosines in the EcoRII sites, the ,Hae III sites and the Sau3 AI sites. 
Analysis of the restriction digestion suggests that the inner cytosine in the EcoRII site 
(CCWGG) is methylated. Identification of the target cytosine in the other target 
sequences awaits further study. 
In vivo Mutagenesis of ORF6 
The E.coli plasmid, pVA891 carrying a streptococcal erythromycin resistance· 
determinant that is expressed in pneumococcf when the plasmid is inserted into the 
chromosome, was .used as a marker DNA segment fqr insertion mutagenesis. The 
strategy used for the site-specific mutagenesis of ORF6 is outlined in Fig. 29 and is 
similar to the one previously reported (97). Briefly, pSJ107 was linearized at the unique 
Kpnl site within ORF6, treated with the Kienow fragment to make the ends blunt ended 
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Figure 28. Agarose gel picture of the restriction digest of methylated pBR322. The 
lane marked (M) contains the 1 kb ladder and the sizes are in kilobases. pBR322 was 
methylated in vitro and subjected to restriction digestion with BstNI, EcoRII, Hae III, 
Mbol and Sau3AI (lanes 8-12 respectively). Unmethylated pBR322 was digested with 
the same enzymes (lanes 2-6 respectively) as a control. Lanes 1 and 7, contain uncut, 
unmethylated and methylated pBR322 DNA respectively. 
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A - Clone the 3.27 kb EcoRlfragment of the transposon into pLS1 
Eco RI KpnI b 
pSJ107 
Pstl Pstl 
B _ Insert the drug resistance marker into the Kpnlsite of the passenger 
DNA. 
Emr 
-----. · . (KpnI/NruI) 
EcoRI (KpnI/NruI) coRI 
b 
pSJ107 
Pstl Pstl 
C - Linearize the vector atthe Pstl, and use it to transform SP1000 (Tn5252) 
Em 
r 
· (KpnUl'l/ruI) 
Pstl b EcoRI stl 
donor DNA 
Tn5252 in the 
chromosome 
D - The resulting insertion mutant (Tn5252 ::Emr) 
Eco RI, (KpnI/NruI) 
::::::iz.:a,zAzzzzqzz.1z) . 
E r (KpnI/Nrul) EcoRI 
m _c . . I zzzzzhn m::= 
a b 
Figure 29 •. Strategy used for insertion m11tagenesis of ORF6. 
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and ligated to p V A891 linearized with Nrul. Cleaving the pLS 1 portion in pSJ107 
following digestion with Pstl linearized the ligated molecules. The digested DNA was 
introduced by transformation into competent SPIOOO cells carrying Tn5252. In this 
homology-dependent recombination event, the heterologous p V A891 was expected to 
be inserted due to the flanking homology provided by the ORF6 DNA Chromosomal 
DNA from one of the Emf transformants, SP1262, was used in transformation 
experiments. 
Pneumococcal Transformation to check for the Em insertion 
To check if the pVA891 inserted intothe transposon, the chromosomal DNA 
from SP1262 was used as donor in filter-mating experiments. The control 
pneumococcalchromosomal DNAs used in this experiment were DP1617 and SP1255. 
The recipients used were Rx.I (the wild-type S. pneumoniae) and DP1322 
(pneumococcus carrying the parent element, Tn5253). Before transformation, a sample 
of each DNA was sheared using a 21112 gauge needle. Both of the recipients were 
transformed with each orie of the sheared, as well as; the unsheared DNAs. The cells 
were then plated by the overlay.method and transformants were selected either with 
streptomycin or with erythromycin. The results of the experiment are presented in Table 
XIII. If the insertion had taken place in the transposon, the frequency of Emf 
transformants ofDP1322 would be greater than that ofRxl as Emf transformants would 
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Table XID •. Transformation of Rxl and DP1322 tQ check if the Em insertion is in • 
· the transposon. 
.. 
Rxl DP1322 
DONOR DNA MARKER· TRANSFORMANTS TRANSFORMANTS 
/ml /ml 
· UNSHEARED str 52000 42000 
DP1617 Em 0 0 
SHEARED str 62000 · 49000 
Em 0 0 
UN SHEARED str .. 94000 53000 
. SP1255 Em 0 · 1260 . 
SHEARED str 79000 24900 
Em 10 360 
UN SHEARED str 19100 18500 
SP1262 Em 0 1150 
SHEARED str 10600 11800 
· Em 10 620 
,· 
·' 
1 µg /ml of each DNA was used to transform 'competent Rxl and DP1322 cells. 
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arise due to flanking homology provided by the transposon DNA. This· high frequency 
of transformation ofDP1322 was expected to decrease due to shearing of the donor 
DNA, as shearing decreases the flanking homology (because of the decrese in the size of 
the DNA). DP1617 was not expected to give rise to any Emr transformants, as there is 
no erthromycin gene in its DNA. From the results, it is evident that the number of Emr 
transformants ofDP1322 was atleast three orders of magnitude gr~aterthan the number 
obtained in Rxl. This confirmed that the insertion of pVA891 had taken place in the 
transposon. 
Southern Hybridization 
To check if the intended mutation had take pl~ce, the chromosomal DNA of 
SP 1262 was digested with Eco RI and HindIII, separated by electrophoresis on an 
agarnse gel, and transferred to nylon membrane. Chromosomal DNAs from Rxl and 
SPlOOO, digested with the same enzymes served as controls. The samples were probed 
with radiolabled pSJl07 DNA. The membrane was washed and exposed to X-ray film. 
Fig. 30 shows the restriction maps of the 3.27 kbEcoRI fragment with pVA891 inserted 
into the unique KpnI site in ~ither one of the two possible orientations. The 
autoradiogram is shown in Fig. 31. As expected, the probe reacted with a 2.1kb (target 
region) and a 3.27 kb (right junction fragment) EcoRI fragment ofRxl and SPlOOO 
DNAs, respectively. Depending on the orientation of the insertion ofpVA891 within 
ORF6, the probe was expected to hybridize either with 6.43 and 2. 75 kb or with 5.13 kb 
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Figure 30. Restriction map of SPl262, the Emr insertion mutant. The two possible 
orientations of the p V A891 in the Kpnl site of ORF6 are shown. T~e Eco RI fragments 
~ . 
that would be obtained frolll the DNA represented by the upper figure would be 5.13 
and 4.05 kb, the sizes fromthelower one:would be 2.75 and 6.43 kb. Crosshatched . 
segment represents the3.27 kb EcoRifragment of interest Solid box indicates pVA891, · 
. . . . . 
the heterologous DNA used for insertion. Relevant restriction sites are shown. 
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,------,~---. 
y a ~ ~ f • W 
. .. -
Figure 31. Autoradiogram showing the insertion of heterologous DNA within the 
ORF6. Chromosomal DNA from an Emr transformant, SP1262, was isolated, digested 
with EcoRI or Hindlll , elctrophoresed on a 0.8% agarose gel, blotted to a nylon 
membrane, and probed with radioactively labeled pSJl 07. I, EcoRI digests; II, Hindlll 
digests; Lanes A and D, DNA from Rxl ; Band E, DNA from SPlOOO (Rxl::Tn5252); 
C and F, DNA from SP1262. and M, molecular weight markers. Nominal molecular 
masses are indicated. 
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and 4.05 kb EcoRI fragments.from SP1262. As evident from the gel, the probe reacted 
with DNA fragments of the latter size indicating the orientation (see Fig.30). Also, the 
. . 
hybridization of pSJ107 with 9 .15 and 2.13 kb Hindi.II fragments (laneF) confirmed the 
orientation as .well as the integrity of the.inserted pVA891. 
' ... , .. 
Transformation ofDP1002 
In order to check the effect of the presence of multiple copies of the methylase in 
the recipient during conjugal transfer, a pneumococcal strain carying pSJ107 had to be 
created. Competent DPl 002 ceHs were ttansfor-med with pSJI 07 as described 
previously. The overlay method was used to select the transformants and the selection 
used was tetracycline (plasmid marker). The plasmid was isolated from one of the Tcr 
. . 
nov transformant and subjected tb restriction enzyme digestion, to make sure that the 
plasmid was intact. 
Conjugal Tran sf er Properties of the Insertion Mutant 
To determine the .role ofORF6 in the conjugal transfer of Tn5252, SP1262 was 
used as a donor in fiiter-mating experiments. SP1254 carrying pVA891 inserted at a 
locus within the element that does not impairits transfer functions and provided the 
control (97). The filter.;matings were performed as described previously (7). After 
mating, the transconjugants were selected on CAT agar containing the recipient marker 
(novobiocin in the case ofDP1002) and donor marker (erythromycin). The Ert{ 
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tra~sconjugants were screened for the unselected markers, chloramphenicol (transposon 
marker), and streptomycin ( chromosomal marker of donor strains). Concentrations of 
the selective drug used are listed in Table III. The transfer property of the ORF6-
insertion mutant in the presence of multiple copies of the methyltransferase in the 
recipient is listed in.Table XIV. Only a two-to-three-fold reduction in the transfer 
frequency ofTrt5252 from SP1262 was observed, as compared to SP1254. The. · 
presence of multiple copies of the methylase (pS1107) in the recipient also decreased the 
transfer frequency by about two-fold. Thus, the insertion mutation in ORF6 does not 
affect the conjugal transfer of the transposon. 
Construction of pSJ119 
In order to create a deletion mutation in ORF6, pSJl 07 was digested with Xbal, 
as there were two sites in the passenger DNA and none on the vector (pLS 1) portion. 
The large fragment (5.88 kb) was electroeluted, self ligated, and used to transform XL-1 
Blue MRA. The plasmid was isolated from a Tcr transformant and was subjected 
to restriction digestion to confirm the loss of the 1.8-kb Xbal fragment. The recombinant 
plasmid obtained was designated pSJl 19. This mutation was expected to delete the 
amino-terminus of0RF6 and ORF41. · 
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Table XIV. Transfer property of SP1262 in the presence of multiple copies. of the 
methylase in the recipient. 
DONOR RECIPENT PLASMID IN FREQUENCY 
RECIPIENT (transconjugants/donor x 106) 
DP1002 None 598 ± 49 
SP1254 ·. 
' ' 
SP1322 pSJ107 232 ± 15 
DP1002 None 175 ±13 
SP1262 
SP1322 pSJ107 71± 8 
The results are from 2 independent experiments representing the range. SP1254 
carries Tn5252 with pVA891 inserted at a locus that is not involved in transfer and 
is str. SP1262 is Tn5252 with pVA891 inserted within the ORF6 and is str. 
SP1322 is DP1002 containing pSJ107. DP1002 is nov, S. pneumoniae. 
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Construction of SP1273 
For reasons not known at present,. the presence. of novobiocin resistance in the 
recipient during conjugation seemed to interfere with ihe conjugal transfer process. To 
avoid this problem, all the donor markers vvere changed from streptomycin to novobiocin 
by conjugation, Mer the filter-mating, one true transconjugant (nov, Crr{, Em\ str8) 
from SP1254 x DP1002 as well as SP1262 x DP1002 matings was chosen and these 
were designated SP1265 and SP1273. Further .conjugations were done with these strains 
as donors and DP1004 (str) as recipient.. 
Transformation of SP1273 
To check.the effect of the presence of pSJ107 or its derivatives in the donor cells, 
SP1273 was made competent using competent Rxl supernatant fluid and transformed 
with j)LS 1, pSJ107, pSJl 17 or pSJ119 as described previously. The transformants were 
selected with tetracycline and the presence of unselected markers (novobiocin, 
·: ' ,; ... ·\ '' '.· ·. ... : ' 
chloramphenicol; and erythromycin) was checked by replica plating. One transformant 
from each transformation experiment was chosen for further study. The plasmid DNA 
was isolated from each of the selected transformant to check for the presence and 
integrity ·of the plasmid. These'strains were designated SP1296 (SP1273 ::pLSl), 
SP1297 (SP1273::pSJ107), SP1298 (SP1273::pSJ117), and SP1299 (SP1273:.:pSJ119) 
and were stored for future use. 
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Conjugation of the methylase insertion mutant with S. pneumoniae 
To check if the insertion mutation in the methylase (ORF6) affected the transfer 
· of the transposon, the above mentioned strains were used as donors in .conjugation 
experiments with DP 1004 as the recipient. After mating, the transconjugants were 
selected on CAT agar containing.streptomycin and erythromycin. The Emr 
transconjugants were then replica-plated for unselected markers (transposon marker and 
donor marker). The results are shown in Table XV. Comparison of the frequency of 
transfer of SP1265 and SP1273 indicated that the transfer of the transposon was not 
affected by the ORF6 insertion mutation, although it is reduced by about two-fold. 
However,·the presence of pLSl in the donor reduces the transfer frequency by about 
four-to six-fold. 
Conjugal transfer of the methylase insertion mutant transposon to S. pyogenes 
To check if the transfer of the transposon to a heterologous host is affected by 
the insertion mutation in the methylase gene, conjugation experiments were carried out 
with the S. pyogenes as recipient. The donor strains were created by transforming 
SP1262 with pLSl to generate SP1292, pSJ1Q7 to generate SP1293, pSJ117 to. 
generate SP1294, andpSJl 19 to generate SP1295. These newly created strains were 
checked for the presence of all the markers and the plasmids from each one was isolated 
to checkfortheir integrity. These strains were used as donors in the filter-mating 
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Table XV. Effect of methylase mutation on the conjugal transfer of the transposon 
to S. pneumoniae, 
DONOR PLASMID IN RECIPIENT TRANSCONJUGANTS 
DONOR /DONORx 107 
SP1265 None· DP1004 200 ± 14 
SP1273 None DP1004 140 ± 12 
SP1296 pLS1 DP1004 30 ± 5 
SP1297 pSJ107 DP1004 36 ±6 
SP1298 pSJl17 DP1004 53 ±7 
SP1299 pSJl 19 DP1004 60 ± 8 
The results are from two independent experiments representing the range.· SP1265 
carries Tn5252 with pVA891 inserted at a locus that is not involved in transfer and is 
nov. SP1273 is Tn5252 with pVA891 inserted within the ORF6 and is nov. SP1296, 
SP1297, SP1298, and SP1299 are the same as SP1273 but carry pLS1, pSJ107, pSJl 17 
or pSJl 19 respectively. 
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experiments. After mating, the transconjugants were selected on CATagar plates 
containing optochin (recipient marker) and erythromycin (donor marker). The results 
obtained are listed in Table XVI. As in the case of pneumococcal recipients, the transfer 
of the transposon from the methylase mutant is reduced two-fold compared to that of 
SP1254. The presence of pLSl or its derivatives in the SP1262 donors were not found 
. ,·· 
to abolish the transfer frequency of the. element to pne,umoc~ccal recipients. However, 
for reasons that are not clear at present, the presence of pLS 1 or any one of the 
' . ' 
recombinant plasmids in the donor dramatically reduces the transfer of thetransposon to 
S.pyogenes. 
Conjugal Transfer of the methylase insertion mutant Tn5252 to 
·. S. pneumoniae (DpnIY) 
Guild, et al. (64) reported-that the transfer of the transposon (Tn5252) to a 
pneumococcal strain that is proficient in.Dpnll restriction modification system was not 
affected whereas simultaneous transfer ofthe conjugative plasmid, pIP501, from the 
same donor was inhibited by at le~sta 1000 fold. To check if the. methylase present in 
. . . . 
the transposon played any rol~ in protecting the transposon during conjugation, the 
insertion'.mutant created was used as donor in :filter Il).ating experiments. The results, 
listed- in Table XVII, indicated that the tra~s:fer was not affected by the insertion 
mutation or by the presence ofpLSl. However, the presence of multiple copies of the 
3.27 kb fragment reduces the transfer frequency by 2-3 fold compared to SP1265. 
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Table XVI. Effect of the methylase insertion mutation on the conjugal transfer of 
the transposon to S. pyogenes. 
DONOR PLA~MIDIN RECIPIENT TRANSCONJUGANTS 
DONOR /DONORx 108 
SP1254 None · S. pyogenes 500 ±22 
,, 
SP1262 None. 
.. 
S.pyogenes 270 ±16 
. SP1292 pLSl- s .. .pyogenes <l 
SP1293 '· pSJ107 S.pyogenes <l 
SP1294 pSJ117 S.pyogenes <l 
SP1295 pSJl 19 S.pyogenes <l 
The results are from two independent·experimentsrepresenting the range.··· SP1254 
carries Tn5252 with pVA891 inserted at a locus that is not involved in transfer and is 
. str. SP1262 is Tn5252 with pVA891 inserted within the ORF6 and is str. SP1292, 
: . . 
SP1293, SPl294~ and SP1295 are the same as SP1262 but carry .. pLSl, pSJ107, pSJ117 
or pSJ119 respectively. The recipient used was S. pyogenes ATCC 19615. 
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Table XVII •. Conjugal transfer properties of the methylase insertion mutant to 
S. pneumoniae DpnIT" host. 
DONOR J.>LASMID IN RECIPIENT TRANSCONJUGANTS 
: DONOR /DONOR X 108 . ' 
SP1265 None DP3111 170 ± 13 
. ' 
SP1273. None DP3111 ·210 ± 14 
SP129.6 pLS1 DP3111 
.. 
, 300 ± 17 
SP1297 pSJ107 DP3111 54±7 
The results are from two independent experiments representing the range. SP1265 
carries Tn.5252 with pVA891 inserted at a locus that is not involved in transfer and is 
nov. SP1273 is Tn5252 with pVA891 inserted within the ORF6 and is nov. SP1292 
. and SP1293 are the same as SP1273 but carry pLS1 and pSJ107 respectively. The 
· recipient (DP31 l 1) used was S. pneumoniae that is Dpnlt and stl. 
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Construction of pSJ144 
In orderto generate aplasmid witha deletion in ORF6, pSJl 19 was digested 
with XbaI and ligated to XbaI digested p V A89 l to generate pSJ144. This plasmid was 
established in E. coli C600 host cells and the restriction map was confirmed by digesting 
with various restriction enzymes. The establishment of pSJ144 without any deletion in 
C600 itself indicated that the methylase was not functional. 
In vivo deletion mutation of the methylase to generate SP1213 
As evident from Table V, the insertion mutation (in pSJ117) of the methylase 
showed an elevated methylase activity. This indicated that thetruncated methylase was 
still active. To mutate the methylase, an alternate strategy (shown in Fig. 32) was used. 
pSJ144 was linearized by cleaving the pLS 1. portion of pSJl 19 with Pstl. The digested 
DNA was introduced by transformation into competent SPIOOO cells. In this homology 
dependent recombination event, p V A89 l was expected to be inserted due to flanking 
homology provided by the 3.27-kb DNA Transformants obtained were replica-plated 
for unselected markers .as before and seven true transformants were chosen for further 
study. The chromosomal DNA from these seven transformants were prepared and used 
as donors in transformation experiments with Rxl and DP1322 cells as recipients. Table 
XVIII shows the results obtained from this experiment and it is evident that the insertion 
had taken place in the transposon in at least in five of the six clones chosen. 
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A - Clone the 3.27 kb EcoRl fragement of the transposon into pLS1 
EcoRl XbaI Xbal b EcoRI C=:J Pstl · Pstl 
B - Delete the Xbalfragment and Insert a drug resistance marker at that 
site. 
C - Linearize the vector atthe Pstl, and use it to transform SPIOOO (Tn5252) 
a b 
donor DNA 
Tn5252 in the 
chromosome 
D - The resulting insertion/deletion mutant (Tn5252 ::EnVKa1{) 
Eco RI Xbal Emr/ Kanr Xbal Eco RI 
=:2'2 ,az22zzz2222J I uzw:kzJ rzc: 
a b 
Figure 32. Deletion mutagenesis strategy used to mutate ORF6. The insertion 
marker was either Emr (pVA891) or Kanr (the cassette from pSJl 70). 
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Table XVIII. Transformation experiment to check if the Em insertion is in the 
transposon. 
Rxl DP1322 
DONOR DNA MARKER TRANS FORMANTS TRANSFORMANTS 
/ml /ml 
str 135000 19200 
DP1617 Em 0 0 
str 88000 20500 
SP1262 Em 10 280 
str 250000 27000 
SPlOOO ~al#l Em 10 700 
str 4900 7100 
SPlOOO ~al #2 Em 0 40 
str 80000 6800 
SPlOOO ~al #3 Em 0 1950 
str 102000 5050 
SPlOOO Mbal #4 Em 10 285 
str .19600 3950 
· SPlOOO ~al #5 Em 0 50 
str 7200 2400 
SPlOOO ~al #6 Em 0 10 
One microgram/milliliter of each DNA was used to transform competent Rxl and 
DP1322 cells. 
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One of these strains was design~ted SP1213 and stored for :future use. 
Construction of pSJ126 
For all the insertion and deletion mutagenesis experiment in the transposon 
. . 
Tn5252, pVA891 expressing the erythromycin resistance has been the only reporter used 
so far. The major limitation to its use as a reporter has been the non-availability of 
compatible restriction sites in the plasmid. To overcome this problem and to generate a 
new antibiotic resistance cassette, pSJ126 was generated. As shown in the Fig. 33, 
' . . . 
pDL276 (53}, a streptococcal-£. coli shuttle plasmid carrying a kanamycin-resistance 
gene was digested with BssIDI and Aval. Also, pRL425 (56) another vector plasmid 
carrying ampicillin, erythromycirt and chloramphenicol resisbmce genes, was digested 
with HindIII. The two digests were mixed and treated with the Kienow fragment of 
E. coli. After cleaning the DNA, they were ligated and used to transform E. coli 
JMl 09 cells. Kanr..; Ampr transformants were selected and replica-plated to check for the 
absence of the unselected markers, Cm and Em. One of the transformants was 
designated pSJ126. In pSH26, eight identical restricti'on sitesflankthe aphA(KanJ. 
Thus, the aphA can be released by digesting with any one these 8 enzymes. 
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Pstl 
Sall/Hincll 
Xbal 
Hamm 
Kpnl 
Sstl 
Figure 33. Construction of pSJ126 using pRL425 vedor and Kan': from pDL276. 
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Construction of pSJ150 
Insertional inactivation of the gene of interest in the transposon using the 
kanamycin cassette from pSJ126 was not Satisfactory, as the concentration ofkanamycin 
needed was only slightly higher than the minimum inhibitory concentration to 
pneumococcus. The reason for this was that the aphA obtained from pDL276 was 
originally from pJHl (53), astrept~coccal plasmid, that was found in E. fecalis. 
Therefore, when introduced as a single copy, the resistance provided to the host was not 
high. This problem was overcome by using th.e aphA from the conjugative transposon 
Tnl 545; It has been shown by others (28) that the aphA from pJHl and TnJ 545 are 
identical except for some changes in the promoter region. So using the aphA from 
. '. . . . ' 
Tn1545, another plasmid was constructed. The source of the aphA ofTn1545 was from 
the pAT21-1.(28). The vector used for this plasmid construction (shown in Fig. 34) was 
pDG792 (62). pDG792 has the kanamycin gene from pJHl flanked by 4 unique 
restriction sites on one side and 16 unique restriction sites on the other side. pDG792 
was. digested with ClaI to r~lease the aphA ofpJHl and a L6-kb ClaI fragment of 
. ., . 
pAT21-1 containing the aphA ofTnJ 545 was ligated and used to transform JM109. 
After transformation, the transformants were selected in LB agar containing 25 µg/ml of 
kariamycin. When pr~sent in muitiple copies the aphA 'of Tn15 45 provided the E. coli 
with only a low level of kanamycin resistance whereas, the aphA of pJHl provided the 
host with high level resistance (50-70 µg/ml of kanamycin). The recombinant plasmid 
generated was designated pSJl 50 and, in this plasmid, 4 unique restriction sites flank 
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pDG792 
(4.175 Kb) 
BamHI 
Nsil 
pSJlSO 
(4.286 Kb) 
Cla I Cla I 
I 1.6Kb \ 
aph A-3 ofpAT21-1 
Nru I 
Figure 34. Construction of pSJ150,- using pDG792 vector and Kanr from pAT21-1. 
171 
the aphAon one side and 16 unique restriction sites on the other side flank the aphA of 
Tnl545. As only one restriction enzyme (Clal) site is present on both sides of the aphA, 
it cannot be released as a cassette by digestion with other enzymes. 
Construction of pSJl 70 
For ease in getting the Tnl 545 aphA as a cassette for the purpose of insertional 
inactivation, pSJ170 was constructed using pSJ126 and pSJ150. Construction of 
pSJl 70 is shown in Fig. 3 5. Briefly pSJ126 was digested with Hincll to release the 
kanamycin (from pJHl) and a· 1. 6-kb Nrull Smal fragment of pSJl 50 was ligated. 
E. coli JMl 09 cells were transformed and the recombinant plasmid obtained was 
designated pSil 70. In pSJl 70, ten restri_ction sites flank the aphA on one side and 9 on 
the other, of this 6 sites are present on both sides that can be used to release the aphA as · 
a cassette. 
Construction of pSJl 72 
To create a methylase-deletion-mutant strain carrying Kan\ pSJl 19 was 
linearized with X'bal and ligated td a 1.6 kb X'bal fragment of pSJ170. The recombinant 
plasmid, designated pSJ172 was checked with various restriction enzymes to determine 
the orientation of the Kanr insert. 
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(HindIII /BssHII) 
SphI 
PstI 
SalI/HincII 
XbaI 
BamHI 
KpnI 
SstI 
Eco RI--
Nco I 
Asp 718 
(HincIII Xb I 
Sma I) BamH~ -
KpnI-
SstI 
Hine II 
pSJ126 
(3.9 kb) 
pSJ170 
(4.3 kb) 
(HindIII/AvaI) 
SphI 
pSJ150 
(4.286 Kb) 
PstI 
Sall/Hine II 
XbaI 
Bamm 
KpnI 
SstI 
(HincII/NruI) 
Figure 35. Construction of pSJl 70, using pSJ150 and pSJ126. 
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Construction of in vivo deletion mutant (SP1214) 
pSJ172 was linearized at the Pstl site, present in the pLSl portion of pSJl 19, 
and used as donor in transformation experiments with SP 1000 as recipient. The strategy 
is as shown in Fig.· 32. Kanr transformants were checked for the unselected markers and . 
one such transformant, designated SP1214 was used for further study. The restriction 
map of the mutant is shown in Fig. 36 .. This strain was constructed with the aim to study 
the transfer of the methylase mutant transposon an~ the conjugative plasmid, pIPSO 1 
(Cm\ EmJ, from the donor cell to different recipient cells. 
Transformation to check if the insertion is in the transposon 
Chromosomal DNA from SP1214 was isolated. A asample of the DNA was 
·sheared using a 21112 gauge needle along with the control chromosomal DNAs. 
Competent Rxl cells and DP1322 cells were transformed with the sheared and 
unsheared donor DNA prepared. Transformants were selected on streptomycin · 
(chromosomal· market). and kanamyciri (insertion marker) containing agarplates. The 
results listed in Table XIX indicated that the insertion·ofkanr was in the transposon as 
DP1322 transforms better th~m Rxl for kanr. DP1402, that was used as a control in the 
transformation experiments ca~ries the kanamycin resistance gene in a conjugative 
transposon,. the BM4200 element, which does not have any homology to Tn5252. So no 
Kanr transformants were expected to be observed while using this DNA as the donor. 
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Figure 36. Restriction map of SP1213 and SP1214. In the case ofSP1213, pVA891 
was inserted after deleting the Xbal fragment and in the case of SP 1214, Kanr cassette 
from pSJl 70 was introduced after deleting the Xbal fragment. Crosshatched box 
indicates the region of interest and solid box indicates the inserted marker DNA. 
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Table XIX. Transformation to show that the insertion in SP1214 is in the 
transposon. 
Rxl DP1322 
DONOR DNA MARKER TRANSFORMANTS TRANS FORMANTS 
/ml /ml 
UN SHEARED str 1250000 250000 
DP1617 . Kan 0 0 
SHEARED str 1300000 230000 
Kan 0 0 
UN SHEARED str 38000 30000 
SP1214 Kan 0 2940 
SHEARED str 48000 13000 
Kan 0 1390 
UN SHEARED str 70000 8000 
DP1402 Kan 0 0 
SHEARED str 31000 5000 
Kan 0 0 
One microgram/milliliter of the Donor DNAwas used totransform competent Rxl 
and DP1322 cells. 
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Southern Hybridization to check the insertion 
Chromosomal DNA from SP1214, SP1213, SP1262, Rxl and SPIOOO were 
Prepared and digested \Vith Eco RI anct run a o'. 8% agarnse gel. The DNAwas then 
transferred to nylon membrane and probed with radiolabled pSJI 07. As evident from the 
autoradiogram, shown i~ Fig: 37, the probe hybridized to a2. l kb fragment in the case 
ofRxl (target site) and a 3.27-kb fragment of SPIOOO (right juncdon fragment), as 
expected. The probe also hybridized to a 5.2 kb and·a 3.95 kb fragment in case of 
SP1262 (pVA891 insertion in the Kpnl site). !twas expected to hybridize to a 3.1 kb 
fragment in case of SP1i14 as the L8 kb Xbal fragment is replaced by the 1.6 kb kanr . 
. In the case ofSP1213 the probe was expected to hybridize to a 5.0 kb and 2.4 kb . 
fragment, as pVA891, which has an internal EcoRl site, replaces the 1.8 kb Xbal 
fragment. Apart from the presence of these two fragments, an unexpected third band 
corresponding to a size of 1.1-kb was also seen. The origin of this band is not clear at 
present. 
Creation of SP1206 and SP1207 
As. me11tioned .. earlier, presence of novobiocin resistance·in the recipient during 
conjugation seems to interfere with the conjugal transfer process. So the chromosomal 
DNA from the deletion mutants SP121J and SP1214 (Fig. 36) were used to transform 
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7.67 -
6.62 -
4.40-
3.27 -
M 12 3 456 
Figure 37. Autoradiogram showing the deletion mutation in SP1213 and SP1214. 
Chromosomal DNA from Rxl , SPlOOO, SP1262, SP1213 and SP1214 were isolated, 
digested with EcoRI, run on a 0.8% agarose gel, blotted to a nylon membrane, and 
probed with radioactively labeled pSJ107. Lane 1, DNA from Rxl ; 2, DNA from 
SPlOOO (Rxl ::Tn5252); 3, DNA from SP1262; 4, DNA from SP1213 ; 5 and 6 DNA 
from SP1214 and M, molecular weight markers. Nominal molecular masses are 
indicated. 
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competent SP1264 (Tn5252, nov). The transformants obtained were checked for the 
presence of appropriate markers. One true transformant designated SP1206 (nm!, Cm\ 
Em\ str8) and SP1207 (nov, Cm\ Kan\ str8) froITI each transformation was stored for 
future use in filter-mating experiments. 
Conjugation of the methylase deletion mutants with S. pneumoniae DP1004 
(DpnII) and DP31ll (Dpnlt') 
The deletion mutants created were used as donors in filter-mating experiments 
with pneumococcus as the recipient. To check if the transfer was affected by the 
presence of Dpnll restriction-modification system, DP3111 was chosen as one of the 
recipients. DP1Q04, which is devoid of any known restriction-modification system, was 
chosen as the control recipient. The results of the mating, presented in Table XX, shows 
that the deletion mutation decreases the transfer frequency by one-to-two orders of 
magnitude. Interestingly, the transfer frequency·of SP1207 in the case ofDP1004 
recipient is reduced by about one order of magnitude, whereas in the case ofDP3111, it 
is reduced by two orders of magnitude. This reduction in the transfer frequency could 
be due the restriction of the transferring DNA as it is not methylated in the donor prior 
to transfer. 
179 
Table XX. Conjugal transfer frequencies of the deletion mutant to Dpnit'" and 
Dpnlf hosts. 
DONOR· RECIPIENT TRANSCONJUGANTS 
/DONORx 108 
SP1273 · DP3111 645 ± 25 
SP1206 DPJlll <2 
SP1207 DP3111 2 ± 1.4 
SP1273 DP1004 119 ± 11 
SP1206 DP1004 <2 
SP1207 DP1004 4±2 
The results are from 2 independent experiments representing the range. SP1273 carries 
Tn5252 with pVA891 inserted within the ORF6 and is novr. SP1206 carries Tn5252 
with the Xbal deletion and the marker DNA inserted at this site is p V A891; 
SP1207carries Tn5252 with the Xbal deletion and the marker DNA inserted at this site is ·. 
the kanr cassette and is novr. The recipients used were strr S. pneumoniae that were 
Dpnli+ (DP3111) andDpnir (DP1004). 
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Construction of SP1208 
To check the transfer properties of the methylase deletion mutant transposon and 
pIPSOl (a conjugative plasmid fromE.fecalis) simultaneously, the strain containing both 
the genetic elements had to be constructed. As the copy number ofpIPSOl is too low 
· and isolation .ofthe plasmid is difficult, i' was conjugally transferred from a donor to the 
- -
methylase mutant transposon containing cell. SP1207 was used as the recipient 
and DP3218 was used as the donor. Thetransconjug~nts were seleyted, by the overlay 
technique, with novobiqcin (recipient marke~) and erythromycin {plasmid marker). The 
transfer frequency wa:s expected to be ve~ high (i 0-3 to 10"4); instead the frequency was 
. . . . . } 
. . . ' 
very low:. This low transfer could be due to the presence of 11ov-marker in the recipient. -
However, transconjugants obtained were checked for the .unselected markers,· Cmt 
(transposon, plasmid markers), Kanr (methylase mutation) and Str' (donor marker)._ One 
true transconjugant (Kan\ Cm\ Em\ Nov, Str') was designated SP1208 and used for_ 
future studies. 
_ Construction-of SP1209, SP1210, SP1211, and SP1212 
To check for complementation of the methylase deletion: mutant~ and also to 
observe any effect due to the presence of pSJ107 or its derivatives on the transfer of the 
pIPSOl, SP1208 was transformed with pLS1, pSJ107, pSJll 7 and pSJI 19. The 
transformants obtained were checked for the presence of appropriate markers, The 
strains were designated as SP1209 (SP1208 containing pLS1), SP1210 (SP1208 
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containing pSJ107), SP1211 (SP1208 containing pSJ117) and SP1212 (SP1208 
containing pSJl 19) and stored for future use. 
Complementation analysis 
. . 
SP1208 and its d~rivatives, SP1209, SP1210, SP1211 and SP1212 were used as donors 
in filter mating experiments with DP3111 as recipient. The transfer of the transposon 
(methylase-deletion mutarit)andthe transfer ofpIPSOl was checked by selecting the 
transconjugants with Streptomycin (recipient marker) and with either kanamycin (for 
transposon) or with erythromycin (for pIP501 ). The transconjugants obtained were then 
checked for the unselected markers as before. As evident from the results shown in Table 
XXI, in spite of the presence of pSJ107, the transposon was still 4eficient in transfer. 
This inability to complement the deletion mutation could be due to the fact that the 
· deletion in the transposon spans not just the amino terminus of ORF6 but also ORF41 
and the upstream region which was found to have numerous indirect and direct repeats 
(refer Fig. 6). These repeats could be involved in regulation of the expression of the 
. . 
entire oper6n like stru6ture,as-10 and :-35regions were found only for ORF41 ahd not 
. . . 
the others. The Emrtranscqnjugants obtained from SP1211 indicated that the transfer of 
' 
plP501 was complemented to some extent{the normal transfer frequency ofpIP501 to a 
Dpnff is 10x"3 to 10x"4/donor) but the same result was expected from SP1210 donors 
also as it has pSJ107. The lack of complementation was found to be due 
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Table XXI. Complementation analysis of the deletion mutants using DP3111 
(Dpnlr) as the recipient. 
Emr Kanr 
DONOR PLASMID IN TRANSCONJUGANTS TRANSCONJUGANTS 
DONOR /DONORx108 /DONORx 108 
SP1208 pIPSOl 10 ± 3.2 2 ± 1.4 
SP1209 pLSl, pIP501 <5 5 ±2.2 
SP1210 pSJ107,pIP501 <7 <7 
SP1211 pSJ117,plP501 290 ± 17 <7 
SP1212 pSJ119,pIP501 190 ± 14 <4 
The results are from two independent experiments representing the range. SP 1208 is 
L1Xbal Tn5252 with Kanr inserted within the ORF6 and is novr. SP1209 (SP1208 
containing pLSl), SP1210 (SP1208 containing pSJ107), SP1211 (SP1208 containing 
pSJl 17) and SP1212 (SP1208 containing pSJ119) were also used as donors. The 
recipient used was st! S. pneumoniae that was Dpnii+ (DP3 ll 1 ). 
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to the donor itself Analysis of SP 1209; SP 1210 showed that the strains were not Emr 
but Em\ indicting that pIP501 was lost .from the donor prior to or during transfer. 
However, these experiments demonstrate that the methylase deletion mutation of the 
transposon could not be. complemented. 
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CHAPTERV 
DISCUSSION 
Studies directed towards understanding the sudden worldwide emergence of 
multiple-antibiotic-resistant S. pneumoniae led to the identification of a conjugative 
transposon, Tn5253 (176). Preliminary studies showed that Tn5253 was a composite 
transposon consisting ofTn5251 and Tn5252 (7). Tn5252 is the prototype of the larger 
elements and our lab has focused on understanding the biology ofTn5252. The ends of 
this transposon have been shown to be essential for conjugal transfer (97). Work on the 
left end and the middle region of the element have been reported earlier (1, 2, 188, 189). 
The current work was undertaken to analyze the right end ofthetransposon at the 
molecular level. To achieve this, attempts were made to clone the 3 .27 kb right-junction 
fragment in its entirety. The fragment could not be cloned in E. coli but was clonable in 
S. pneumoniae . . ·This indicated that some protein or proteins specified by the transposon 
. DNA were toxic to the E. coli host. The nucleotide sequence of the fragment of interest 
was obtained using subclones and the sequences were manually assembled. Analysis of 
the sequence revealed the presence of four open-reading frames (ORF41, ORF6a, 
ORF6J3, and ORF42), all transcribed in the same orientation. ORF6J3 was localized 
within ORF6a but in an alternate reading frame. 
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In vitro transcription-translation studies revealed the presence of at least two of the four 
expected proteins. The sizes of these two proteins matched those of ORF6a and 
ORF6f3. Genbank search showed that the amino-acid sequences ofORF6a were similar 
to a variety of srnC-cytosine methyltransferases. DNA methyltransferases are a 
universally distributed, diverse group of enzymes and·are a part of the restriction-
modification systems. The restriction,-modification systems have been divided into three 
types, Type!, Type Hand Type III. Some of the properties of these three types are listed 
in Table XXII. Methyltransferases belonging to these three types have been shown to 
play essential roles in a number ofbiological processes including gene regulation, DNA 
mismatch repair, and restriction-modification (131, 143). Type II methylases have three 
major groups and they are srnC-cytosine methylases, 4~-cytosine methylases, and 6~-
adenine methylases. Among the three major groups, there is a remarkable amino acid 
similarity between the srnC-cytosine methylases and a remarkable structural similarity 
between all of the type II methylases (129). The deduced amino acid sequence of 
ORF6a contained all the ten conserved motifs found in prokaryotic Type II methylases 
and the order of the motifs was the same as those of srnC-cytosine methylases. With the 
. . 
data from in vitro methylation experiments, we have demonstrated the methylating 
activity of protein extracts ofthe cells carrying the ORF6a gene. However, the highly 
purified ORF6a fusion protein obtained.from the insoluble fraction of these cells lacked 
methylase activity implying. that the· denaturation and renaturation steps involved in the 
isolation may have led to the loss of the enzymatic activity. On the other hand, it is 
possible that there was a need for as yet unidentified additional factors for methylation 
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Table XXII. Some Properties of the three Types of Restriction-Modification 
systems. 
CO-FACTOR· SITE OF 
TYPE STRUCTURE REQUIREMENTS METHYLATION/ 
·. R M CLEAVAGE 
Enzyme complex 
consisting ENase, ATP, SAM 
I MTase and specificity SAM, (ATP, Remote from the 
determining subunits Mg++ Mg++) Target site 
ENase and MTase Mg++ SAM Within the target or at a 
II are separate enzymes defined location within 20 bp 
on one site of the target 
Enzyme complex ATP, SAM At a defined distance of 
III consisting ofENase SAM, (ATP, 25.;.27 bp from the 3' end of 
and MTase Mg++ Mg++) the target 
ENase refers to the endonuclease and MTase to Methylase. Cofactors shown in 
parentheses indicate that their presence stimulates the methylation (M) reaction. The 
above information was obtained from reference 143, 
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activity by the ORF6a product. It is worth noting nere the unusual structure of the 
DNA cytosine methylases, M.EcoHK.3 l l (122) and M.Aqul (95), which require the 
expression of two polypeptides for enzymatic activity. Interestingly in case of 
M.EcoHK3 l l, one of the polypeptides, the P sub-unit, is encoded within an alternate 
reading frame of the polypeptide a (122). ORF6P is also encoded. within an alternate 
reading frame of ORF6a and it showed a significant sequence similarity of the p sub-unit 
of M.EcoHK3 l l. However in the case ofM.EcoHK3 l l, the a or the p sub-unit alone 
has been shown to be functional. Addition of the a to the p sub-unit has been shown to 
increasethe methylation potential of the enzyme, M. EcoHK3 l l, by about ten fold. In 
the case ofM.EcoHK3 l l, conserved motifIX, absent in the a-subunit was found to be 
present in the p sub-unit. In the case of ORF6P, no conserved sequence motifnormally 
found in the methylase was present. · Also, the region of homology between ORF6P and 
the P sub-unit ofM . EcoHKJl 1 did not span the conserved motif Unlike the a sub-unit 
ofM.EcoHK3 U, the insoluble- fraction-purified ORF6a was not functional. Attempts 
to clone ORF6Pin expression vectors to over-express and purify the protein were 
unsuccessful. So attempts were made to purify the functional methylase from the soluble 
fraction, as the extract9f the soluble fraction was found to be active. The partially-
purified methylase fraction from the soluble fraction using affinity chromatography 
yielded a mixture of several proteins of various molecular masses. Nevertheless,. this 
fraction showed an increase in the specific activity of the methylase. Attempts to further 
purify the methylase from this mixture using HPLC involving size-exclusion 
chromatography were unsuccessful. Analyses of the HPLC data revealed that the 
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proteins were forming aggregates and thus eluting in the first few fractions. However, 
the fractions collected failed to show any methylase activity. The reason for the 
disappearance of methylase activity is not known at present. Having not resolved this, 
the possibility of two· or more proteins interacting with one another to form a functional 
methylase is still an open question .. 
Comparison of the structure of the three classes of type II methylases (the 4nw-
cytosine methylase, 6~-adenine methylase and the smC-cytosine methylase) has 
revealed the presence of nine of the ten conserved motifs in the ORF. The conserved 
.. . . 
motif corresponding to· motifIX of smC-cytosine methylases. is absent in 4~ -cytosine 
methylases and·i~6~-adenine methylases. The a sub ... unit ofMEcoHK311 (a 5mC-. 
cytosine methylase) has been shown to·function in spite of lacking motif IX suggesting 
that ORF6a protein purified from the insoluble fraction should be functional, at least to 
some extent, in the absence of ORF6f3. In addition, the presence of a protein of the size 
expected for ORF6f3 was observed iri the insoluble fraction purified methylase. The 
presence of all ten conserved motifs in ORF6a, the lack of any conserved element in 
ORF6f3 and the lack of any methylase activity in the insoluble fraction purified· methylase 
strongly suggests that ORF6f3 might not be involved in the process. Thus, the loss of 
activity could be due to the denaturation-rena~ration 'process itself 
In any event, :this. is the first DNA smC-cytosine methylase known in 
pneumococci and also the first methylase to be identified in a transposon. The Tn5252 
methylase has been named M.Spn5252I. Analysis of the methylase actiyity of the 
pneumococal host carrying the transposon indicated that the activity is similar to that of 
· a wild-type pneumococcal strain. Also, there are several inverted and direct repeats 
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observed upstream of ORF6 suggesting that the methylas~ might be regulated. Attempts 
to identify the time ofinduction of the methylase during mating using antibodies directed 
against ORF6a·has so far been unsuccessful. This could be due to the fact that the 
' ' ' 
induction of the methylase might be too low to detect as· only very few molecules are 
needed for the·methyla:tion process. The presence of a large.variable region between the 
conserved motif VIII and IX indicated that the methylase might recognize novel target 
sequences for methylation suggesting that M.Spn5252I might be a member of the multi-
specific family of methylases. Based on the invitro methylation.assays protection 
. . . ' . . 
', ' 
against EcoRilrestriction, HaeIIIrestriction andSau3AI restriction was observed. 
Protection of Sau3Alsite is of evolutionary importance as this is the site the DpnII (for 
Diplococccus pneumoniae) restriction system recognizes for restriction. Thus, as in the 
case of bacteriophages of B. S!,lbtilis, Tn5252 has a protective mechanism to overcome 
the host's potential to restrict unmethylated GATC site. M.Spn5252I has also been 
shown to. protect the DNA against restriction by EcoRII and HaeIII. Restriction systems 
directed towards unmethylated EcoRII or HaeIII sites in streptococci are not known at 
present but the presence of a protective me,chanism against these two sites in the 
streptococcal transposon, Tn5252 suggests that this restriction could possiblly be there . 
.. . •. . . , . 
' ' 
Guild, et al. (64)reported that Tn5253, the parental element ofTn5252 (7), was 
not subjected to restriction during transfer by conjugation to' a DpnII+ strain while the 
simultaneous transfer of conjugative plasmid, pIP501, was reduced 104 fold. This 
implies that Tn5253 was in a protected state only during the mating event came from the 
observation that the chromosomal DNA was sensitive to DpnII digestion in vitro. 
M.Spn5252I might be the one responsible for this protection as it has been shown to give 
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protection against Sau3AI, which is an isoschizomer of Dpnll. The ten-fold difference 
in the transfer frequency of the Xbal-deletion mutant, between a Dpnff and a Dpnii+ 
recpient also confirms the protective role of the methylase. To study the role of the 
methylase, an insertion mutantwas created which showed hyperactivity. This increased 
activity might be due to the removal of the specificity domain because of the frame shift 
mutation introduced at the carboxyl end. The deletion mutant constructed here reduced 
the transfer frequency dramatically butthe deletion spans an upstream ORF and the 
regulatory regions also. Complementatio11 analysis revealed that this deletion mutant 
could not be complemented, by the presence of,the 3.27 kb fragment in a plasmid in 
trans. This further supports the idea that the deficiency in transfer is due to loss of the 
regulatory signals. Thus, in this study! have obtained the nucleotide sequence of the 3.5 
kb right junction fragment, demonstrated the presence of a functional· smc cytosine 
methyltransferase, identified some of the target sites for methylation, and showed that 
the methylase is involved in anti-restriction activity. 
Analysis of the methylase to determine if it is made up of two sub-units and the 
role of the methylase in.regulation awaits further study. One way to study this would be 
to purify the methylase from the insoluble fraction as before but instead of eluting the 
protein and then doing the step dialysis to remove the urea, it can be done in the column 
itself This procedure would not give adequate time for the proteins to come together 
and form aggregates like dialysis. If the protein eluted after removing urea in the column 
shows activity then one can conclude that ORF6f3 or any other protein is not needed for 
the methylase activity, as urea would prevent protein interactions. Another interesting 
question that needs to be answered concerns the regulation ofM.Spn5252I during 
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conjugal transfer. Western blots could be done using the lysates obtained by mating a 
donor carrying pSJ107 and Tn5252 with a wild-type pneumococcal recipient. This 
would ease visualization of the methylase as more methylase would be made from the 
plasmid. Regulation of the methylase could also be studied by using lacZ reporter 
constructs. Apart frqm playing a protective role, the methylase might also be responsible 
for regulating, the transfer process of the trans po son as in the case of Tn5 (222} and ISJ O 
(157). This question could be answered only by constructing strains that carry deletion 
. ., . . 
mutations totally within ORF6 and not the flanking regions. 
The definitively demonstrated roles of~NA methylases in X-chromosome 
inactivation, oncogenesis, DNA mismatch r~pair, and protection from restriction show 
the biological importance of this class of enzymes. Further studies should enlarge our 
understanding of the biological roles of these interesting molecules. 
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